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Triple Helix Formation by Oligonucleotide Analogs on Double-Stranded 
DNA 
Chapter 1: Design of Novel Bases for pH-Independent Wecognition of GC 
Base Pairs by Triple Hek  Formation 
The ability to design synthetic molecules that  bind sequence-specifically to 
unique sites on human DNA could have major applications in  the 
treatment of genetic, neoplastic, and viral diseases. One powerful approach 
to sequence-specific binding of double helical DNA is  oligonucleotide- 
directed triple helix formation. Specificity arises from the base triplets 
(TOAT and C+GC) formed by Hoogsteen base pairing of the second 
pyrimidine strand with the purine strand of the double helix. Because 
protonation of the N3 is required for cytosine, triple helix formation a t  G- 
rich sequences is limited to a narrow pH range. The novel base 3-methyl-5- 
amino-7H-pyrazolo(4, 3-d)pyrimidine-7-one (PI) specifically recognizes GC 
base pairs as selectively and strongly as  C + ,  but with greater affinity and 
over an extended pH range. Such selectivities allow binding a t  a 15 base 
pair site in  pDMAGlO DNA (pH 7.8) containing dA5(GA)5 and a t  a 16 base 
pair site in pHN-CAT DNA (pH 7.4, 37°C) containing dA4GA4GsA. 
Abstract 
Part I 
Triple Helix Formation by Oligonucleotide Analogs on Double-Stranded 
DNA 
Chapter 2: Extension of aiple H e k  Formation. Design of Novel Bases for 
Recognition of CG Base Pairs 
Oligonucleotide recognition offers a powerful chemical approach for the 
sequence-specific binding of double-helical DNA. Because pyrimidine 
oligonucleotides limit triple helix formation t o  homopurine tracts 
containing AT and GC base pairs, i t  is desirable to study whether 
oligonucleotides can be designed t o  bind to all four base pairs. A general 
solution would allow targeting of oligonucleotides to any sequence. The 
novel base 3-methyl-5-amino-7H-pyrazolo(4, 3-d)pyrimidine-7-one (PI) and 
cytosine (C) moderately recognize CG base pairs. Such specificities allow 
binding at  an 18 base pair site in SV 40 (pH 7.0, 37OC) DNA containing all 
four base pairs. 
Abstract 
Part I1 
Design of DNA Cleaving Groups 
Chapter 3: Design of New DNA Cleaving F'uctional Groups and Studies of 
Their DNA Cleaving Mechanisms 
The utility of the DNA cleaving molecules is enormous, ranging from the 
creation of synthetic restriction enzymes for use by molecular biologists t o  
the development of chemotherapeutic agents which may be effective against 
a variety of neoplastic diseases. We synthesized three compounds: 12 (P3- 
Ga-His), 19 (P3-Ga-PYML), and 23 (P3-Ga-Phe). Compound 12 shows 
sequence-specific cleavage in the presence of Cu(I1) and dioxygen, while 
compound 19 shows sequence-specific cleavage in the presence of 
dithiothreitol and dioxygen. Interestingly, compound 23  shows strong 
cleavage at  a single site in 167 base pair fragment (EcoRI/RsaI) from 
plasmid pBR322 in  the presence of UV light and P -  
carbonato(trien)cobalt(III)perchlorate complex. The end product analysis of 
the cleaved oligonucleotide shows 5'-phosphate, 3'-phosphate, and an 
unknown 3'-product. 
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The sequence-specific cleavage of double helical DNA by restriction 
endonucleases is essential for many applications in molecular biology, 
including gene isolation, DNA sequencing, and recombinant DNA 
manipulations (1,2). With the advent of pulsed-field gel electrophoresis, the 
separation of large segments of DNA is now possible (3,4). However, the 
recognition sequences of naturally occurring restriction enzymes are in the 
range of 4-8 base pairs, and hence their sequence specificities may be 
inadequate for isolating genes from large chromosomes (108 base pairs in 
size) or mapping genomic DNA. The design of sequence-specific DNA 
cleaving molecules that go beyond the specificities of the natural enzymes 
depends on a detailed understanding of the chemical principles underlying 
two functions: sequence-specific recognition and cleavage of DNA. 
The design of DNA-cleaving molecules is generally based on the 
attachment of a cleaving function to  a DNA-binding molecule. The 
synthetic sequence-specific binding moieties for double helical DNA that 
have been studied are coupled analogs of natural products (5-7), transition 
metal complexes (8), and peptide fragments derived from DNA-binding 
proteins (9). One DNA-cleaving function used in our laboratories is 
EDTA*Fe(II), which cleaves the DNA backbone by oxidation of the 
deoxyribose with a short-lived diffusible hydroxyl radical (10). The fact that 
a hydroxyl radical is a relatively nonspecific cleaving species is useful 
when studying recognition: the cleavage specificity is due t o  the binding 
moiety alone, not the combination of cleavage specificity superimposed on 
binding specificity. The sequence-specific molecule best characterized so 
far, with regard to  the natural product analog approach, is bis(EDTA- 
3 
distamycin)fumaramide, which binds in the minor groove and cleaves at  
sites containing 9 bp of contiguous A, T DNA (11). A synthetic peptide 
containing 52 residues from the DNA-binding domain of Hin protein with 
EDTA at  the amino terminus binds and cleaves at  the 13-bp Hin site (9). 
DNA-cleaving is illustrated in the attachment of EDTAoFe(I1) to 
oligonucleotides (12). 
Triple helix formation. One approach to sequence-specific recognition 
of double helical DNA is the use of an oligodeoxyribonucleotide that can 
bind in the major groove to  a complementary sequence of DNA forming a 
triple-stranded structure. 
The first nucleic acid triplex was described by A. Rich and coworkers 
three decades ago (13). Poly(U) and poly(A) were found to  form a stable 2:l 
complex in the presence of MgC12 (12 mM). After this, several triple- 
stranded structures were discovered (14,15). One case is of particular 
interest: at  pH 6.2 and moderately high salt conditions, 2 poly(C) can form a 
triple helical complex with a single equivalent (with respect to  bases) of 
short guanine ribonucleotides. This complex contains one of the pyrimidine 
strands in the protonated form (16-18). In principle, isomorphous base 
triplets (TOAT and C+GC) can be formed between any homopurine- 
homopyrimidine duplex and a corresponding homopyrimidine strand (19) 
(Figure 1). The DNA duplex poly(dT-dC)*poly(dG-dA) associates with 
poly(U-C) or poly (dT-dC) below pH 6.0 in the presence of MgC12 to form a 
triple-stranded complex (20,21). Several investigators proposed an anti- 
parallel orientation for the two polypyrimidine strands on the basis of an 
anti conformation of the bases (19-21). 
4 
The first X-ray data of triple-stranded fibers (poly(A)*2 poly(U) and 
poly(dA)*2 poly(dT)) supported this hypothesis and provided additional 




Figure 1. (Top) Watson-crick base pairs. (Bottom) Isomorphous base triplets 
T*AT and C+GC. The additional pyrimidine base is bound in the major 
groove by Hoogsteen hydrogen bonds to the purine base in the Watson-Crick 
duplex. Protonation of the Hoogsteen bound cytosine is required. 
tween experimental and calculated diffraction patterns was obtained with 
an A'-RNA-like conformation of the two Watson-Crick base paired strands 
(12-fold helical symmetry, dislocation of axis almost 3A, C3'-endo sugar 
puckering and small base-tilts providing a large and deep major groove 
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that accomodates the additional strand). The third strand has a similar 
backbone conformation (C3'-endo), and is bound parallel t o  the homopurine 
strand of the duplex by Hoogsteen-hydrogen bonds (25,26) (Figure 2). CPK- 
models support this structure; however, a high resolution X-ray crystal 
structure of a triple helical DNA or RNA molecule has not been reported so 
far. 
Long stretches of homopurine-homopyrimidine sequences are often 
found in eukaryotic genomes (27-30). These DNA regions appear t o  be 
hypersensitive to  S1 nucleases (known to recognize single-stranded DNA). 
S1 nuclease has an optimum pH of 4.5 for activity that could favor cytosine 
protonation (27-30). It has been suggested that under superhelical stress 
and acidic pH any mirror-repeated sequence of purines in one strand can 
adopt the H-form (31-33). The major element of this structure is a triple 
helix associated with a homopyrimidine loop through Hoogsteen base pairs. 
I t  has been suggested that an acidic pH is important to  facilitate 
protonation of cytosine required for GC Hoogsteen base pairing. It is 
believed that formation of secondary structures in promoter regions of 
genes might be important in control of transcription (27-30). 
Oligonucleotide-EDTA probes. Oligonucleotides equipped with a DNA 
cleaving moiety have been described, and these can produce sequence- 
specific cleavage of single-stranded DNA (34-35). An example of this is 
oligonucleotide-EDTA.Fe(I1) hybridization probes which cleave the 
complementary single strand sequence. Moser and Dervan have reported 
that homopyrimidine oligodeoxyribonucleotides with EDTAmFe attached at  




Axial rise per residue: 
Rotation per residue: 
Dislocation from helix axis: 
Base tilt: 
Sugar puckering: 
conformation at glycosidic links: 
orientation of strands: 
2.80 A (Watson-Crick bp) 
8.5" 
C3'-endo (all strands) 
anti 
homopyrimidine strands antiparallel 
Figure 2. S t e r e o  p r e s e n t a t i o n  of a t r i p l e - s t r a n d e d  1 6 - m e r  
(poly(dA)*2poly(dT)) that was constructed by  using the coordinates given in 
ref. 24. The  general features as determined by  X-ray crystallography of 
fibers a r e  tabulated. 
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tracts within large double-stranded DNA by triple helix formation and 
cleave at that site (12) (Figure 3). 
Oligodeoxyriboucleotides with EDTA*Fe a t  the 5' end cause a 
sequence-specific double strand break. The location and asymmetry of the 
cleavage pattern reveal that the homopyrimidine-EDTA probes bind in the 
major groove parallel t o  the homopurine strand of Watson-Crick double 
helical DNA. Cleavage is not observed in the absence of cations such as 
spermine or C O ( N H ~ ) ~ ~ + ,  which are presumably required to  overcome the 
repulsion between the two anionic chains of the Watson-Crick duplex and a 
third negatively charged phosphodiester backbone. The efficiency of 
oligonucleotide duplex cleavage is increased by a factor of 10 by the addition 
of ethylene glycol (40% by volume) or other organic solvents that lower the 
relative humidity. Dehydration of the DNA favors a transition from B form 
to A form and facilitates formation of a triple helical complex (25). The 
efficiency of oligonucleotide duplex cleavage by cytidine rich 
oligonucleotide-EDTA*Fe(II) probes is very sensitive to  pH and base 
composition (37). The oligonucleotide dT*T4(CT)5*Fe(II) (T*=thymidine- 
EDTA) does not cleave Watson-Crick DNA above pH 7.0, and the 
oligonucleotides dTqT*Cs-lo-EDTA*Fe(II) do not cleave Watson-Crick DNA 
above pH 6.6, and require 30% or more ethanol (37). Cleavage efficiency of 
oligonucleotides-EDTA*Fe(II) decreases sharply below pH 6.0, most likely 
the result of partial protonation of the EDTA and the resulting loss of Fe(I1) 
or some pH dependence of the cleavage reaction. Footprinting experiments 
confirm that the triple helix forms at acidic pH values (38). 
Povsic and Dervan recently reported triple helix formation by 
oligonucleotides on DNA can be extended to the physiological pH range for 
8 
the pDMAGlO containing dA5(GA)5 site (39). The incremental effect on the 
stability and pH dependence of triple helix formation by substitution at the 
5' position of pyrimidines in the Hoogsteen strand was studied. 
Oligonucleotide-EDTAoFe probes containing bromouracil and 5- 
methylcytosine bind and cleave a polypurine sequence in duplex DNA with 
specificities comparable to  those of their thymidine-cytosine analogues, but 
with greater affinities and over an extended pH range. Oligonucleotides 
containing uracil bind a polypurine sequence with lower affinity. 
Strobel, Moser, and Dervan have reported the double strand cleavage of 
genomic DNA a t  a single site by triple helix formation. An oligonucleotide- 
EDTAmFe probe equipped with thymidine-EDTA (T*) at  the 5' end, 5'- 
T*T~CTGCT~CT-~ ' ,  causes double strand cleavage at  a single homopurine 
site 18 base pairs in size (5'-AqGAgGAqGA-3') within 48,502 base pairs of 
bacteriophage h DNA (40). The double strand cleavage efficiency is 25% (100 
mM NaC1, 25 mM tri-acetate, pH 7.0, 1 mM spermine, 24OC). No secondary 
cleavage sites were detected under these reaction conditions. The 
oligonucleotide-EDTAmFe-mediated site-specific double strand cleavage 
reaction can also be carried out in a low melting point agarose matrix. 
Maher, Wold and Dervan have demonstrated the inhibition of DNA 
binding proteins by oligonucleotide-directed triple helix formation (41). 
Oligonucleotides that bind to  duplex DNA in a sequence specific manner by 
triple helix formation offer a means for the experimental manipulation of 
sequence-specific protein binding. Micromolar concentrations of 
pyrimidine oligodeoxyribonucleotides have been shown to block recognition 
of double helical DNA by procaryotic modifying enzymes and transcription 
factors a t  a homopurine site. Inhibition is  sequence specific. 
Oligonucleotides containing 5-methylcytosine provide substantially more 
efficient inhibition than oligonucleotides containing cytosine. These results 
have implications for gene-specific repression by oligonucleotides or their 
analogs. 
Figure 3. Oligonucleotide-directed cleavage of double helical DNA by a triple 
helix forming oligonucleotide-EDTA.Fe probe. One thymine has been 
replaced by thymine with the iron chelator EDTA covalently attached at C-5. 
Reduction of dioxygen generates localized hydroxyl radical at  this position. 
Recently, it has been postulated that purine oligonucleotides bind to  
purines in duplex DNA by triple helix formation (AmAT and GmGC base 
triplets). Kohwi et al. have reported that the GmGC triplex forms in 
supercoiled DNA in the presence of divalent magnesium ion Mg++ (42). 
Cooney et al. have demonstrated in uitro gene repression using a G-rich 
oligonucleotide t o  bind a G-rich target site (43). However, purine 
oligonucleotide recognition of double helical DNA is less well understood. a- 
10 
Oligonucleotides have also been observed to form triple-stranded structures 
(44,45). 
Studies in the area of oligonucleotide-directed recognition and cleavage 
of duplex DNA by triple strand formation clearly demonstrate the power 
and potential of this technique for duplex DNA recognition. However, 
because triple s trand formation is  presently limited to 
homopurine*homopyrimidine tracts of DNA and is sensitive t o  pH for the 
C+GC triplet, a general solution to duplex DNA recognition is still lacking. 
The extension of recognition by triple helix formation to  any sequence over a 
wide range of pH (AT, GC, TA and CG base pairs, Figure 4) is an 
interesting and challenging problem. Recently, it was demonstrated that 
guanine in a pyrimidine oligonucleotide specifically recognizes TA base 
pairs within mixed purine-pyrimidine sites. Although the G*TA triplet 
within a pyrimidine oligonucleotide extends triple helix specificity to  three 
of the four possible base pairs of double helical DNA, some limitations on 
sequence composition are likely. It is not clear how far one can deviate from 
homopurine-homopyrimidine target sequences and still obtain triple helix 
formation. Rather this result provides structural leads for the design of 
deoxyribonucleotides (or their analogs) with nonnatural heterocycles 
directed toward a more general solution. The quest for a general solution 
will test and refine our understanding of molecular recognition of double 
stranded DNA. This thesis describes: a) studies of nonnatural bases for pH- 
independent GC recognition (chapter I), and b) studies of nonnatural bases 
for CG recognition (chapter 2). 
Figure 4. (Top) Isomorphous base triplets ToAT and C+GC. (Middle 
and Bottom) Unknown new base triplets ?oGC, ?*TA and ?CG. 
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Chapter 1 
Design of Novel Bases for pH-Independent Recognition of GC Base Pairs by 
Oligonucleotide-mted Triple Helix Formation 
16 
Introduction 
Pyrimidine oligonucleotides recognize extended purine sequences in 
the major groove of double helical DNA via triple helix formation (1-7). 
Specificity is imparted by Hoogsteen base pairing between the pyrimidine 
oligonucleotide and the purine strand of the Watson-Crick duplex DNA (7- 
20). Complexes of triple helical nucleic acids containing cytosine (C) and 
thymine (T) in the Hoogsteen strand are stable in acidic to  neutral 
solutions, but dissociate on increasing pH (4, 5). Sensitivity of triple helix 
formation to pH also depends on the number and position of the cytosines in 
the third strand. Oligonucleotides containing contiguous C-rich sequences 
are most sensitive to pH (21). 
Povsic and Dervan have shown that oligonucleotide-EDTA.Fe(I1) 
probes containing 5-bromouracil and 5-methylcytosine bind and cleave the 
polypurine sequence containing dA5(GA)5 by triple helix formation with 
specificity comparable to  those of their thymine-cytosine analogs, but with 
greater affinities and over an extended pH range (5). Substitution of 5- 
methylcytosine (mC) for C increases the pH range -0.4 units for triple helix 
stability in this sequence. However, protonation at N-3 of 5-methylcytosine is 
still required. 
G-rich sequences are often found in eukaryotic genomes. These DNA 
regions appear to  be hypersensitive to S1 nucleases (22-25). It has been 
suggested that under superhelical stress and acidic pH, any mirror-repeat 
sequence of purines in one strand can adopt H-form DNA (26-29). The 
major element of this structure is a triple helix associated with a 
homopyrimidine loop through Hoogsteen base pairs. Since S1 optimum 
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activity is observed at  pH 4.5, protonation of C could be favored in triple helix 
formation. 
Because oligonucleotide specificity could provide a method for the 
artificial repression of gene expression, it is desirable to  design and 
synthesize a novel base that could recognize GC base pairs without the 
requirement of protonation. Oligonucleotides containing such bases could 
then recognize G-rich sequences over a wide range of pH. From model 
building studies we chose deoxyriboisoguanosine (G'), l-(2-deoxy-P-D- 
erthro-pentofuranosyl)l, 4, 5, 6-tetrahydro-3-methyl-5-amino-7H-pyrazolo(4, 
3-d)pyrimidine-7-one (17a, P1 nucleoside), and 2-(2-deoxy-P-D-erthro- 
pentofuranosy1)-2, 4, 5, 6-tetrahydro-3-methyl-5-amino-7H-pyrazolo(4, 3- 
d)pyrimidine-7-one (17b, P2 nucleoside) as initial targets and chose an 
abasic compound, 1,2-dideoxy-D-ribose as a reference to  study the ability of 
these bases to  recognize GC base pairs. Isoguanosine (G'), P I  and P2 bases 
were designed to form two hydrogen bonds to G in the purine strand with 
no requirement for protonation (Figure 1). 
Base P1 was found t o  recognize GC base pairs as selectively and 
strongly as C+ does, while isoguanosine (G') and base P2 were found to 
recognize GC selectively, but weakly relative to  P1 and C+. Although 
isoguanosine (G') was found to recognize GC selectively, the general usage 
of G' has limitations due to  its instability to  the conditions employed in 
automated synnthesis. ~HNMR,  FABMS and enzyme digestion show that 
the nucleosides P I  and P2 nucleosides are found stable during the 
automated oligonucleotide synthesis and base deprotection. The utility of P1 
is demonstrated for the site-specific binding of the 15 base pair sequence 
Figure 1. Base triplets C+*GC, Gt*GC, Pl*GC and P2aGC. 
dAs(GA)s in the plasmid pDMAGlO and the 16 base pair sequence 
dA4GA4GsA in the 3' long terminal repeat (LTR) of HIV DNA. 
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Results and Discussion 
Synthesis of Phosphoramidite 10. The synthetic scheme for the 
nucleoside phosphoramidite 10 is shown in Figure 2. 5-amino-l-P-D- 
ribofuranosylimidazol-4-carboxamide (AICA-ribose) was reacted with 1,3- 
dichloro-l,1,3,3-tetraisopropyldisiloxane to  give 5-amino-1-[3,5-0-(1,1,3,3- 
tetraisoproyldisiloxanyl)-~-D-ribofuranosyl]imidazol-4-carboxamide 2. 
Reaction of 2 with phenoxythiocarbonylchloride in the presence of N,N- 
dimethylaminopyridine (DMAP) gave 5-amino-1-[3,5-0-(1,1,3,3- 
tetraisopropyldisiloxanyl-2-O-phenoxythiocarbonyl)-~-D-ribofuranosyl]- 
imidazole-4-carboxamide (3), which was reduced with tributyltinhydride to  
afford a 2'-deoxynucleoside 4 (30). Condensation of 5-amino-1-[3,5-0-(1,1,3,3- 
tetraisopropylsiloxanyl)-~D-deoxyribofuranosyl]imidazole-4-carboxamide 4 
with benzoylthiocyanate and treatment of the resulting thiourea derivative 
with DCC furnished 5-(N'-benzoylcarbonyl)amino-imidazole-4-carbonitrile 
(5 ) ,  which was then annulated with ethanolic ammonia to  afford the 
deoxyriboisoguanosine derivative 6 in a 60% yield (31). 6 was treated with 
benzoylchloride to  give the benzoyl-protected deoxyriboisoguanosine 
derivative 7, which was deprotected with tetrabutylammonium fluoride t o  
afford 8 .  The 5' hydroxy group of 8 was protected with 
dimethoxytritylchloride to  give 9. The reaction of 9 with 2-cyanoethyl-N,N- 
diisopropylchloro-phophoramidite afforded the 5'-DMT-protected 
phosphoramidite 10. 
Synthesis of P1 and P2. The synthetic scheme for nucleoside 
phosphoramidites P I  and P2 is shown in Figure 3. Ethyl 3-methyl-4- 
nitropyrazole-5-carboxylate (11) (32) was condensed with 1-chloro-2-deoxy-3, 
5-di-o-p-toluoyl-a-D-erthrofuranose (12) (33-35) t o  give the N1 P anomer 
N Bz, 
I 
Ho$:fi N OBz m T o & : f ~  N OBZ 
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Figure 2. Synthetic scheme of phosphoramidite 10 (G'). a) 1, 3-dichloro-1, 
1, 3, 3-tetraisopropyldisiloxane, pyridine b) phenoxythiocarbonyl chloride, 
DMAP, acetonitrile c) 2', 2'-azobis(2-methylpropionitrile), n-Bu3SnH, 
toluene d) benzoylisothiocyanate, DMF e) DCC f l  NH40H (30% in HzO), 
ethanol, 10°C g )  benzoyl chloride, pyridine, 4°C h) 1N 
tetrabutylammoniumfluoride in THF, THF i) DMTC1, pyridine j) N, N- 
diisopropylethylamine, 2-cyanoethyl-N, N-diisopropylamino- 
chlorophosphoramidite, methylene chloride. 
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Figure 3. Scheme for the synthesis of P1 and P2 a) NaH, acetonitrile b) 
ammonia, MeOH c) 10% Pd/C, Hz, EtOHIwater d) phenylisocyanate, 
pyridine 150°C e) NH40H f) Hz02 g) sat. ammonia 160°C h) TMSC1, 
isobutyric anhydride, pyridine i) DMTC1, pyridine j 1 
di i sopropyle thy lamine ,  2-cyanoethyl-N,  N-diisopropyl-  
chlorophosphoramidite, methylene chloride. 
in 46% yield and N2 P anomer 13b in 44% yield. The toluyl protecting 
groups and the ethyl ester group were removed in saturated ammonia in 
methanol and hydrogenation of 14a (50psi, H2, 10% PdC) reduced the nitro 
group to an amine. Ring closure of 15a with phenylisocyanate gave 16a (36). 
The SH group was oxidized to  a sulfonic acid group, and the sulfonic acid 
displaced with saturated aqueous ammonium hydroxide in a sealed 
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pressure bottle a t  160°C to give 17a. The amine was selectively acylated by 
the transient protection method (37). The 5' hydroxy groups were protected 
with dimethoxytrityl chloride (DMTC1) to  give 19a. Reaction of 19a with 2- 
cyanoethyl-N,N-diisopropylchlorophosphoramidite and  di- 
isopropylethylamine (DIPEA) afforded the 5'-DMT-protected 
phosphoramidite (37) P1 (Phosphoamidous acid, bis(1-methylethyl)-, 2- 
cyanoethyl ester, 3'-ester with N-[1-[5-0-[bis(4-methoxypheny1)- 
phenylmethyl]-2-deoxy-~D-erthro-pentofuranosyl]]-4,7-dihydro-3-methyl-7- 
oxo-1H-pyrazolo[4,3-d]pyrinnidin-5-yl]-2-methyl-propanamide). P2 (Phospho- 
amidous acid, bis(1-methylethyl)-, 2-cyanoethylester, 3'-ester with N-[2-[5-0- 
[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-~-D-e~hro-pentofuranosyl]4, 
7-dihydro-3-methyl-7-oxo-2H-pyrazolo[4, 3-dlpyrimidin-5-yl]-2-methyl- 
propanamide) was prepared by the same method. Abasic 
phosphoramidite(5-0-(4,4'-dimethoxytrity1)-1,2-dideoxy-D-ribose-3-(~-cyano- 
ethylN,N-diisopropy1)phosphoramidite) was a generous gift from Dr. Dave 
Horne. 
Structural analysis of compounds 13a and 13b. The structures of 13a 
and 13b were analyzed by NMR and X-ray crystallography. In a NOE study, 
irradiation of the C-HI' proton enhanced the methylene proton peaks of the 
5-ethylcarboxlate of 13a and 5-methyl protons of 13b. 13b was recrystallized 
from a solution of ether and hexane (1:l vlv). X-ray crystallographic 
analysis revealed the structure assigned from the NOE study (Figure 3). It 
crystallized in the orthorhombic system, in the space group P212121. 
Synthesis of oligonucleotides containing novel base heterocycles. 
Oligonucleotides 20-31 were synthesized using standard solid phase P- 
cyanoethyl-phosphorarnidite chemistry (38). The novel base phosphor- 
Figure 4. Structure of 13b as determined by X-ray crystallography. 
amidites PI ,  P2 and abasic phosphoramidite were coupled with an 
efficiency comparable to A, G, C, and T phosphoramidites; however 
deoxyriboisoguanosine phosphoramidite coupled with a a lower yield of 
-60%. 
It has been reported that isoguanosine derivatives are more easily 
depurinated in an acidic solution than either guanosine or adenosine (39). 
Because oligonucleotides 20-31 contain dT* (thymidine-EDTA) (40), 0.1N 
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NaOH was substituted in the deprotection steps for NH40H to  circumvent 
possible ammonolysis of the T* ethylesters. To examine the stability of the 
novel bases through several machine synthesis coupling and base 
deprotection cycles, the 4-mers 5'-T-T-PI-T-3' and 5'-T-T-P2-T-3' were 
synthesized on a 10 pmol scale for NMR and FABMS studies. The glycosidic 
bonds of P1 and P2 were found to be stable under these conditions. From 
the NMR and FABMS data it was shown that the isobutyrylamido group of 
P1 or  P2 was completely removed to give a free amine, and that the novel 
bases were stable in the machine synthesis. 
Product Analysis of Oligonucleotides by Enzyme Digestion. The individual 
oligonucleotide and its nucleoside composition can be analyzed by HPLC to 
ensure that the nucleoside is not chemically changed during automated 
synthesis. Purified oligonucleotides were digested with snake venom 
phosphodiesterase and calf intestine alkaline phosphatase to give their 
nucleosides (Figure 5a) (41-42). Snake venom phosphodiesterase treatment 
of oligonucleotides gives 5'-monophosphate nucleotides, and subsequent 
treatment with calf intestine alkaline phosphatase gives the corresponding 
nucleosides. HPLC analysis of the digestion products was carried out on a 
C18 reverse phase column using 10 mM ammonium phosphate pH 5.11 8% 
MeOH as the eluent (Figures 5b, c, d, and e). Analysis of the oligonucleotide 
5'-T*(T)4(PlT)5-3' gave T*, P1 and T nucleosides after enzyme digestion 
(Figures 5c and 5d). The oligonucleotide 5'-T*(T)3C(T)4PlgT-3' gave T*, T, 
C, and P1 nucleosides (Figures 5e and 50. The oligonucleotide 5'-TP2TT-3' 
gave T and P2 nucleosides. These analyses suggest that the P1 and P2 
nucleosides can be used in automated DNA synthesis without 
complications. 
1 Snake Venom Phosphodiesterase 
1 Calf Intestine Alkaline Phosphatase 
a HPLC Analysis with Standard Nucleosides 
Figure 5a. Scheme for the enzyme digestion of oligonucleotides for HPLC 
analysis. 
Cleavage of oligonucleotide 30 mer complex. The use of 
oligonucleotides equipped with the DNA-cleaving moiety thymidine- 
EDTA*Fe(II)(T*) allowed a qualitative ordering of relative stabilities of 
triple helices formed between 30 base pair (bp) DNA duplexes containing 
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Figure 5b. HPLC chromatogram (monitored a t  260 nm) of the nucleosides C, T, PI, and P2. The samples 
were eluted on a C18 reverse phase column with 8% MeOH in 10 mM ammonium phosphate pH 5.1 at  a 
flow rate of 1 mllrnin. The UV-Vis spectra of the different peaks are recorded in the upper left panel. 
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Figure 5d. HPLC chromatogram (monitored a t  230 nm) of the mixture of the enzyme digested products of 
oligonucleotide 27 ( 5'-T*'M'TT(PlT)s-3') and nucleosides C, T, PI ,  and P2. The samples were eluted on a C18 
reverse phase column with 8% MeOH in 10 mM ammonium phosphate pH 5.1 a t  a flow rate of 1 mumin. 
The UV-Vis spectra of the different peaks are recorded in the upper left panel. 
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Figure 5e. HPLC chromatogram (monitored at 230 nm) of the mixture of the enzyme digested products of 
oligonucleotide 31 (5'-T*TTTCTTTTPlPlPlPlPlPlT-3'). The samples were eluted on a C18 reverse phase 
column with 8% MeOH in 10 mM ammonium phosphate pH 5.1 at  a flow rate of 1 d m i n .  The UV-Vis 
spectra of the different peaks are recorded in the upper left panel. 'i 
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Figure 5f. HPLC chromatogram(monitored at  230 nm) of the mixture of the enzyme digested products of 
oligonucleotide 31 (5'-T*mCTTTTPlPlP1P1P1P1T-3') and nucleosides C, T, P I ,  and P2. The samples were 
eluted on a C18 reverse phase column with 8% MeOH in 10 mM ammonium phosphate pH 5.1 at  a flow rate 
1 d m i n .  The UV-Vis spectra of the different peaks are recorded in the upper left panel. 
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the site d(A7XA7)/d(T7YA7) (XY=AT, GC, TA or CG) and a series of 15 nt 
oligonucleotides differing a t  one base position d(T7NT7)(N=C, G', PI,  P2, 
Ab) (Figure 6). The 30-bp duplexes were labeled with 3 2 ~  at  the 5' end of the 
target site strand d(T7YT.7). The DNA cleavage reactions of oligonucleotides 
20-21 were performed to compare the base specificity and binding affinity. 
The most intense cleavage patterns were observed when N=C, XY=GC and 
N=Gt, XY=GC (Figure 7a). A bar graph representing the relative cleavage 
is shown in Figure 7b. The DNA binding reactions of oligonucleotide 2 1  
were performed at  various temperatures in the presence of 40% ethanol 
(Figure 8a). As the temperature increased, the cleavage efficiency of base 
triplets decreased sharply for all the base triplets except for Gt*GC. The 
most intense cleavage pattern was observed for N=Gt, XY=GC under 
stringent conditions (pH 7.4, 35OC, 40% ethanol) (Figure 8a). The relative 
cleavage is shown in Figure 8b. The strong cleavage pattern in G'*GC 
suggests that isoguanosine (G') can recognize GC base pair selectively as 
C+ does (Figure 8c). The DNA cleaving reactions of 20,22,23, and 24 were 
also performed under conditions that were sensitive t o  the stability of the 
variable base triplet in the middle of the thymine 15 nt fragment within the 
triple helix (pH 7.4, 3Ei°C, 40% ethanol). The most intense cleavage patterns 
were observed when N=C, XY=GC and N=Pl, XY=GC (Figure 9a). The 
cleavage for the C+GC triplet (lane 4 in Figure 9a) represents the known 
ability of C to bind GC base pairs. Strong cleavage patterns were observed 
for the base P I  in Pl*GC base triplets (lane 8 in Figure 9a), while moderate 
cleavage patterns were observed for the base P2 in the PZOGC triplet (lane 
12 in Figure 9a). The abasic compound shows a preference for 
pyrimidine/purine base pairs (CG and TA) over purine/pyrimidine base 
Figure 6. (Above) Sequence of oligonucleotides-EDTA 20-24 where T* is 
thymidine-EDTA. The oligonucleotides differ at  one base position indicated 
in bold type. (Below) The box indicates the double stranded sequence bound 
by oligonucleotides-EDTAeFe(I1) 20-24. The Watson-Crick base pair (AT, 
GC, TA or CG) opposite the varient base in the oligonucleotide is also in bold 
type. 
pairs (AT and GC). The bases P I  and P2 were designed to form two hydro- 
gen bonds to the GC base pair. 
The strong cleavage pattern in PleGC suggests that two hydrogen 
bonds are formed in the Pl*GC triplets like C+GC. The weak cleavage 
pattern in P2.GC suggests that the position of the backbone in P2.GC is 
not appropriate or that the methyl group disfavors the anti conformation of 
base P2 (Figures 9c, d, and e). 
Figure 7a. Autoradiogram of the 20 percent denaturing polyacrylamide gel. 
The cleavage reactions were carried out by combining a mixture of 
oligonucleotide-EDTA (2 yM), spermine(lmM), and Fe(I1) (25 yM) with the 
3 2 ~  labeled 30-mer duplex (40,600 cpm) in a solution of tris-acetate, pH 7.0 
(50 mM, pH 7.4), NaCl (100 mM), calf thymus DNA (100p.M bp), and 40% 
ethanol and incubated at  25OC for 1 hour. Cleavage reactions were initiated 
by the addition of DTT (3 mM) and allowed to proceed for 6 h at  25OC. The 
reactions were stopped by freezing and lyopholization and the cleavage 
products were analyzed by gel electrophoresis (1,500-2,00OV, BPB 25 cm). 
Lanes 1-8: duplex containing 5' end-labeled ( A ~ T ~ Y T ~ G ~ o ) .  Lanes 1-8: DNA 
cleavage products produced by oligonucleotide-EDTAoFe(I1) (20-21); 20 
(lanes 1 to  4); 21 (lanes 5 to  8). ==AT (lanes 1 and 5); XY=GC (lanes 2 and 
6); XY=CG (lanes 3 and 7); XY=TA (lanes 4 and 8). 
Oligo. 20(C) 21 (G') 
X= A G C T  A G C  T  
Base Triplet 
AT a2 0s T A 
Watson-Crick Base Triplets 
Figure 7b. Bar graph representing the relative cleavage data from 
densitometric analysis of Fig. 7a. Eight base triplets were examined for 
binding specificity compatible with the pyrimidine triple helix motif shown 
by the experiment described in Fig. 7a. 
Figure 8a. Autoradiogram of the 20 percent denaturing polyacrylamide gel. 
The cleavage reactions were carried out by combining a mixture of 
oligonucleotide-EDTA (2 pM), spermine (1 mM), and Fe(I1) (25 pM) with the 
3 2 ~  labeled 30-mer duplex (40,000 cpm) in a solution of tris-acetate (50 rnM 
pH 7.4), NaCl(100 mM), calf thymus DNA (100pM bp), and 40% ethanol and 
incubated at  20°C, 25"C, 30°C, and 35°C for 1 hour. Cleaving reactions were 
initiated by the addition of DTT (3 mM) and allowed to proceed for 6 h at 
each temperature. The reactions were stopped by freezing and 
lyopholization and the cleavage products were analyzed by gel 
electrophoresis (1,500-2,00OV, BPB 25cm). Lanes 1-18: duplex containing 5' 
end-labeled ( A ~ T ~ Y T ~ G ~ o ) .  Lane 1: control showing intact 5' labeled 30 bp 
DNA standard obtained after treatment according to  the cleavage reaction 
in the absence of oligonucleotide-EDTA. Lane 2: products of Maxam-Gilbert 
G+A sequncing reaction (43). Lane 3-18: DNA cleavage products produced 
by oligonucleotide-EDTAeFe(I1) (21); 20°C (lanes 3 to  6); 25°C (lanes 7 t o  10); 
30°C (lanes 11 to 14); 35°C (lanes 15 to  18). XY=AT (lanes 3,7,11, and 15); 
XY=GC (lanes 4, 8, 12, and 16); XY=CG (lanes 5, 9, 13, and 17); XY=TA 
(lanes 6, 10, 14, and 18). 

lsoguanosine Recognition 
Watson-Crick Base Pair 
Figure 8b. Bar graph representing the relative cleavage data from 
densitometric analysis of Fig. 8a. Sixteen base triplets were examined for 
binding specificity compatible with the pyrimidine triple helix motif shown 
by the experiment described in Fig. 8a. 
Figure 8c. Possible base triplets GP*AT, GP*GC, G1*CG, G1*TA. For each 
base triplet the positioning of the third base with respect to  the Watson- 
Crick base pair is based upon forming possible hydrogen bonds, and an 
anti- confomation at  the glycosidic link. 
Figure 9a. Autoradiogram of the 20 percent denaturing polyacrylamide gel. 
The cleavage reactions were carried out by combining a mixture of 
oligonucleotide-EDTA (2 pM), spermine (1 mM), and Fe(I1) (25 pM) with the 
3 2 ~  labeled 30-mer duplex (40,000 cpm) in a solution of tris-acetate (50 mM 
pH 7.4), NaCl (100 mM), calf thymus DNA (100 pM bp), and 40% ethanol 
and incubated at 20°C, 25"C, 30°C, and 35°C for 1 hour. Cleaving reactions 
were initiated by the addition of DTT (3.3 mM) and allowed to  proceed for 6 h 
a t  each temperature. The reactions were stopped by freezing and 
lyopholization and the cleavage products were analyzed by gel 
electrophoresis (1,500-2,00OV, BPB 25 cm). Lanes 1 to 18: duplex containing 
5' end-labeled (AgT7YT7G10). Lane 1: control showing intact 5' labeled 30 bp 
DNA standard obtained after treatment according to the cleavage reaction 
in the absence of oligonucleotide-EDTA. Lane 2: products of Maxam-Gilbert 
G+A sequnce reaction. Lanes 3 to  18: DNA cleavage products produced by 
oligonucleotide-EDTA*Fe(II) (20,22-24); 20 (lanes 3 to  6); 22 (lanes 7 t o  10); 
23 (lanes 11 to 14); 24 (lanes 15 to 18). ==AT (lanes 3,7,11,and 15); XY=GC 
(lanes 4, 8, 12, and 16); XY=CG (lanes 5,9, 13, and 17); XY=TA (lanes 6, 10, 
14, and 18). 
Oligo. 2o(c) 22(P1) 23(P2) 24(Ab) 
X = A G C  T  A G C T  A G C T  A G C T  
1 2  3 4 5 6  7 8 9 10 11 12 13 14 15 16 17 18 
Base Triplets 
120 1 
AT C (w; TA 
Watson-Crick Base Pair 
Base Triplets 
120 1 
C P I  P 2 Ab 
Third Strand 
Figure 9b. Bar graph representing the relative cleavage data from 
densitometric analysis of Fig. 9a. Sixteen base triplets were examined 
for binding specificity compatible with the pyrimidine triple helix motif 
shown by the experiment described in Fig. 9a. 
Figure 9c. Possible base triplets PlmAT, PlmGC, PleCG, Pl*TA. For 
each base triplet the positioning of the third base with respect to the 
Watson-Crick base pair is based upon forming possible hydrogen 
bonds, and an anti- confornation at  the glycosidic link. 
Figure 9d. Possible base triplets P2*AT, PZaGC, P2aCG, PZaTA. For 
each base triplet the positioning of the third base with respect to  the 
Watson-Crick base pair is based upon forming possible hydrogen 
bonds, and an anti- confomation at  the glycosidic link. 
Figure 9e. Possible base triplets P2*AT, P2*GC, P2*CG, P2aTA. For each 
base triplet the positioning of the third base with respect to  the Watson- 
Crick base pair is based upon forming possible hydrogen bonds, and a syn- 
confomation at  the glycosidic link. 
P2*GC suggests that the position of the backbone in P2*GC is not 
appropriate or  that the methyl group disfavors the anti conformation of base 
P2 (Figures 9c, d, and e). 
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Site-specific double strand cleavage of pDMAGlO DNA. The ability of 
oligonuceotides 25-28 to  execute site-specific double strand breaks in 
pDMAGlO is documented in Figure 10a. The plasmid was linearized with 
Sty1 and labeled with C X - ~ ~ P - ~ T T P ,  producing a 4.06 kb restriction fragment 
specifically labeled 1.02kb from the  ta rge t  sequence 
d(AAAAAGAGAGAGAGA). The 32~-end-labeled DNA was allowed to  
react with oligonucleotide-EDTAoFe(I1) in the presence of DTT at  various 
pH's a t  25OC. The separation of the cleavage products by agarose gel 
electrophoresis revealed one major cleavage site. The cleavage efficiency of 
oligonucleotide 25 containing C and T decreases sharply above pH 7.0. 
Replacement of C with mC (oligonucleotide 26) extended the stability of 
triple helix formation to  pH 7.4, but not to  pH 7.8. Incorporation of P1 in 
place of C (oligonucleotide 27) afforded the same cleavage efficiency as C 
and mC below pH 7.0, and extended the pH range to pH 7.8 for binding of 
the target (Figure lob). Despite apparent GC recognition by P2 in the 
previous experiment, oligonucleotide 28 showed no cleavage even at lower 
pH (Figure 10 b). 
Site-specific double strand cleavage of pHIV-CAT Plasmid DNA The ability 
of oligonucleotides 29-31 to cause site-specific double strand breaks in HIV- 
CAT plasmid DNA is documented in Figure l l a .  pHIV-CAT was digested 
with BamHI to produce a 4.95-kbp fragment, which contained the 3' LTR of 
HIV with the site d(AAAAGAAAAGGGGGGA) located 1.72 kbp and 3.23 
kbp from the ends. The 3 2 ~  end-labeled DNA was allowed to react with 
oligonucleotide-EDTA*Fe(II) in the presence of ascorbate at 30°C (pH 6.2 to 
7.0). 
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Figure 10a. (Top) Oligonucleotides 25-28 constructed from deoxy- 
ribonucleotide phosphoramidites containing cytosine (C) ,  5-methylcytosine 
mC), thymidine, PI ,  P2 and thymidine-EDTA (T*). (Bot tom) Coarse 
resolution pattern for cleavage of plasmid DNA (4.06 kbp) by 
oligonucleotides-EDTA 25-28 with a simplified model of the triple helical 
complex between oligonucleotide 27 (T/Pl) and a 15 base pair single site. 
Figure lob. Double strand cleavage of plasmid DNA analyzed on a 0.9% 
agarose gel. Plasmid pDMAGlO was linearized with StyI and labeled with 
( a - ~ ~ P ) T T P ,  producing a 4.06 kbp restriction fragment. The 3' 32~-end-  
labeled DNA was dissolved in a buffer containing NaCl, Tris, and spermine 
and was mixed with oligonucleotide 25-28 previously equilibrated for 30 
minutes with 1.5 equiv. of Fe(I1). After incubation at  25OC for 30 minutes, 
the reaction was initiated by the addition of DTT (final concentration: 25 
mM tris-acetate, 1 mM spermine,100 mM NaC1, 100 pM calf thymus, 2 pM 
oligonucleotide-EDTA*Fe(II), and 2.5 mM DTT). The cleavage reactions 
were allowed to proceed for 6 h at  25OC. The reactions were stopped by 
precipitation with ethanol and the cleavage products were analyzed by gel 
electrophoresis. (Top) Lane 1: DNA size markers obtained by digestion of 
StyI linear pDMAGlO with EcoRI (1060 bp), BamHI (998), Asp700 (1460),and 
PstI (1814); (lane 2) control containing no oligonucleotide-EDTAoFe(I1); 
(lanes 3 to 5) 25*Fe(II); (lanes 6 to  8) 28*Fe(II); (lanes 9 to  11) 27oFe(II). 
(Lanes 3,6 and 9 ) at pH 6.2; (lanes 4,7, and 10) at pH 7.0; (lanes 5 ,8  and 11) 
at pH 7.8. (Bottom) (Lane 1) DNA size markers as above. Lane 2: control 
containing no oligonucleotide-EDTAoFe(I1); (lanes 3 to  5) 260 Fe(I1); (lanes 
6 to 8) 27*Fe(II).Lanes 3 and 6: at  pH 7.0; (lanes 4 and 7) pH 7.4; (lanes 5 and 
8) at pH7.8. 
Oligo. 25(C) 28(P2) 27(P1) 
Oligo. 26(mC) 27(P1) 
pH= 7.0 7.4 7.8 7.0 7.4 7.8 
Cleavage of pDMAG10 
120 , 
Figure 10c. Bar graph presenting the reaction cleavage data from the 
densitometric analysis of Fig. lob (Top and Bottom). 
Separation of cleavage products by agarose gel electrophoresis revealed a 
major cleavage site producing two DNA fragments, 1.72 and 3.23 kb in size 
(Figure llb). Cleavage efficiency by oligonucleotides 29 and 30 was very 
sensitive to the pH and no cleavage was observed above pH 6.6 (Figure l l c ) .  
Interestingly, 5-methylcytosine did not extend the pH range for this target 
sequence. However, oligonucleotide 31 cleaved double-stranded DNA up t o  
pH 7.4 at  30°C. The temperature dependence of cleavage by oligonucleotide- 
EDTA-Fe(I1) 31 at pH 7.0 is shown in Figures l ld .  These data suggest that 
the 16 nt  oligonucleotide 31 can bind the HIV-LTR a t  physiological 
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Figure 1 la. ( T o p  ) Oligonucleotides 2 9 -3 1 constructed from 
deoxyribonucleotide phosphoramidites containing cytosine (C), 5- 
methylcytosine (mC), thymidine, P1 and thymidine-EDTA (T*). (Bottom) 
Coarse resolution pattern for cleavage of plasmid DNA (4.95 kbp) by 
oligonucleotides-EDTA 29-31 with a simplified model of the triple helical 
complex between olgonucleotide 31 (TIPI) and a 16 base pair single site. 
Figure Ilb Autoradiogram of double strand cleavage of pHIV-CAT DNA 
(4.95 kbp) analyzed on a 0.9% agarose gel. The reactions were carried out by 
combining a mixture of oligonucleotide-EDTA 29-31 (2 yM), spermine (1 
mM), and Fe(I1) (2 yM) with the 32~-labeled linearized plasmid [-I00 
yM(bp) (-40,000 cpm)] in a solution of Tris-acetate (25 mM), NaCl(100 mM), 
Calf thymus DNA [I00 pM (bp)] and incubated for 1 hour at  the reaction 
temperature. Cleavage reactions were initiated by the addition of ascobate (1 
mM) and allowed to proceed for 10 h at 30°C. The reactions were stopped by 
precipitation with ethanol and the cleavage products were analyzed by 
agarose gel electophoresis. Lanes 1 to 8: pHIV-CAT linearized with Bam HI 
and 3'-end labeled a t  both ends. Lane 1: control containing no 
oligonucleotide-EDTAoFe(I1); (lane 2) DNA size markers obtained by 
digestion of BamHI linearized pHIV-CAT with Hind111 and XhoI: 4950 
(undigested), 3725,3003, 1947, 1225 bp; (lanes 3 to 6) DNA cleavage products 
produced by 29*Fe(II); (lanes 7 to 10) DNA cleavage products produced by 
30*Fe(II); (lanes 11 to 14) DNA cleavage products produced by 31*Fe(II). 
(Lanes 3 ,7  and 11) at  pH 6.2; (lanes 4 ,8  and 12) at pH 6.6; (lanes 5 ,9  and 13) 
at pH 7.0; (lanes 6, 10 and 14) at pH 7.4. 
Oligo. 29(C) 30(mC) 31 (PI) 
HIV-CAT 
Figure Ilc. Bar graph presenting the relative cleavage data from the 
densitometric analysis of Figure llb. 
Figure lld. Autoradiogram of double strand cleavage of pHW-CAT DNA 
(4.95 kbp) analyzed on a 0.9% agarose gel. The reactions were carried out by 
combining a mixture of oligonucleotide-EDTA 31 (2 pM), spermine (1 mM), 
and Fe(I1) (2pM) with the 32~-labeled linearized plasmid [-I00 nM (bp) 
(-40,000 cpm)] in a solution of Tris-acetate (25 mM, pH 7.0), NaCl(100 mM), 
calf thymus DNA [I00 pM (bp)] and incubated for 1 hour at  the reaction 
temperature. Cleavage reactions were initiated by addition of ascorbate(1 
mM) and allowed to  proceed for 10 h at  the reaction temprature. The 
reactions were stopped by precipitation with ethanol and the cleavage 
products were analyzed by agarose gel electophoresis. Lanes 1 to  5: pHIV- 
CAT linearized with Bam HI and 3'-end labeled a t  both ends. Lane 1: 
control containing no oligonucleotide-EDTAaFe(I1); (lane 2) DNA size 
markers obtained by digestion of BamHI linearized pHIV-CAT with 
Hind111 and XhoI: 4950 (undigested), 3725, 3003, 1947, 1225 bp; (lane 3) 
DNA cleavage products produced by 31*Fe(II) a t  25OC; (lane 4) DNA 
cleavage products produced by 31*Fe(II) at  30°C; (lane 5) DNA cleavage 




The novel bases isoguanosine (G') and the two 3-methyl-5-amino- 
pyrazolo(4, 3-d)pyrimidine-7-ones, PI and P2, enable the selective binding 
and cleavage of a target site containing GC base pairs by triple helix 
formation. The utility of isoguanosine (G') in oligonucleotide synthesis has 
limitations due to its instability in the conditions of automated synthesis. It 
is possible that the benzoyl protected isoguanosine base may be depurinated 
during the deprotection of DMT by trichloroacetic acid. P1 and P2 are stable 
under the conditions of automated synthesis, and P1 can be used to  
substitute for any cytosine base in oligonucleotides used for triple helix 
formation. Replacement of C with P1 in a dT*T4(CT)5 (T*=thymidine- 
EDTA) probe extended the pH range for binding to pH 7.8 for the plasmid 
containing the dA5(GA)5 site. Although P2 has the same hydrogen bond 
donor groups as PI ,  its ability to recognize GC is weak. One possible 
explanation for this weak binding is that the backbone position is positioned 
inappropriately. Another explanation is that the 5-methyl group of P2 
disfavors the anti conformation of P2 nucleotides as an 8-bromo substituent 
on guanosine does. Oligonucleotide dT*T4(P2T)5-EDTA-Fe(II) (28) does not 
appreciably cleave its target site a t  pH values between 6.2 and 7.8, 
suggesting that unfavorable interactions within the 15 nt site disfavor triple 
helix formation. The HIV-DNA data suggested that triple helix formation 
with oligonucleotides containing consecutive cytosines or 5-methylcytosines 
is very sensitive to pH. Although 5-methylcytosine extended the pH range 
of triple helix formation for the plasmid containing dA5(GA)5 site, no pH 
extention was observed in HIV-DNA containing the clAqGAqGgA site. It 
has been suggested that the presence of hydrogen bonding can raise the pK, 
60 
at  N3 of cytosine. For a (CT)n sequence in a third strand, thymidine next to 
cytosine can facilitate the binding, and raise the pKas of N3 of cytosine and 
5-methylcytosine, respectively. However, for a (C)n sequence in a third 
strand, protonation of consecutive cytosines may result in charge repulsion 
that disfavors protonation. Oligonucleotide 31, containing PI,  shows less pH 
sensitivity in triple helix formation than its cytosine or 5-methylcytosine 
analogs. It is able to bind the sequence dA4GA4GsA in HIV DNA at  pH 7.4, 
30°C. Presumably, the base P1 does not require protonation t o  form 2 
hydrogen bonds in triple helix formation. The pDMAGlO and HIV DNA 
data suggest that the P1 base can be put at any cytosine position in the 
third strand to achieve pH- independent triple helix formation. 
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Experimental and Materials 
Synthesis. ~ N M R  spectra were recorded at 400 MHz on a JEOL-GX 400 
NMR spectrometer. The NOE spectra were measured in CDC13 after 
degassing in a freeze-thaw cycle vacuum line. Chemical shifts are reported 
in parts-per-million downfield from tetramethylsilane. IR spectra were 
recorded on a Shimadzu IR-435 Infrared Spectrometer. High resolution 
Fast Atom Bombardment Mass Spectra (FABMS) and EI mass spectra 
were obtained at the University of Nebraska, Lincoln, and the Mass Spectra 
Lab a t  the University of California, Riverside. Flash chromatography was 
carried out under positive air pressure using EM science Kieselgel 60 (230- 
400 mesh). Elemental analyses were performed by the analytical lab at  
Caltech. Reagent grade chemicals were used as received, except for 
diisopropylethylamine, which was distilled from CaH2. A Beckman 
System1 Plus DNA synthesizer was utilized for the synthesis of 
oligonucleotides. Concentrations of oligonucleotides were determined by 
UV using a Perkin-Elmer Lambda 4C UV-VIS spectrometer. Analytical 
HPLC was performed with a Hewlett-Packard 1090 Liquid Chromatograph. 
Analytical reverse phase HPLC was performed on a BrownLee Labs 
Aquapore OD-300 4.6 mm x 22 cm 7 micron C18 column using no 
precolumn. Densitometry was performed by an LKB Ultrascan XL laser 
densitometer and scintilation counting was performed by a Beckman LS 
3801 scintillation counter. All enzymes for DNA manipulation were 
purchased from Boehringer Mannheim or  New England Bio Lab. 
5-~0-l-[3,5-0-(1,1,3~-tetraisopropy1disilo~yl)-~D-ribo~osyl]- 
imidazole-4-carboxamide (2). To a solution of 5-amino-l-P- D - 
ribofuranosylimidazol-4-carboxamide (1, 5.16 g, 20mmol) in pyridine (50 
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mL) was added 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (6.9 g, 22 mmol) 
and the mixture was stirred under argon a t  room temperature for 3 h. 
Water (50 mL) was added to the solution and the mixture was extracted 
with three 100 mL portions of ethyl acetate. Concentration of the dried 
(Na2S04) solution gave a syrup, which was purified over a silica gel 
column using ethyl acetate to give desired product 2 (Rf= 0.45 in 
ch1oroform:ethyl acetate (1:l v/v) ( 7.9 g, 79%). IR (KBr), 3450,3400, 3380, 
3300,2900,2880,1650,1570,1470,1270,1230 cm-l. ~ N M R  (DMSO-d6) 6 7.21 
(s, lH), 6 6.74 (s, 1H), 6 6.64 (s, lH), 6 5.80 (s, 2H), 6 5.61 (d, lH, J=4.12, 
2'hydroxy), 6 5.52 (s, 1H), 6 4.30 (m, lH), 6 3.80-4.20 (m, 4H), 6 0.90-1.04 (m, 
28H), EIMS calcd. for C21H40N406Si2 (M+) 500.2486. Found 500.2473. 
5~~1-[3,5-0-(1,1,3$-te~~0pmpyldi~iloxazlyl-2-O-pheno~~oc~- 
bony1)-P-D-ribo-osyllimidazol-carboxdde (3) Compound 2 (6.8 g, 13.6 
mmol), phenoxythiocarbonyl chloride (3.74g, 21.6 mmol), N, N-dimethyl- 
aminopyridine (10.4 g, 86.4 mmol) were dissolved in acetonitrile (300 mL). 
The mixture was stirred for 3 h at room temperature under nitrogen 
atmosphere and then poured onto ice water (ca 200 g). The mixture was 
extracted with 500 mL portions of chloroform. The organic layer was 
washed with water (500 mL), dried over Na2S04, and concentrated in vacuo 
to give a crude sample of 3, which was chromatographed over a silica gel 
column with chloroforrn/ethyl acetate (50:50 vlv Rf= 0.74) as the eluent to 
give 3 (4.23 g, 49 %). IR (KBr), 3300,2900,2880,1650,1574,1470,1270,1180 
cm-1. ~ N M R  (DMSO-d6) 6 7.36 (t, 2H, J=8.23, phenoxy), 6 7.27 (m, 2H), 6 7.16 
(d, 2H, 5~8.23,  phenoxy), 6 6.74 (s, lH), 6 6.64 (s, lH), 6 6.07 (d, lH, J=6.98, 
H1'),6 5.94 (m, 2H), 6 4.72 (m, lH), 6 4.12 (m, lH), 6 3.98 (m, 2H), 6 0.90-1.04 
(m, 28H), EIMS calcd. for C28H44N407SSi2 (M+) 636.2469. Found 636.2468. 
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syllimidazole-4-carboxamide (4). To a refluxing solution of 3 (4.0 g, 6.28 
mmol) and a catalytic amount of 2',2'-azobis(2-methylpropionitrile) in 
toluene (100 mL) was added n-BugSnH (10 mL) and the mixture was 
refluxed for 30 minutes under nitrogen. The solvent was evaporated in 
vacuo to give yellow syrup, which was purified with a silica gel column 
using chloroformlethylacetate (50:50, vlv Rf=0.44) t o  give a white product 
(2.07 g, 4.29 mmol Y=68%). IR (KBr), 3310,2940,2850, 1614, 1550, 1470, 1135, 
1120 cm-1. 1 N ' M ~ ( ~ ~ ~ ~ - d 6 )  6 7.23 (s, lH), 6 6.74 (s, IH), 6 6.65 (s, lH), 6 6.07 
(d, lH, JS.76,  H11),6 5.83 (m, 3H), 6 4.60 (m, lH), 6 3.90 (m, 2H), 6 3.76 m, 
lH), 6 2.27 (m, lH), 62.21 (m, lH), 6 0.90-1.04 (m, 28H), EIMS calcd. for 
C21HQoN405Si~ (M+) 484.2537. Found 484.2528. 
5~~-benzoylcarb~oyl)amio-1-[3,5-0-[1,1,3$-te~opropyLsiloxa- 
nyl)-~-D-deoxyribofuranosyl]imidazole-4-carbonitrile (5). A solution of 
compound 5 (1.5 g, 3.09 mmol) and benzoylisothiocyanate (628 mg, 3.3 
mmol) in DMF (10 mL) was stirred a t  room temperature for 7 h. To the 
resulting solution was added N, N'-dicyclohexyl-carbodiimide (DCC) (1.4g, 
7.0 mmol) and the mixture was continuously stirred a t  room temperature 
for 15 h. The solvent was then removed in vacuo (50°C) to  an oil residue. The 
residue was chromatographed on a silica gel column using 14% ethyl 
acetate in chloroform to afford product 5 (1.2 g, 65%). IR (KBr), 3200, 2950, 
2930,2250,1700,1670,1570,1250,1030,850 cm-I . INMIX (DMSO-d6) 6 11.46 
(s, lH), 6 10.58 (s, lH), 6 8.03 (d, 2H, J=6.96, benzoyl), 6 8.00 (s, lH), 6 7.69 (t, 
lH, J=6.96, benzoyl), 6 7.55 (m, 2H), 6 6.0 1 (t, lH, J=3.30, H11),6 4.54 (m, lH), 
6 3.93 (m, 2H), 6 3.76 (m, lH), 6 2.64 (m, HI, 6 2.43 (m, lH), 6 0.90-1.04 (m, 
28H), EIMS calcd. for C2gH43N506Si2 (M+) 613.2779. Found 613.2749. 
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3,5-0- (1 ,1 ,3$-tetraisopmpyIsi loxanyl)disoose(6) .  Com- 
pound 5 (1.2 g, 1.95 mmol) was suspended in a mixture of ethanol (20 mL) 
and 33% aqueous ammonia (20 mL) in a round bottom flask. The flask was 
well tightened with a rubber stopper, and the mixture was stirred for 72 h 
a t  10°C. After 72 h, the ammonia was removed in vacuo a t  room 
temperature and a white solid was collected by filteration to  give 6 (530 mg, 
1.027 -01, Y=52.6%). IR (KBr) 3100,2950,1670,1620,1530,1470,1410 cm-1. 
~ N M R  (DMSO-d6) 6 7.80 (s, 2H), 6 6.04 (t, lH, J=4.23, Hlt),6 4.79 (m, lH), 6 
3.82 (m, 2H), 6 3.75 (m, lH), 6 2.63 (m, H), 62 .42 (m, lH), 6 0.90-1.04 (m, 
28H), FABMS calcd. for C22H3gN505Si2Li (M+Li) 516.2649. Found 516.2625. 
&Np-dibe11zoyl-2-O-be11u)yl-7- [3,50- (1,1,3,3- te traisopropyIsiloxacny1)- 
deoxyribofuranosyl]-isoguanosine (7). To a solution of compound 6 (700 mg, 
1.35 mmol ) in pyridine (10 mL) was added benzoylchloride (2.37g, 16.27 
mmol) and the mixture was stirred for 72 h a t  4OC. After 72 h, 5 mL cold 
water was added to  the solution and the mixture was extracted with ethyl 
acetate. The organic layer was dried over Na2S04 and concentrated in 
vacuo to give residue. The residue was chromatographed on silica gel using 
7% ethyl acetate (Rf=0.32) in chloform to give compound 7 (1 g, 1.12 mmol, 
Y=83%). IR (KBr) 2980,2930,1750,1710,1600,1583,1500,1230,1125 cm-1- 
~ N M R  (DMSO-d6) 6 8.71 (s, lH), 68.01 (d, lH, J=7.32, benzoyl), 6 7.79 (m, 
5H), 67.60 (m, 3H), 67.43 (m, 5H), 66.31 (m, lH),65.12 (m, lH), 63.70-3.90 (m, 
3H), 62.97 (m, lH), 62.61 (m, lH), 60.90-1.04 (m, 28H), FABMS calcd. for 
C43H51N50gSi2 (M+H)+ 885.2832. Found 885.1860. 
6-Nn-dibemoyl-2-0-benzoyl-deoxyriboisoose (8). To a solution 
of compound 7 (960 mg, 1.08 mmol) in tetrahydrofuran (THF) (50 mL) was 
added dropwise 1 M tetrabutylammonium fluoride solution in THF (2.3 mL) 
at  4OC. The cooling bath was removed and the mixture was stirred for 2 h. 
After 2 h, water (50 mL) was added and the mixture was extracted with 
ethylacetate (150 mL). The organic layer was dried over Na2S04 and 
concentrated under reduced pressure to give a residue. The residue was 
chromatographed on silica gel using ethyl acetate (Rf=0.33) to give 
compound 8 (420 mg, 0.74 mmol Y=60.4%) IR (KBr), 3400,3295, 2980,1750, 
1710, 1600,1582, 1500 cm-1. ~ N M R  (DMSO-d6) 6 8.81 (s, lH), 68 .03 (d, 2H, 
J=7.34, benzoyl), 6 7.78 (m, 5H), 6 7.60 (m, 3H), 6 7.45 (m, 5H), 6 6.39 (t, lH, 
J=6.23, HI'), 6 5.38 (d, lH,  J=4.35, 3' hydroxy), 6 4,91 (t, lH ,  J=5.23, 5' 
hydroxy), 6 4.40 (m, lH), 6 3.83 (m, lH), 6 3.56 (m, 2H), 6 2.72( m, lH), 6 2.18 
(m, lH), FABMS calcd. for C31H26N507 (M+H)+ 580.1832. Found 580.1860. 
6-N;N-dibe11~)yl-2-0-bellzoy1-7-[50- (4,4'-dimethoxytri tyl)deoxyribo- 
fura-nosyll-isoguanosine (9). To a solution of compound 8 (193 mg, 0.33 
mmol) in pyridine (3 mL) was added 4,4'-dimethoxytritylchloride (113 mg, 
0.33 mmol) and the mixture was stirred under argon for 24 h. After 24 h, 
ethyl acetate (50 mL) was added and washed with water (50 mL). The 
organic layer was dried over Na2S04 and concentrated in reduced pressure 
to afford a yellowish residue. The residue was chromatographed on silica 
gel using 25% ethyl acetate (Rf=0.6) in chloroform to give compound 9 (230 
mg, 0.26 mmol Y=79%). IR (KBr), 3295, 2980, 1750, 1710, 1600, 1580, 1500, 
1230, 1120 em-1. ~ N M R  (DMSO-d6) 6 8.20 (s, lH), 6 7.98 (d, 2H, J=7.34, 
benzoyl), 6 7.77 (m, lH), 6 7.70 (d, 4H, J=8.12), 6 7.63 (t, 2H, J=8.12), 6 7.58 (t, 
2H, J=8.12),67.48 (m, 4H), 6 7.24 (m, 2H), 6 7.12 (m, 7H), 66.75 (d, 2H, 
J=8.97, methoxyphenyl), 6 6.70 (d, 2H, J=8.96, methoxyphenyl), 6 6.43 (t, lH, 
J=5.45, HI'), 6 5.39 (d, lH, J=4.56, 3' hydroxy), 6 4,41 (m, lH), 6 3.95 (m, lH), 
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6 3.75 (m, 6H),6 3.11 (m, lH), 6 3.05 (m, lH), 6 2.83 (m, lH), 6 2.20 (m, lH), 
FABMS calcd. for C52H44N50g (M+H)+ 882.3 139. Found 882.3 137. 
Phosphoramidite (10). To a solution of compound 10 (160 mg, 0.19 
mmol), N, N-diisopropyl ethylamine (93.7 mg, 0.8 mmol) in dry methylene 
chloride (3 mL) was added 2-cyanoethyl-N, N-diisopropylamino- 
chlorophosphoramidite (71 mg, 0.3 mmol). The reaction mixture was 
stirred for 3 h and ethyl acetate (50 mL) was added. The ethyl acetate 
solution was washed with sat. sodium bicarbonate solution (50 mL) 2 times 
and sat. sodium chloride solution (50 mL) 2 times. The organic layer was 
washed over Na2S04 and concentrated under reduced pressure to give a 
yellowish residue. The residue was chromatographed on silica gel using 
methylene chloride: triethylamine: isopropyl alcohol (97:1:2 vlv) solution 
(Rf=0.65) to afford compound 10 (140 mg, 0.13 mmol ). lNMR (DMSO-d6) 6 
8.21 (d, lH, J=18.12), 6 8.02 (d, 2H, J=7.46, benzoyl), 67.81 (m, 4H), 6 7.60 (m, 
lH), 6 7.43 (m, 4H), 6 7.12-7.28 (m, 13H), 6 6.76 (m, 4H), 6 6.43 (t, lH, J=5.67, 
HI'), 6 4.64 (m, lH), 6 4,22 (m, lH), 6 3.21-3.80 (m, lOH), 6 2.60-2.80 (m, 2H), 6 
2.60 (t, lH, J=5.98, methylene), 6 2.41 (t, lH, J=5.98, methylene), 6 1.00-1.30 
(m, 14H), FABMS calcd. for C61H61N7010P (M+H)+ 1082.4217. Found 
1082.4268. 
lH-Pyrazole-5-carboxylic acid, 1-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)- 
P-D-erythro-pentofuranosyll-3-methyl-4-nitro-, ethyl ester (l3a) and 1H- 
Pyrazole-3-carboxylic acid, 1-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-~- 
erythro-pentofuranosyl]-5-methyl-4-nitro-, ethyl ester (l3b). Ethyl(3-methyl- 
4-nitropyrazole-carboxlate) (11) was prepared by the method of Townsend 
(32). 1 -Ch lo ro -2 -deoxy-3 ,5 -d i -o -p - to luoy l -a -Dranose  (12) was 
prepared by Hoffer's method (34). Sodium hydride (60% dispersion in oil, 4.4 
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g, 1.11 mol) was added to a suspension of 11 (19.9 g, 0.1 mol) in dry CH3CN 
(1 L). The mixture was stirred under argon a t  room temperature for thirty 
minutes. 12 (42.8 g, 0.11 mol) was added portionwise with stirring over a 
period of 30 minutes. After stirring under argon a t  room temperature for 
an additional hour, the reaction was filtered to  remove a small amount of 
insoluble material and evaporated. Flash chromatography (hexane: ether, 
2:1, vlv, TLC, Rf=0.3, 0.45) yielded 25.3 g of 13a (Rf=0.45) and 24.3 g of 13b 
(Rfz0.3). Crystallization from hexanelether gave pure white needles. 13a 
~NMR (CDC13) 6 7.96 (d, 2H9 J=8.03, toluoyl), 6 7.95 (d, 2H9 J=8.03, toluoyl), 6 
7.24 (d, 2H, Jd .03 ,  toluoyl), 6 7.19 (d, 2H, J=8.03, toluoyl), 6 6.38 (t, lH, 
J=6.72, HI'), 6 5.81 (m, 1H),6 4.62 (m, 2H),64.20 (m, 3H) 6 3.32 (m, lH), 6 2.63 
(m, lH), 6 2.40 (s, 6H), 6 2.38 (s, 3H), 6 1.37 (t, 3H, J=6.72, methyl). IR 3000, 
1730,1720, 1610,1503,1380,1250, cm-l EIMS calcd. for C28H2gN30g (M+) 
551.1903. Found 551.1898. Elemental Analysis calcd. for C28H2gN30g C, 
60.97; H, 5.30; N, 7.61. Found C, 60.98; H, 5,35; N, 7.63. 13b ~ N M R  (CDC13) 6 
7.93 (d, 2H, J=8.06), 6 7.90 (d, 2H, J=8.06), 6 7.22 (d, 2H, J=8.06), 6 7.18 (d, 2H, 
J=8.06), 6 6.21 (t,lH, J=6.74, HI'), 6 5.26 (m, lH), 6 4.23-4.62 (m, 5H), 6 3.61 
(m, lH), 6 2.71 (s, 3H), 6 2.65 (m, lH), 6 2.37 (s, 3H), 6 2.42 (s, 3H) 6 1.32 (t, 
3H, J=6.76, methyl). IR 3000,1735,1730,1710,1618,1380,1270,1130 cm-1 
EIMS calcd. for C28H2gN30g (M+) 551.1903. Found 551.1897. EA calcd. for 
C28H2gN30g C, 60.97; 5.30; N, 7.61. Found C, 60.98; H, 5.32; N, 7.63. 
lH-~ le -5carbodde , l - (2 -deoxy  P-D-erythro-pento-fimmosyl) -3- 
methyl-4-nitro-(14a). 13a (22.04 g, 40 mmol) was stirred in saturated NH31 
MeOH (500 d) in a 1 L round bottom flask equipped with a tight stopper a t  
room temperature for 4 h. The mixture was evaporated, and dried under 
vacuum to give a light yellow residue. Flash chromatography 
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(MeOHEtOAc, 1:19, vlv, TLC; Rf=0.42) yielded 10.8 g of a clear colorless 
product. ~ N M R  (DMSO-d6) 6 8.49 (s, IH), 6 8.28 (s, lH), 6 6.00 (t, lH, J=6.13, 
HI'), 6 5.28 (d, lH, J=4.25,3' hydroxy), 6 .71 (t, lH, J=5.12, 5' hydroxy), 6 4.32 
(m, lH), 6 3.83 (m, lH), 6 3.45 (m, lH), 6 3.35 (m, lH), 6 2.68 (m, lH), 6 2.43 
(s, 3H), 6 2.23 (m, 1H). IR (KBr) 3330,3170,2950,1690,1650,1435,1320,1080, 
1020 cm-1. FABMS calcd. for CloH15N406 (M+H)+287.0991. Found 287.0974. 
1H-Pyrazole-3-carbodde, 1 - ( 2 - d e o x l y - ~ D - e ~ - p e n t o ~ o s y l ) - 5 -  
methyl-4-nitro- (14b). 13b (22.04 g, 40 m o l )  was stirred in saturated NH3 in 
MeOH (500 mL) as described for the synthesis of l4a.The mixture was 
evaporated, and dried under vacuum to a give light yellow residue. Flash 
chromatography (MeOHEtOAc, 1;18, vlv, TLC, Rf=0.20) yielded 10.08 g 
(95%) of a clear colorless product. ~ N M R  (DMSO-d6) 6 7.95 (s, lH), 6 7.70 (s, 
lH), 6 6.24 (t, lH, J=6.87), 6 5.30 (d, lH, J=4.26, 3'hydroxy ), 6 4.7 l(t ,  lH, 
54.14, 5' hydroxy), 6 4.34 (m, lH), 6 3.80 (m, lH), 6 3.20-3.50 (m, 3H), 6 2.82 
(m, lH), 6 2.64 (s, 3H), 6 2.22 (m, 1H). IR (KBr) 3350, 2950, 1670,1500,1370, 
1380,1080,1060cm-1- FABMS calcd. for CloH15N406 (M+H)+ 287.0991. 
Found 287.0974. 
lH-Pyrazole-5-carbodde, 1-(2-deo~~DerythrO-pento~osyl ) -3-  
methyl-4-amino- (15a). A solution of the nitro compound 14a (8.6 g, 30 
mmol) in 300 mL (EtOH/H20 8:2, vl v) was shaken with 10% PdC (800 mg) 
under H2 (50 psi) for 5 h, using a parr apparatus. Filtration and 
evaporation afforded 7.9 g of a clear colorless oil, which crystallized upon 
standing. ~ N M R  (DMSO-d6) 6 7.49 (s, ZH), 6 6.56 (t, lH, J=6.13, HI'), 6 5.12 
(d, lH, J=4.25, 3' hydroxy), 6 4.72 (t, lH, J=5.12,5' hydroxy), 6 4.32 (m, 3H), 6 
3.71 (m, lH), 6 3.42 (m, lH), 6 3.23 (m, lH), 6 2.76 m, lH), 6 2.04 (m, 4H).IR 
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(KBr) 3400,2950, 1700,1590, 1215cm-l. EIMS calcd. for CloH16N404 (M+) 
256.1172 Found 256.1167. 
lH-Pyrazole-3-carboxamide, 1- (2 -deoxy-P-D-e~-pento~osy1) -5 -  
methyl-4-amino- (15b). A nitro group of 14b (8.6 g, 30 mrnol) was reduced by 
the procedure described for 15a. Filtration and evaporation gave 7.7 g of a 
colorless oil, which crystallized upon standing. ~ N M R  (DMSO-d6) 6 7.08 (s, 
lH), 6 7.04 (s, IH), 6 6.04 (t, 1H, J=6.14, HI'), 6 5.13 (d, lH, J=4.24, 3' 
hydroxy), 6 4.66 (t, lH, J=5.12,5' hydroxy), 6 4.31-4.50 (m, 3H), 6.75 (m, lH), 
6 3.20-3.50 (m, 2H), 6 2.93 (m, lH), 6 2.15 (m, 4H). IR (KBr) 3400,2950, 1672, 
1600, 1320, 1300 cm-1. EIMS calcd. for CloH16N404 256.1171. Found 
256.1167. 
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 1-(2-deoxy-P-D-erythro-pento- 
fura~1osyl)-l,4,5,6-tetrahydro-3-methyl-5-thioxo- (16a).Nucleoside 15a (5.12 
g, 20 mmol) and phenylisocyanate (7.8 g, 60 mmol) was dissolved in 
pyridine (50 mL) in a round bottom flask and the solution heated a t  reflux 
temperature for 16 h. The solution was taken to  dryness and ethanol (50 
mL) was added and removed in vacuo. Flash chromatography (5% MeOH 
in EtOAc) yielded 4.1 g (70%) of 16a as a white solid. ~ N M R  (DMSO-dg) 8 
13.02 (s, lH), 6 12.02 (s, lH), 6 6.68 (t, lH, J=6.15, HI'), 6 5.27 (d, lH, J=4.16, 
3'hydroxy), 6 4.68 (t, lH, J=5.25, 5'hydroxy), 6 4.35 (m, lH), 6 3.78 (m, lH), 6 
3.45 (m, lH), 6 3.31 (m, IH), 6 2.71 (m, lH), 6 2.31 (s, 3H), 6 2.20 (m, lH).IR 
(KBr) 3400, 3100, 1700, 1600, 1290, 1200, 1160 cm-1. EIMS calcd. for 
CllH14N404S (M+) 298.0735. Found 298.0737. 
7 H - ~ l o ( 4 & d ) p ~ d i n e - 7 - o n e $ - ( 2 - d m q ~ D e ~ p n ~  
furanosyl)-2,4,5,6-tetrahydro-3-methyl-5-thioxo- (16b). Nucleoside 1% (5.12 
g, 20 mmol) and phenylisocyanate (7.8 g, 60 mmol) was dissolved in 
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pyridine (60 mL) and the solution heated a t  reflux temperature for 16 h. The 
solution was evaporated to give an oil and triturated in ethyl acetate to give 
a white precipitate. The precipitate was filtered and dried to give 4.3 g of a 
white solid. ~NMR(DMSO-d6) 612.61 (s, lH), 612.08 (s, lH), 66.25 (t, lH, 
J=6.15, H11),65.29 (d, lH,  J=4.24, S'hydroxy), 6 4.73 (t, l H ,  J=5.15, 
5'hydroxy), 6 4.37 (m, lH), 63.81 (m, lH), 6 3.21-3.50 (m, 2H), 6 2.90 (m, lH), 6 
2.47 (s, 3H), 6 2.25 (m, 1H). IR (KBr) 3300, 3100, 1700, 1620, 1600, 1280.cm-~ 
EIMS calcd. for CllH14N404S 298.1735. Found 298.0727. 
7H-Pyrazolo(4~-d)p~dim-7-one, l -(2-d~D-e~penC-F.lramo- 
syl)l, 4,5,6-tetrahydro-3methyl-5-amino- (17a). Nucleoside 16a (2.98 g, 10 
mol) was dissolved in 10 mL concentrated NH4OH and evaporated until the 
solid appeared. The mixture was cooled to O°C, and 2.98 mL of 30% 
hydrogen peroxide solution was added dropwise and stirred for 20 minutes 
at 0°C. The reaction mixture was saturated with ammonia gas a t  O°C. The 
solution was transferred to a pressure reaction bottle and the reaction was 
carried out a t  150°C for 10 h, then cooled to O°C. The light brown solution 
was evaporated to give a brown solid. The solid was recrystallized in water 
to give 2.01 g of white crystal (71%). ~NMR(DMSO-d6) 6 10.96 (s, lH), 6 6.73 
(t,lH, J=6.92), 6 6.13 (s, 2H), 6 5.18 (d, 1H, J=4.32, 3' hydroxy), 6 4.69(t, lH,  
J=5.23, 5' hydroxy), 6 4.44 (m, lH), 6 3.76 (m, lH), 6 3.30-3.65 (m, 2H), 6 2.72 
(m, lH), 6 2.22 (s, 3H), 6 2.13 (m, 1H). IR (KBr) 3400,3330,2950,1690,1650, 
1570,1435, 1320cm-l. UV (HzO) hmax 228,310 nm (&228=20,950, ~260=3,387, 
and ~310=6,020). FABMS calcd. for C1 1H16N504(M+H)+ 282.1202. Found 
282.1212. 
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 2-(2-deoxy-P-D-erythro-pentoh- 
nosyl)-2,4,5,6-tetrahydro-3-methy1-5-amino- (17%). Nucleoside 16b (2.98 g, 
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10 mmol) was transformed to amine by the same procedure described for 
17a. The light brown solution was evaporated to  give a brown solid. The 
solid was dissolved in pyridine and filtered to  remove ammonium sulfite. 
The solvent was evaporated to  a brown solid. Flash chromatography 
(MeOH) yielded 1.9 g of a white solid. ~ H N M R  (DMSO-d6) 6 10.55 (s, lH), 
66.33 (t, lH, J=6.67, HI'), 6 6.00 (s, 2H), 6 5.32 (d, lH,J=4.34, S'hydroxy), 6 
4.75 (t, lH, J=5.23, Ei'hydroxy), 6 .40 (m, lH), 6 .79 (m, IH), 6 3.39 (m, lH), 6 
3.26 (m, lH), 6 2.92 (m, lH), 6 2.31 (s, 3H), 6 2.24 (m, 1H). IR (KBr) 3400,3320, 
2960,1695,1630,1600,1320 cm-l. UV (H20) hmax 224,310 nm (&224=23,000, 
&260=4,142, and &310=3,857). FABMS calcd. CllH16N504 (M+H)+ 282.1202. 
Found 282.1210. 
Propanamide, N-[1-(2-deoxy-P-D-erythro-pento-furanosl-4, 7- 
dihydro-3-methyl-7-oxo-2H-pyrazolo[4,3-d]pyridine-5-yl]-2-methyl- (18a). 
Amine compound 17a (1.41 g, 5 mmol) was suspended in dry pyridine (25 
mL) in a 100 mL round bottom flask equipped with a drying tube and cooled 
in an ice bath; trimethylchlorosilane (5 eq., 2.16 mL, 25 mmol) was added 
dropwise with stirring. After 30 minutes isobutyric anhydride (5 eq., 3.95 
mL, 25 mmol) was added dropwise to the stirring solution. The reaction 
was allowed to warm to room temperature and stirred for 3 h. The reaction 
mixture was neutralized by addition of saturated aqueous NaHC03, then 
rotoevaporated several times with toluene and EtOH. The residue was 
dissolved in ethyl acetate and washed with water and dried over Na2S04. 
Chromatography (ethyl acetate Rf=0.5) yielded 1.31 g (75%) of isobutyryl 
protected nucleoside. ~HNMR(DMSO-d6) 6 12.15 (s, lH), 6 11.55 (s, lH), 6 
6.77 (dxd, lH, J=6.41, 6.74, HI'), 6 5.23 (d, lH, J=4.27, 3' hydroxy), 6 4.68 (t, 
lH, J=5.65, 5' hydroxy), 6 4.49 (m, lH), 6 3.79 (m, lH), 6 3.48 (m, lH), 6 3.3 1 
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(m, 1H), 6 2.75 (m, 2H), 6 2.31 (s, 3H), 6 2.21 (m, lH), 6 1.05 (d, 6H, J=6.84, 
methyl). IR (KBr) 3250,2980,1680,1610,1490,1300 cm-1- FABMS calcd. for 
C15H22N505 (M+H)+ 352.1620. Found 352.1608. 
Propanamide,  N-[2-(2-deoxy-P-D-erythro-pento-furanosyl-4, 7- 
dihydro-3-methyl-7-oxo-2H-pyrazolo[4,3-d]pyrimidine-5-yl]-2-methyl- (18b). 
The synthesis of 18b was carried out as described for the synthesis of 18a. 
Chromatography (EtOAc, Rf=0.35) yielded 1.30 g of a light yellow solid 
(75%). ~HNMR(DMSO-d6) 611.89 (s, lH), 611.37 (s, IH), 66.32 (dxd, lH,  
J=5.86, 6.35, HI'), 65.28 (d, lH, J=4.18, S'hydroxy), 64.69 (t, lH, J=5.24, 
li'hydroxy), 64.39 (m, lH), 63.81 (m, lH), 63.37 (m, lH), 63.22 (m, lH), 62.94 
(m, lH), 62.69 (m, lH), 62.43 (s, 3H), 62.22 (m, lH), 61.07 (d, 6H, J=6.83, 
methyl). IR (KBr) 3250, 2980, 1680, 1610, 1490, 1300.cm-1 FABMS calcd. for 
C 15H22N505 (M+H)+ 362.1620. Found 352.1610. 
Propanamide, N-[l-[5-O-~is(4-methoxyphenyl)methyl]2-deoxy-~D- 
e~pen~furanosy1]-4,7-dihydro-3-methyl-7-oxo-1H-pyrazolo(4$-d)pyri- 
midin-5-yll-2-methyl- (19a). Protected nucleoside 18a (1.06 g, 3 mmol) was 
dissolved in dry pyridine(6 mL). 4, 4-dimethoxytritylchloride (TMTC1) (1.14 
g, 3.3 mmol) was added to the solution, and this mixture was stirred a t  4OC 
overnight. An additional portion of DMTCl (35 mg, 0.1 mmol) was added 
until most of the starting material was converted to product as determined 
by TLC. The reaction was stopped by the addition of MeOH (2 mL) and 
diluted in methylene chloride (50 mL). The organic layer was washed three 
times with water, dried over anhydrous Na2S04, filtered, and evaporated to  
a yellow foam. Chromatography (CH2C12/EtOAc, 2:1, v/v, Rfz0.31) yielded 
1.46 g (75%) of the product as a white solid. ~ H N M R  (DMSO-d6) 6 12.28 (s, 
lH), 6 11.59 (s, lH), 6 7.31 (d, 2H, J=7.84, phenyl), 6 7.16 (m, 7H), 6 6.76 (m, 
73 
5H), 6 5.27 (d, lH, J=4.70,3' hydroxy), 6 4.45 (m, 1H), 6 3.92 (m, lH), 6 3.70 (s, 
3H), 6 3.69 (s, 3H), 6 3.00 (m, 2H), 6 2.73 (m, 2H), 6 2.26 (m, lH), 6 2.18 (s, 3H), 
6 1.10 (d, 6H, J=6.84, methyl). IR (KBr) 3400,3200,2980,1670,1610,1500,1250 
cm-1. FABMS calcd. for C36H40N507 (M+H)+ 654.2927. Found 654.2938. 
P r o p d d e ,  N- [2-[5-0- fiis (4methoxyphenyl)phenyImethyll-2-deoxy- 
P-D-erthro-penbfuranosyl] -4,7-dihydro-3-methyl-7-oxo-2H-pyrazolo[4,3- 
dlpyrimidin-5-yll-2-methyl- (19b). The procedure for the synthesis of 18a was 
followed for the 5'-OH protection of 18b (1.06 g, 3 mmol). Chromatography 
(CH2C12/EtOAc, 2:1, vlv, Rf=0.23) yielded 1.52 (76 %) of 19b. ~HNMR (DMSO- 
d6) 6 11.94 (s, lH), 611.39 (s, lH), 6 .00-67.30 (m, 9H), 6 .75 (d, 2H, J=8.98,4- 
methoxyphenyl), 6 6.73 (d, 2H, J=8.55, 4-methoxyphenyl), 6 6.41 (q, lH), 6 
5.35 (d, lH, J=5.13, 3'hydroxy), 6 4.57 (m, lH), 6 3.96 (m, lH), 6 3.68 (m, 3H), 
6 3.66 (s, 3H), 6 3.00 (m, 2H), 6 2.81 (m, lH), 6 2.72 (m, lH), 6 2.55 (s, 3H), 6 
2.27 (m, lH), 6 1.09 (d, 6H, J=6.86, methyl). IR (KBr) 3400, 3200, 2980, 1670, 
1620, 1500, 1470,1290, 1250 cm-1. FABMS calcd. C36H40N507 (M+H)+ 
654.2927. Found 654.2950. 
P h o s p h o d d o u s  acid, bis(1-methylethyl)-, 2-cyanoethyl ester, 3'-ester 
with N-[l-[5-O-[bis(4-methoxyphenyl)phenyhethyl]-2-deoxy-~-D-erythro- 
penb~osyl]-4,7-dihydro-3-met~l-7-oxo-1H-pyrazolo(4,3-d)p~din-5 
yl] -2-methyl-propanamide (P 1). 2-cyanoethyl-N, N-diisopropyl- 
chlorophosphoramidite (200 mL, 0.90 mm01) was added dropwise to  a 
solution of 19a (392 mg, 0.60 mmol) and diisopropylethylamine (312 mL, 1.80 
mmol) in dry CH2C12 (4 mL, purified by passing through basic aluminum 
oxide) under argon. After 1 hour, the reaction was quenched with ethanol 
(1.0 mL), diluted with EtOAc (60 mL), and washed with saturated aqueous 
NaHC03 (2x60 mL) and brine ( 2x60 mL). The organic layer was dried over 
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anhydrous Na2S04 and then concentrated. The phosphoramidite 
diastereomers were purified by f lash  chromatography 
(EtOAc/CH2C12/TEAlisopropyl alcohol, 5:90:2:2, v/v/v/v, Rf=0.70) to  give a 
white solid. ~ H N M R  (DMSO-66) 6 12.29 (s, lH), 6 11.61 (s, lH), 6 7.37 (m, 
2H), 8 7.16 (m, 7H), 6 6.76 (m, 5H), 8 6.76 (m, 5H), 6 4.75 (m, lH), 6 4.06 (m, 
lH), 6 3.40-3.85 (m, lOH), 63 .09 (m, lH), 6 2.80 (m, 2H), 6 2.72 (m, 2H), 6 2.65 
(m, lH), 6 2.45 (m, lH), 6 2.18 (s, 3H), 6 0.90-1.40 (m, 18H). IR (KBr) 3200, 
2980, 2250, 1680, 1610, 1500, 1305, 1250 cm-1. FABMS calcd. for 
C45H57N7OgP (M+H)+ 854.4006. Found 854.4036. 
Phosphoramidous acid, bis(1-methyethyl)-, 2-cyanoethylester, 3'-ester 
with N-[2-[5-0-[bis(4-metho~henyl)pheny~-2-deoxy-P-D-erythro- 
pen~~osyl]-4,7-dihy~3-methyl-7-oxo-2H-pyrazolo(4~-d)p~din-5- 
yll-2-methyl-propanamide (P2). P2 was prepared by the same procedure 
described for the synthesis of PI (400 mg, 0.6 mmol). Chromatography of the 
phosphoramidite diastereomers (EtOAc/CH~C1~/TEAlisopropyl alcohol, 
5:90:2:2, v/v/v/v, Rf=0.48) gave P2 in an 82% yield. ~HNMR (DMSO-d6) 6 11.94 
(s, lH), 6 11.40 (s, lH), 6 6.9-7.4 (m, 9H), 66.75 (m, 4H), 6 6.50 (t, lH, J=4.27, 
HI'), 6 4.89 (m, lH), 6 4.10 (m, lH), 6 3.40-3.80 (m, 10H),6 3.21 (m, lH), 6 3.05 
(m, lH), 6 2.30-2.80 (m, 8H), 6 0.8-6 1.50 (m, 18H). IR (KBr) 3250,2990, 1680, 
1610,1245 cm-1. FABMS calcd. for C ~ ~ H ~ ~ N ~ O B P  (M+H)+ 854.4006. Found 
854.4026. 
Oligonucleotides. Oligonucleotides 20-31 were machine synthesized 
using P-cyanoethyl phosphoramidite chemistry. Modified nucleosides 
coupled with >97% efficiency except phosphoramidite 10. The 
oligonucleotides were removed from the support and deprotected by 
treatment with 0.1 N NaOH (1.5 mL11 pmol, 55"C, 24 h), neutralized with 
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glacial acetic acid (6-7 pL11.5 mL 0.1 N NaOH), applied to a column of 
Sephadex G-10-120 (Sigma), and eluted with water. The crude 
oligonucleotides were lyophilized and purified by electrophoresis (550V, 20 
h) on a 2 mm-thick 20% polyacrylamide gel (Maxam-Gilbert). The major 
UV-absorbing bands were excised and eluted (0.2N NaCl, 1 mM EDTA, 
37OC, 24 h), then passed through Sephadex G-10-120, and dialyzed against 
water for 3 days. Oligonucleotide 4 mers 5'- T-T-PI-T-3', 5'-T-T-P2-T-3' were 
synthesized on a 10 mmol scale in a similar manner as in the NMR and 
FABMS studies. The crude deprotected 4-mers were filtered, lyophilized, 
and chromatographed on a Sephadex G-10-120 column to give 6.12 mg of a 
white solid. ~ H N M R  (DMSO-d6) T-T-PI-T 6 11.30 (m, 4H), 6 7.90 (s, lH), 6 
7.87 (s, lH), 6 7.81 (s, lH), 6 6.71 (t, lH, J=5.01, HI'), 6 6.31 (s, 2H), 6 6.18 (m, 
3H), 6 5.89 (m, lH), 6 4.82 (m, 2H), 6 4.75 (m, lH), 6 4.45 (m, lH), 6 3.50-4.20 
(m, 13H), 6 2.98 (m, lH), 6 2.25 (s, 3H), 6 2.00-2.50 (m, 7H), 6 1.85 (s, 6H), 6 
1.29 (s, 3H). FABMS calcd. for C41H52N11025P3Na3 (M+H)+ 1260.2041. 
Found 1260.2009. 1HNMR (DMSO-d6) T-T-P2-T 6 11.20 (m, 4H), 6 7.81 (s, 
lH), 6 7.79 (s, lH), 6 7.74 (s, lH), 6 6.22 (m, 4H), 6 6.01 (m, lH), 6 5.78 (m, 
lH), 6 4.81 (m, lH), 64.72 (m, lH), 64.65 (m, lH), 84.38 (m, lH), 64.31 (m. 
lH), 6 3.22-4.00 (m, 16H), 63.00 (m, lH), 6 2.31 (s, 3H), 6 1.90-2.60 (m, 7H), 6 
1.78 (s, 6H), 6 1.73 (s, 3H). FABMS calcd. for C41H52N11025P3Na3(M+H)+ 
1260.2041. Found 1260.2075. 
HPLC Analysis. 3 nmoles of purified oligonucleotide was digested 
simultaneously with snake venom phosphodiesterase (3 pL, 2 pgl pL), calf 
intestine alkaline phophotase (3 pL, 1 u/ pL), 50 mM Tris-pH 8.1, 100 mM 
MgCl2. The reaction mixture was incubated at  37OC for 2 h and lyophilized 
to dryness. The dry sample was dissolved with 10 pL of Milli-Q water. 5 pL 
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of the solution was injected onto a C18 reverse phase column utilizing 10 
nM ammonium phosphate pH 5.1/8.0% MeOH as eluent. 5 pL of the 
standard solution containing C (4 nmols), T (4 nmols), P I  (12 nmols) and P2 
(12 nmols) was also injected under same conditions as a standard. Each 
peak was compared with the peaks of the standard solution. 5 pL of digested 
solution was mixed with 5 pL of the solution containing standard 
nucleosides, and 5 pL of resulting solution was injected to  show that each 
nucleoside peak was identical. 
DNA manipulation. Distilled, deionized water was used for all 
aqeuous reactions and dilutions. Enzymes were purchased from either 
Boehringer-Mannheim or New England Biolabs. Deoxynucleoside 
triphosphates were purchased from Pharmacia as 100 mM solutions. 5'[a- 
~ ~ P I ~ N T P S  (3000 Cilmmol) and 5 ' [ y - 3 2 ~ ] ~ ~ ~  (7000 Cilmmol) were obtained 
from Amersham. The plasmid pDMAGlO was a gift from D. Mendel, who 
const ructed i t  by in se r t i ng  a duplex conta ining 
d(AAAAAGAGAGAGAGA) into the large BamHIIHindIII restriction 
fragment of pBR322. The plasmid pHW-CAT was a gift from Dr. Alan 
Frankel and Tom Povsic. DNA reactions were typically carried out in 1.5 
mL polypropylene tubes obtained from Tekma company. Calf thymus DNA 
was purchased from Sigma, sonicated, and extracted with 3x0.2 volume 
water saturated phenol, 0.2 volume 24:l CHClgIisoamyl alcohol, and 0.2 
volume CHC13. After extensive dialysis against water, the DNA was passed 
through a 4.5 pm Centrex filter (Schleicher Schuell) and assayed for 
concentration by UV assuming ~260=11,800 L/mol.bp.cm. DNA was 
precipitated from either 0.3M NaOAc pH5.2/EtOH (1:3) or NH40AcIE tOH 
(k2.5). DNA pellets were dried in a Savant speed vac. Agarose gel 
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electrophoresis was carried out using 40 mM tris-acetate, 5 mM NaOAc, 1 
mM EDTA, pH 7.9 buffer. The ten-fold concentration (lox) loading buffer for 
agarose gels was 25% (wlv) ficoll solution, which contained 0.2% (wlv) 
bromophenol blue (BPB) and xylene cyan01 (XC) tracking dyes. 
Polyacrylamide gel electrophoresis was carried out using 100 mM tris- 
borate, 1mM EDTA, pH 8.3 buffer. The loading buffer for denaturing 
polyacrylamide gels was 80% formamide in 100 mM tris-borate, 1mM 
EDTA, pH 8.3 buffer. 3' labeling of DNA was prepared by standard 
procedures (47). Specific radioactivity was measured with a Beckman LS 
2801 scintillation counter. Gels were dried (after transferring them t o  
Whatman 0.3 mm paper) on a Bio-Rad Model 483 slab dryer at  80°C. 
Autoradiography was carried out using Kodak X-Omat film. Optical 
densitometry was performed using LKB Broma Ultrascan XL Laser 
Densitometer operating at 633 nm. The relative peak area for each cleavage 
band or  locus was equated to  the relative cleavage efficiency at that site. 
Cleavage of 5' 3 2 ~  end-labeled 30 mer duplex. 50 picomoles of each 
single-stranded oligonucleotide AgT7YT7G10 (Y=T, C, G, A) were 
dissolved in 28 pL water, 5 pL lox kinase buffer (10x=700 mM Tris.HC1, 100 
mM MgC12, 1 mM spermidine, 1 mM EDTA, pH 7.6)' and 5 pL 10 mglml 
DTT. This solution was treated with 10 pL 5' [ U - ~ ~ P I A T P  and 2 pL T4 
polynucleotide kinase (10 u/pL). The 5' end labeling was allowed to proceed 
for 45 minutes a t  37OC. The end-labeled DNA was precipitated from 
NaOAcIEtOH, washed with 70% EtOH, and dried. The pellets were 
dissolved in 100 mM NaC1, 50 mM tris-acetate, pH 7.4, and 50 picomoles of 
the complementary 30 mer in a total volume of 30 pL. To effect hybridization 
of the 30 mers, the oligonucleotide mixture was heated to 90°C for 5 minutes 
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and allowed to cool to  room temperature. The oligonucleotide mixtures 
were treated with 5 pL 25% ficoll loading buffer, loaded onto a 
nondenaturing polyacrylamide gel and electrophoresed at  240 V until the 
BPB tracking dye was near the bottom of the gel. The four bands (Y=T, C, G, 
A) of end-labeled DNA were visualized by autoradiography, excised from 
the gel, crushed, transferred to 1.5 mL polypropylene tubes, and eluted into 
0.2 N NaCl at  37 "C for 24 h. The end- labeled DNA 30 mer duplexes were 
recovered by passing the eluents through a 4.5 mL Centrex filter and 
extensive dialysis against water. The labeled DNA solution was used for the 
cleavage reaction. For the cleavage reactions the DNA (20,000 cpdreaction) 
was mixed with salts, buffer, spermine and the oligonucleotide-EDTA with 
Fe(I1). This solution was incubated for 30 minutes a t  37OC before the 
cleavage reaction was initiated by the addition of DTT to make a final 
volumn of 40 yL. The reaction was stopped by lyophilization. To each 
eppendorf tube a certain volume of formamide loading buffer was added 
(80% formamide, 20% 5X TBE buffer, 0.02% bromophenol blue and 0.02 % 
xylene cyanol) to  give approximately 3,000 cpdpL  for each reaction. To 
dissolve the solid the tubes were vortexed (10 sec). 5 yL of the resulting 
solutions were transferred to  new tubes and counted afterwards. The 
volume of buffer was loaded on each lane to give the same amount of 
radioactivity (-6000 cpdane )  for each reaction. Electrophoretic separation 
of the cleavage products was achieved on a 20% denaturing polyacrylamide 
gel until the bromophenol blue was 25 cm from the starting position. 
Cleavage products were visualized by autoradiography without drying the 
gel. The relative cleavage was analyzed by LKB densitometry. 
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Double strand cleavage of pDMAG10. The plasmid pDMAGlO was 
precipitated twice from NaOAc with ethanol, rinsed with 70% ethanol, 
briefly dried in vacuo and digested with StyI, which produces an asymetric 
cleavage site that enables a selective labeling at  only one of two ends. The 
linearized plasmid (10 ng) was labeled with [ ~ - ~ ~ P I ~ T T P  and 
DNApolymerase (large Klenow fragment, reaction volumn =I00 yL) 
according to standard procedures (44). 100 pL Milli-Q water was added to 
reaction mixture. The resulting DNA solution was extracted with 2x1 
volume water saturated phenol and 3x1 volume ether. Half of the resulting 
DNA-solution (100 pL) was passed through the column containing 1 mL 
Sephadex G-50-80 resin to remove mononucleotides. The labeled DNA 
solution was used for the cleavage reaction. For the cleavage reactions the 
DNA (20,000 cpdreaction) was mixed with salts, buffer, spermine and the 
oligonucleotide-EDTA with Fe. This solution was incubated for 30 minutes 
at  25°C before the cleavage reaction was initiated by the addition of DTT to 
make a final volumn of 40 yL. The reaction was stopped by precipitation: 60 
yL water was added followed by 20% NaOAc-solution (10 yL) and 300 yL cold 
ethanol, and the DNA was precipitated as usual. The pellets were rinsed 
once with 70% cold ethanol (50 yL) and briefly dried in vacuo. To each pellet 
a certain volume of ficoll loading buffer was added (2.5% ficoll 400, 1xTAE- 
buffer, 0.02% bromophenol blue and 0.02 xylene yanol) t o  give 
approximately 600 c p m L  for each reaction. To dissolve the pellet the tubes 
were vortexed 10 sec). 20 yL of the resulting solutions were transferred to  
new tubes and counted afterwards. The volume of buffer was loaded on 
each lane to give the same amount of radioactivity (-6000 cpm/lane) for each 
reaction. Electrophoretic separation of the cleavage products was achieved 
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on a 0.9% agarose gel (20~14~0.4  cm, TAE-buffer, 120 V, 4.0 h) until the 
bromophenol blue was 15 cm from the starting position. The gel was dried 
on a Bio-Rad Slab Gel Dryer Model 483 (1.5 h at  80°C) and cleavage products 
were visualized by autoradiography. 
Double strand cleavage of HN-CAT DNA. HIV-CAT was precipitated 
twice from NaOAc with ethanol, rinsed with 70% ethanol, briefly dried in 
vacuo and digested with BamHI according to conditions provided by the 
manufacturers. The linearized DNA was labeled with a - [~~PIGTP using 
DNA polymerase according to  standard procedures. Purification of the 
labeled DNA and performance of the cleavage experiments were carried out 
exactly as described for the double-stranded cleavage of pDMAGlO except 
where sodium ascorbate was used instead of DTT as the reducing agent. 
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Figure 3. ~ H N ~ I R  (Me2SO-dg) of oligonucleotide tetramer 5'-T-T-P2-T-3'. 
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Figure 6. Schematic of plasmid HIV-CAT, which contains the entire HIV 
promoter region on a Xho-Hind111 fragment derived from the Long 
Terminal Repeat (LTR) of HIV DNA, and the sequence of the target site. 
Chapter 2 
Extension of Triple Helix Formation. Design of Novel Bases for 
Recognition of CG Base Pairs 
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Introduction 
The sequence specific recognition of double helical DNA is essential for 
the recognition of cellular functions including transcription, replication 
and cell division. The ability to design synthetic molecules that bind 
specifically to unique sequences on human DNA could have major 
implications for the treatment of genetic, neoplastic, and viral diseases (1- 
3). 
Triple Helix Formation. Double helical DNA recognition using 
pyrimidine oligonucleotides by triple helix formation offers a powerful 
chemical approach for the sequence-specific binding of double helical DNA. 
Specificity arises from base triplets (T*AT and C+GC) formed by Hoogsteen 
base pairing of the second pyrimidine strand with the purine strand of the 
double helix (4-20). It is believed that each base pair (bp) in a homopurine 
double helical DNA sequence involves two specific hydrogen bonds for 
triple helix formation in which the pyrimidine oligonucleotide is oriented 
in the major groove of DNA parallel to the Watson-Crick purine strand (4-7, 
18). In the pyrimidine-Hoogsteen triple strand model, a binding site size of 
>15 homopurine base pairs affords >30 discrete sequence-specific hydrogen 
bonds to  duplex DNA. An oligonucleotide 15 nucleotides (nt) in length could 
conceivably bind uniquely to one site on a human chromosome. 
Moser and Dervan have reported that  homopyrimidine 
oligodeoxyribonucleotides with EDTAeFe(I1) attached at a single position 
bind the corresponding homopyrimidine/homopurine tracts within large 
double-stranded DNA by triple helix formation and cleave at  those sites (4). 
Cleavage efficiency by homopyrimidine probes is sensitive to single base 
mismatches. Cleavage by triple strand formation is not observed in the 
absence of cations such as spermine or cobalt hexamine, which are 
necessary to overcome the repulsion between the anionic chains of the 
Watson-Crick duplex and the third negatively charged phosphodiester 
backbone. The binding affinities of oligonucleotides containing cytosine are 
sensitive to  pH. The sensitivity of binding also depends on the number and 
position of cytosines in the oligonucleotides (21). This is probably influenced 
by the requirement for protonation of cytosine N-3 in the third strand to 
enable the formation of two Hoogsteen hydrogen bonds. 
Povsic and Dervan have shown that oligonucleotide-EDTAoFe(I1) 
probes containing 5-bromouracil and 5-methylcytosine bind and cleave at  
the target site dA5(GA)5 with specificity comparable to  those of their 
thymine-cytosine analogs, but with greater affinities and over an extended 
pH range (5). However, because the protonation of N3 is still required for 5- 
methylcytosine, triple helix formation a t  consecutive G-rich sequences is 
still limited over a wide range of pH. Recently, an oligonucleotide- 
EDTAoFe(I1) probe containing 3-methyl-5-amino-pyrazolo(4, 3- 
d)pyrimidine-7-one (PI)  was shown to  bind and cleave duplex DNA 
containing the sequence dAqGAqGgA with specificity comparable to  5- 
methylcytosine, but with greater affinities and over an extended pH range 
(22). This finding allows the recognition of the consecutive G-rich double 
helical DNA via triple helix formation over an extended pH range. 
Less well understood is purine oligonucleotide recognition of double 
helical DNA (purineopurineopyrimidine triplets) (23-26). Purine 
oligonucleotides have been postulated to bind parallel to  the purine strand 
in duplex DNA by triple helix formation (AoAT and GoGC base triplets) 
(26). a-Oligonucleotides have also been observed t o  form triple-stranded 
structures (27, 28). 
G-TA ?-CG 
Figure 1. (Top) Isomorphous base triplets T*AT and C+ GC. (Middle and 
Bottom)  New base triplets Pl*GC,  G*TA and unknown base triplet ?*CG. 
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Extension of triple helix formation. Because homopyrimidine, 
homopurine and synthetic base oligonucleotides limit triple helix formation 
to homopurine tracts containing AT and GC base pairs, it is desirable to  
study whether oligonucleotides can be designed to bind to all four base pairs 
of DNA (Figure 1). A general solution would allow targeting of 
oligonucleotides (or their analogs) to any given sequence. Recently, Horne 
and Dervan have shown that the incorporation of a 3'-3' phosphodiester and 
1,2-dideoxy-D-ribose linker permits construction of a pyrimidine 
oligonucleotide that binds to  a stretch of purines on one strand of the DNA 
double helix and then crosses over the major groove to bind to  a stretch of 
purines on the opposite side of the major groove (29). This work extended 
the triple helix formation to  mixed DNA sequences of the type 
( ~ u r i n e ) ~ N N ( p y r i m i d i n e ) ~ .  Griffin and Dervan found that guanine 
contained within a pyrimidine oligonucleotide specifically recognized 
thymineeadenine base pairs (GeTA base triplets, Figure 1) (30). Although 
there are sequence-composition effects, this finding extended specific 
recognition within the pyrimidine triple helix motif to  three of the four 
possible base pairs in double helical DNA. 
It is our goal to design and synthesize a novel base that can bind CG 
base pairs strongly and selectively for the extension of triple helix 
formation to the four possible base triplets in double helical DNA. From 
model building studies we have chosen isoguanosine analogs (G' and G"), 
3-methyl-5-amino-pyrazolo(4,3-d)pyrimidine-7-one analogs (PI and P2), and 
cytosine analogs (C, C' and C") as initial targets (Figure 2) and an abasic 
compound as a reference for the relative recognition. Enzymatic digestion 
of oligonucleotides containing synthetic bases gives their corresponding 
!% 
nucleosides as detected by HPLC except oligonucleotides containing 2- 
pyrimidinone (C'). Oligonucleotides containing 2-pyrimidinone gave the a- 
anomer, P-anomer and pyrimidinone, which indicates that the p-anomer 
undergoes anomerization and acid catalyzed hydrolysis during 
oligonucleotide synthesis. Isoguanosine analogs G' and G", and isocytosine 
(C") have been found to recognize CG base pairs very weakly. However, 
cytosine, 2-pyrimidinone (a mixture of a-anomer, p-anomer and acid and 
P 1 *CG C '*CG 
Figure 2. Possible base triplets GoTA, G'mCG, P1.CG and C'mCG. 
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acid hydrolyzed products) and P1 have been found to recognize 
moderately CG base pairs relative to TOAT, CoGC, PloGC, and 
GOAT. The utility of cytosine, 2-pyrimidone, and P1 is demonstrated 
in the site-specific binding of an 18 base pair sequence in SV40 DNA 
and 16 base pair sequence in HIV DNA containing all four base pairs. 
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Result and Disscussion 
Synthesis of nucleosides. The synthetic scheme of phosphoramidite 9 
(G") is shown in Figure 3. 5-Methylamino-1-(2',3',5'-triacetyl-PD- 
ribofuranosyl)imidazole-4-carboxamide 1 was prepared by the published 
method (31). Dehydration of compound 1 in the presence of phosphorous 
oxychloride gave nitrile 2 in 75% yield (32). Compound 2 was reacted with 
benzoyl isocyanate and subsequent annulation gave 3-methylisoguanosine 
(3). Benzoyl protected 3-methylisoguanosine 4 was prepared by the known 
method from 3 (33). Compound 4 was protected with 1,3-dichloro-1,1,3,3- 
tetraisopropylsiloxane (TIPDC12) to give compound 5 (34) and subsequent 
methylation of 5 gave compound 6 (35). Deprotection of 6 by 
tetrabutylammoniun fluoride (TBAF) gave compound 7. The 5' hydroxyl 
group of compound 7 was protected with 4,4-dimethoxytritylchloride 
(DMTC1) to  give compound 8, and the reaction of 8 with 2-cyanoethyl-N,N- 
diisopropylchlorophosphoramidite afforded the phosphoramidite 9 ( G"). 
l-(2'-deoxy-5'-dimethoxytrityl-~D-ribofuranosyl)-2(1H)-pyrimidinone-3'-N, 
N'-diisopropylamino-2-cyanoethylphosphoramidite (C', 10) was synthesized 
according to the method of Rolf Altermatt and Christoph Tamm (Figure 4) 
(36-38). ~ ~ - ~ e n z o ~ l - ( 2 ' - d e o x ~ - 5 - d i m e t h o x ~ t r i t ~ l - ~ i -  
dine-3'-N,N'-diisopropylamino-2-cyanoethylphosphoramidite (C", 11) was 
prepared by the published method (39,40). Synthesis of protected 
isoguanosine (G') and 3-methyl-5-amino-pyrazolo(4, 3-d)pyrimidine-7-one 
phosphoramidites (PI and P2) was prepared according to the method of 
J.S. Koh and P.B. Dervan (22). Abasic phosphoramidite (5-0-(4,4'- 
dimethoxytrityl)-l,2-dideoxy-D-ribose-3-(~-cyanoethyl-N, N-diisopropy1)- 
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Figure 3. Synthetic scheme of phosphoramidite 9 (C'). a) POC13lTEA b) 
OCNCOC~HI;/DMF c) NH40HIEtOH d) BzCVpyNaOH e) TIPDC12lpy f) 
C H 3 I I A g 2 O  g) TBAFITHF h )  DMTClIpy i)  2-cyanoethyl N, N- 
diisopropylchlorophosphoamidite/diisopropylaminelmethylene chloride. 
OBz 
Figure 4.The structures of phosphoramidites 10 (C') , 11 (C"), P I ,  P2,  Ab 
and G'. 
The chemical structures of C', C", P I ,  P2, Ab, G' are shown in Figure 4. 
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Synthesis of oligonucleotides containing novel base heterocycles. 
Oligonucleotides 12-31 were synthesized using P-cyano-phosphoramidite 
chemistry (41). The novel base phosphoramidites PI ,  P2, G" C" and the 
abasic phosphoramidite were coupled with an efficiency equal to  A, G, C 
and T phosphoramidites, but deoxyriboisguanosine (GI) and 2- 
pyrimidinone (C') showed lower yields due to depurination, anomerization 
or dep yrimidination during oligonucleotide synthesis (42). I t  has been 
reported that deoxyriboisoguanosine derivatives and 2-pyrimidinone are 
acid labile (42). Because oligonucleotides 12-31 contain thymidine-EDTA 
(dT*), 0.1N NaOH was substituted in the deprotection steps for NH40H to 
circumvent possible aminolysis of the T* ethylester (43). 
Enzyme digestion product analysis of oligonucleotides. The stability of 
the synthetic bases during automated synthesis and base deprotection is 
very important. The oligonucleotide and its composition of bases obtained 
from the oligonucleotide synthesizer can be analyzed by HPLC to ensure 
that the individual base is not chemically changed during the synthesis. 
Purified oligonucleotides were digested with snake venom 
phosphodiesterase and calf intestine alkaline phosphatase t o  give 
corresponding nucleosides. Snake venom phosphodiesterase treatment of 
oligonucleotides gives 5'-monophosphate nucleotides, and subsequent calf 
intestine alkaline phosphatase treatment of the mononucleotide gives the 
corresponding nucleosides. HPLC analysis of the enzyme digested products 
was carried out on a C18 reverse phase HPLC column using 10 mM 
ammonium phosphate pH 5.118% MeOH as the eluent. All of the 
oligonucleotides gave only their corresponding nucleosides except for 
oligonucleotides containing C' . 
L. .  . . . .- _ .. . .. -1 i 
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Oligonucleotides containing C' gave the 2-hydroxypyrimidinone base, the P- 
anomer and a-anomer (Figure 5). It is believed that 1-(P-D-2'-deoxyribosy1)- 
2-pyrimidinone undergoes anomerization during the deprotection of DMT 
by trichloroacetic acid and then loses the base slowly in water (42). The 
proposed mechanism of anomerization is described in Figure 6. The P- 
anomer can form the oxonium ion in the presence of acid. Subsequent 
nucleophilic reaction can give a mixture of anomers. 
I 
HO 
- H+  a-anomer 
Figure 6. The possible mechanism of anomerisation of 1-(P-D-2'- 
deoxyribosy1)-2-pyrimidinone. 
Binding-cleavage of oligonucleotide to 30 mer complex. The relative 
affinities of the bases thymidine (T) , cytosine (C), guanosine (G), 
isocytosine (C"), 2-pyrimidinone (C', a mixture of a , P- anomer and 
hydrolyzed products), PI ,  P2, Ab, isoguanosine (G'), and 3-methyl-N6- 
methyl-isoguanosine (G") for all possible base pair combinations within a 
pyrimidine triple helix motif were examined (Figure 7a). The use of 
oligonucleotides equipped with the DNA cleaving moiety thymidine- 
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EDTAeFe(I1) (T*) allowed the relative stabilities of triple helix formation 
between 30 base pair  (bp) DNA duplexes containing the  sites 
d(A7XA7)/d(TyYA7) (XY=AT, GC, TA or CG) and a series of 15 n t  
oligonucleotides differing a t  one base position d(T7NTy)(N=T, C, G, C', C", 
PI ,  P2, Ab, G' and G") to be determined by the affinity cleaving method. 
The 30-bp duplexes were labeled with 3 2 ~  a t  the 5' end of the target site 
strand d(T7YT7). The DNA binding-cleaving reactions of oligonucleotides 
12-21 were performed under conditions that were sensitive to the stability of 
the base triplet formed upon hybridization of a T7NT7 oligonucleotide and 
triple helix formation (pH 7.4, 35"C, 40% ethanol). The most intense 
cleavage patterns were observed for the conditions N=T, XY=AT, N=C, 
XY=GC, N=Pl,  XY=GC, N=C', XY=CG, N=G, XY=TA (Figure 7b, c and d). 
The cleavage observed for three of these combinations represents the 
previously known ability of T to bind AT, C to bind GC, P1 to bind GC and G 
to bind TA base pairs. P 1  strongly recognizes the GC base pair as  reported 
(22). Strong and selective cleavage patterns are observed for the base C' in 
C'eCG base triplets, while moderate cleavage patterns are observed for the 
base P 1  in  PleCG, Ab in  AbeCG and C in  CeCG triplet. Isoguanosine 
analogs G' and G" show selectivity for GC recognition but not for CG 
recognition. The selectivty of C' in  the C'eCG triplet is due to the removal of 
the amino group of C. It is not clear why cleavage is stonger in the Ct*CG 
triplet than in  the CeCG triplet, since the oligonucleotide contains a 
mixture of the a-anomer, p-anomer and hydrolyzed base. Although 
isocytosine can accept one hydrogen bond a t  N3 in  C"*CG, C" shows only 
very weak cleavage and is selective for AT and CG base pairs over GC and 
TA base pairs. From model building studies, it is  possible that  the C5 
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hydrogen in the C of the Watson-Crick strand can interact with the N2 
hydrogen in third strand in the C"*CG triplet (Figure 8). The bases P1 and 
C" were designed to form one hydrogen bond each to  the CG base pair, as is 
postulated for the GeTA and CeCG triplets, but the cleavage efficiency is 
low. The difference in cleavage efficiency might be due to  the different 
hydrogen bond acceptor, base stacking or the backbone position. 
Figure 7a. (Above) Sequence of oligonucleotides-EDTA (12-21) where T* is 
the position of thymidine-EDTA. The oligonucleotides differ a t  one base 
position indicated in bold type. (Below) The box indicates the double- 
stranded sequence bound by oligonucleotide-EDTA*Fe(II) (12-21). The 
Watson-Crick base pair (AT, GC, TA or CG) opposite the variant base in the 
oligonucleotide is also in bold type. The arrow indicates a cleavage site and 
intensity. 
Figure 7b. Autoradiogram of the 20 percent denaturing polyacrylamide gel. 
The cleavage reactions were carried out by combining a mixture of 
oligonucleotide-EDTA (2pM), spermine (1 mM), and Fe(I1) (25pM) with the 
3 2 ~  labeled 30-mer duplex (40,000 cpm) in a solution of tris-acetate (25 mM 
pH 7.4), NaCl(100 mM), calf thymus DNA (100pM bp), and 40% ethanol and 
incubating a t  35OC for 1 hour. Cleaving reactions were initiated by the 
addition of D n '  (3 mM) and allowed to proceed for 6 h at  35OC. The reactions 
were frozen and lyophilized and the cleavage products were analyzed by gel 
electrophoresis. Lanes 1 to 14: duplex containing 5' end- 
labeled(AgT7YT7Glo). Lane 1: control showing intact 5'labeled 30 bp DNA 
standard obtained after treatment according to the cleavage reaction in the 
absence of oligonucleotide-EDTA. Lane 2: products of Maxam-Gilbert G+A 
sequnce reaction. Lanes 3 to  18: DNA cleavage products produced by 
oligonucleotide-EDTAeFe(I1) (12, 13 and 14); 12 (lanes 3 to  6); 13 (lanes 7 t o  
10); 14 (lanes 11 to 14); XY=AT (lanes 3, 7,and 11); XY=GC (lanes 4, 8, and 
12); XY=CG (lanes 5'9, and 13 ); XY=TA (lanes 6, 10, and 14). 
Oligo. 12(G') 
X= A G C T  
1 3(GW) 14(c) 
A G C T  A G C T  
7 8 9 1 0  11 1213 14 
Figure 7c. Autoradiogram of the 20 percent denaturing polyacrylamide gel. 
The cleavage reactions were carried out by combining a mixture of 
oligonucleotide-EDTA (2 pM), spermine (1 mM), and Fe(I1) (25 pM) with the 
3 2 ~  labeled 30-mer duplex (40,000 cpm) in a solution of tris-acetate (25 mM 
pH 7.4), NaCl (100 mM), calf thymus DNA (100 pM bp), and 40% ethanol 
and incubating at 35OC for 1 hour. Cleaving reactions were initiated by the 
addition of DTT (3.3 mM) and allowed to proceed for 6 h at  35OC. The 
reactions were frozen and lyophilized and the cleavage products were 
analyzed by gel electrophoresis. Lanes 1 to 22: duplex containing 5' end- 
labeled(AgT7YT7Glo). Lane 1: control showing intact 5' labeled 30 bp DNA 
standard obtained after treatment according to the cleavage reaction in the 
absence of oligonucleotide-EDTA. Lane 2: products of maxam-Gilbert G+A 
sequnce reaction. Lanes 3 to 22: DNA cleavage products produced by 
oligonucleotide-EDTAoFe(I1) (14-18); 14 (lanes 7 to 10); 15 (lanes 3 t o  6); 16 
(lanes 11 to 14); 17 (lanes 15 to 18); 18 (lanes 19 to  22). XY=AT (lanes 3,7, 11, 
15, and 19); XY=GC (lanes 4, 8, 12, 16, and 20); XY=CG (lanes 5, 9, 13, 17, 
and 21); XY=TA (lanes 6, 10, 14, 18, and 22). 
Oligo. 15(T) 
X= A G C T  
14(c) 16(C') 17(G) 
A G C T  A G C T  A G C T  
1 8(CW) 
A G C T  
Figure 7d. Autoradiogram of the 20 percent denaturing polyacrylamide gel. 
The cleavage reactions were carried out by combining a mixture of 
oligonucleotide-EDTA 2 pM), spermine (1 mM), and Fe(I1) 25 pM) with the 
3 2 ~  labeled 30-mer duplex (40,000 cpm) in a solution of tris-acetate (25 mM 
pH 7.4), NaCl (100 mM), calf thymus DNA (100 pM bp), and 40% ethanol 
and incubating at  35OC for 1 hour. Cleaving reactions were initiated by the 
addition of DTT (3.3 mM) and allowed to  proceed for 6 h at  35°C. The 
reactions were stopped, frozen and lyophilized, and the cleavage products 
were analyzed by gel electrophoresis. Lanes 1 to  18: duplex containing 5' 
end-labeled(AgT7YT7Glo). Lane 1: control showing intact 5' labeled 30 bp 
DNA standard obtained after treatment according to  the cleavage reaction 
in the absence of oligonucleotide-EDTA. Lane 2: products of Maxam-Gilbert 
G+A sequnce reaction. Lanes 3 to  18: DNA cleavage products produced by 
oligonucleotide-EDTAoFe(I1) (14, 19-21); 14 (lanes 3 to 6); 19 (lanes 7 to 10); 
20 (lanes 11 to 14); 21 (lanes 15 to 18). XY=AT (lanes 3,7,11, and 15); XY=GC 
(lanes 4, 8, 12, and 16); XY=CG (lanes 5, 9, 13, and 17); XY=TA (lanes 6, 10, 
14, and 18). 
Oligo. 14(c) 19(P1) 20(P2) 24(Ab) 
X = A G C  T  A G C T  A G C T  A G C T  
CG Recognition 
0s 
Watson-Crick Base Pair 
Figure 7e. Bar graph representing the relative cleavage data from 
densitometric analysis of Figures 7b, 7c and 7d. 36 base triplets were 
examined for binding specificity compatible with the pyrimidine triple helix 
motif shown by the experiment described in Figures 7b, c and d. 
- 
R-N 0 2= 
Figure 8. Possible base triplets CW*CG, C'eCG, TeCG and CeCG 
triplets. For each base triplet the positioning of the third base with 
respect t o  Watson-Crick base pair is based on forming possible 
hydrogen bonds with the anti conformation at  the glycosidic link. 
5 ' - ? T G T T T C C T C T  C T  T C T - 3 '  22 
5 ' -?T  G T T  T C C T  C T  C  T  T  C'T-3' 23 
5 ' - ? T G T T T C C T C T C T T B ~ T - 3 '  2 4  
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Figure 9a. (Top)  Oligonucleotides 22 -24 constructed from 
deoxyribonucleotide phosphoramidites containing cytosine (C), 2- 
pyrimidinone (C'), thymidine, PI and thymidine-EDTA (T*). (Bottom) 
Coarse resolution pattern for cleavage of plasmid DNA (4.95 kbp) by 
oligonucleotides-EDTA 22-24 with a simplified model of the triple 
helical complex between oligonucleotids 22-24 and a 16 base pair single 
site. 
Figure 9b. Autoradiogram of double strand cleavage of pHN-CAT 
DNA (4.95 kbp) analyzed on a 0.9% agarose gel. The reactions were 
carried out by combining a mixture of oligonucleotides-EDTA 22-24 (2 
pM), spermine 1 mM), and Fe(I1) (2 pM) with the 3 2 ~  labeled 
linearized plasmid [-I00 nM (bp) (-40,000 cpm)] in a solution of tris- 
acetate (25 mM pH 6.2, 6.6, 7.0, 7.4), NaCl (100 mM), calf thymus DNA 
[I00 pM (bp)]. Reactions were incubated for 1 h at 25OC, initiated by the 
addition of ascorbate (1 mM) and allowed to proceed for 10 h at 25OC. 
The reactions were stopped by precipitation with ethanol and the 
cleavage products were analyzed by agarose gel electophoresis (120 V, 
BPB run near the bottom of the gel). Lanes 1 t o  14: pHIV-CAT 
linearized with BamHI and 3'-end labeled at both ends. Lane 1: control 
containing no oligonucleotide-EDTAoFe(I1). Lane 2: DNA size 
markers obtained by digestion of BamHI linearized pHIV-CAT with 
Hind111 and XhoI: 4950 (undigested), 3725, 3003, 1947, and 1225 bp. 
(Lanes 3 to 6) DNA cleavage products produced by 22*Fe(II). (Lanes 7 
to 10) DNA cleavage products produced by 23*Fe(II). (Lanes 11 to 14) 
DNA cleavage products produced by 24oFe(II). (Lanes 3, 7 and 11) at  
pH 6.2, (lanes 4,8 and 12) at  pH 6.6, (lanes 5 ,9  and 13) at pH 7.0, (lanes 
6,10 and 14) at pH 7.4. 
Oligo. 22(c) 23(C') 2 11(P1) 





C C ' P 1 
Third Strand 
Figure 9c. Bar graph presenting the relative cleavage data from the 
densitometric analysis of Figure 9b. 
Site-specific double strand cleavage of pHN-CAT plasmid DNA. The 
ability of oligonucleotides 22-24 to cause site-specific double strand breaks in 
HIV-CAT plasmid DNA is documented in Figure 9a. pHIV-CAT was 
digested with Barn HI to  produce a 4.95 kbp fragment, which contained the 
3' long terminat  repeat (LTR) of HIV with the  site 
d(AATAAAGGAGAGAACA) located 1.52 kbp and 3.43kbp from the ends. 
Cleavage a t  this site demonstrates binding to  a sequence containing all 
four base pairs. The 3 2 ~  end labeled DNA was allowed to  react with 
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oligonucleotide-EDTA.Fe(I1) in the presence of ascorbate at  30°C (pH 6.2 t o  
7.0). Separation of the cleavage products by agarose gel electrophoresis 
revealed one major cleavage site producing two DNA fragments, 1.52 and 
3.43 kb in size (Figure 9b). The cleavage efficiency by 01igonucleot;ides 22-24 
was very sensitive to pH, and very little cleavage was observed above pH 6.6 
(Figure 9b). Interestingly, oligonucleotide-EDTAaFe(I1) containing 2- 
pyrimidinone (23) does not show significantly strong cleavage efficiency. 
This finding is not consistent with the oligonucleotide data where the 
cleavage intensity observed for the C'aCG base triplet is greater than for the 
CaCG and PlaCG base triplets. 
Cleavage of SV40 PpuRlI-BglI restriction fragment at a site containing 
a TA and CG base pair. The cleavage of a 596 bp SV40 restriction fragment 
by the oligonucleotides-EDTAaFe(I1) series 25-28 (5'-T*T2GT4CTNT5CT-3') 
was examined (Figures 10a, b, and c). This restriction fragment contains 
the 18-bp sequence d(AAATAAAGA@JAAAAAGA), which represents a 
purine-rich site containing two pyrimidines (T and C). Cleavage at this site 
demonstrates binding of a sequence containing all four base pairs. The 
cleavage efficiencies of oligonucleotides 2 5-28, which differ at  one base 
position opposite the CG Watson-Crick base pair, were examined under 
conditions sensitive to  the stability of the base triplets at  the CG sites (pH 
7.4,37"C). Oligonucleotides-EDTA 26 (CaCG) and 27 (PlaCG) produced the 
most significant site specific cleavage on the 596-bp fragment. 
Oligonucleotides-EDTA.Fe(I1) 25 (TaCG) and 28(P2*CG) show only 
moderate cleavage. This finding is consistent with oligonucleotide data 
where the cleavage intensities observed for the TaCG and P2aCG base 
triplets are very weak. 
Figure 10a. (Above) Sequence of oligonucleotides-EDTA 25-28 where T* is 
the position of thymine-EDTA. The oligonucleotides differ a t  one base 
position indicated by bold type. (Below) The box indicates the double strand 
sequence bound by oligonuceotides-EDTAeF'e(I1) 25-28 in SV40 restriction 
fragment. 
F i g u r e  lob. (Le f t )  Autoradiogram of an  8 percent denaturing 
polyacrylamide gel of the cleavage reactions on a PpuMI-BglI restriction 
fragment of SV40 DNA. The cleavage reactions were carried out by 
combining a mixture of oligonucleotide-EDTA (2 pM), spermine (1 mM), 
and Fe(I1) (25 pM) with the 3 2 ~  labeled restriction fragment [-I00 nM(bp) 
(20,000 cpm)] in a solution of Tris-acetate, pH 7.4 (50 mM), NaCl (100 mM), 
and calf thymus DNA [I00 pM (bp)]. This was incubated at  37OC for 1 hour. 
Cleavage reactions were initiated by the addition of DTT (3 mM) and 
allowed to proceed for 4 h at  37OC. The reactions were stopped by 
precipitation with ethanol and the cleavage products were analyzed by gel 
electrophoresis (BPB 30 cm). Lanes 1 to 6: 3' end-labeled PpuMI-BglI 
restriction fragment of SV40. Lane 1: control containing no oligonucleotide- 
EDTAoFe(I1). Lane 2: Maxam-Gilbert G sequencing reactions. Lanes 3 to  6: 
DNA cleavage products by oligonucleotide-EDTAoFe(I1) (25-28): 25 (lane 3); 
26 (lane 4); 27 (lane 5); 28 (lane 6). 
F igu re  10c. ( R i g h t )  Autoradiogram of an 8 percent denaturing 
polyacrylamide gel of the cleavage reactions on a PpuMI-BglI restriction 
fragment of SV40 DNA. The cleavage reactions were carried out by 
combining a mixture of oligonucleotide-EDTA (2 pM), spermine (1 mM), 
and Fe(I1) (25 pM) with the 3 2 ~  labeled restriction fragment [-I00 nM(bp) 
(20,000 cpm)] in a solution of Tris-acetate, pH 7.4 (50 mM), NaCl (100 mM), 
and calf thymus DNA [I00 pM (bp)]. This was incubated at  37OC for 1 h. 
Cleavage reactions were initiated by addition of DTT (3 mM) and allowed to 
proceed for 4 h at 37OC. The reactions were stopped by precipitation with 
ethanol and the cleavage products were analyzed by gel electrophoresis 
(BPB 30 cm). Lanes 1 to 6: 5' end-labeled PpuMI-BglI restriction fragment of 
SV40. Lane 1: control containig nooligonucleotide-EDTAoFe(I1). Lane 2: 
Maxam-Gilbert G sequencing reactions. Lanes 3-6: DNA cleavage products 
by oligonucleotide-EDTAoFe(I1) (25-28); 25 (lane 3); 26 (lane 4); 27 (lane 5); 28 
(lane 6). 
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32~> PDuMI - Ball 
Figure 1Od. (Top) Sequence of oligonucleotides-EDTA 25, 26, 27, and 28 
where T* is thymidine-EDTA.(Below) Histogram of the DNA cleavage 
patterns for oligonucleotides 2 7  derived from densitometry of 
autoradiogram in Figures 9b and c. The box indicates the original target 
sequence. 
Double Strand Cleavage of SV40 DNA The double strand cleavage of 
SV40 DNA by the oligonucleotide-EDTAaFe(I1) series 25-27, 29-31 (5'- 
T*TzGT~CTNT~CT-~')  was examined. SV40 contains the 18-bp sequence 
d( AAATAAAGAC AAAAAGA), which represents a purine-rich site 
containing two pyrimidines (T and C). Cleavage at this site demonstrates 
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binding to a sequence containing all four base pairs. The cleavage 
efficiencies of oligonucleotides 25,26, 27,29, 30, and 31 which differ at a 
single position opposite a CG Watson-Crick base pair, were examined 
under conditions sensitive to the stability of the base triplets at  the CG sites 
(pH 7.4, 37°C). SV40 DNA was digested with BclI to produce a 5.24 kbp 
fragment, which contained the sequence d(AAATAAAAGACAAAAAGA) 
located 2.21 kbp and 3.03 kbp from the ends. The 3 2 ~  end-labeled DNA was 
allowed to react with oligonucleotide-EDTA*Fe(II) in the presence of 
ascorbate (pH 7.0, 30°C or 37OC). Separation of the cleavage products by 
agarose gel electophoresis reveals one major cleavage site producing two 
DNA fragments, 2.21 and 3.03 kb in size (Figures l l a  and b). Interestingly, 
oligonucleotide-EDTA*Fe(II) 29 which contains the abasic compound 
(AbmCG) produced significant site specific cleavage, which is consistent 
with earlier oligonucleotide studies. Oligonucleotides-EDTA*Fe(II) 2 6 
(C*CG) and 27 (Pl*CG) also produced significant site specific cleavage. 
However, oligonucleotides 25,30 and 31 did not produce significant site- 
specific cleavage. The effects of temperature on binding to this sequence for 
oligonucleotides 26,27,29,30,31 are presented in bar graph form in Figure 
1 ld. Raising the temperature increases the stringency of triple helix 
formation. 
3's 
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Figure lla. (Top) Oligonucleotides 25,26,27,29,30 and 31 constructed from 
deoxyribonucleotide phosphoramidites containing cytosine(C), 2- 
pyrimidinone(C'), isocytidine(C"), thymidine, PI,  Ab and thymidine-EDTA 
(T*). (Bottom) Coarse resolution pattern for cleavage of plasmid DNA (4.95 
kbp) by oligonucleotides-EDTA 25,26,27,29,30 and 31 with a simplified 
model of the triple helical complex between oligonucleotides 25, 26,27,29, 
30 and 31 (T, C , G, T*/X, X=T, C, PI, Ab, C' and C") and an 18 base pair 
single site. 
Figure l l b  Autoradiogram of double strand cleavage of SV40 DNA (5.24 kbp) 
analyzed on a 0.9% agarose gel. The reactions were carried out by 
combining a mixture of oligonucleotide-EDTA (2 pM), spermine (1 mM), 
and Fe(I1) (2 pM) with the 3 2 ~  labeled linearized plasmid [-I00 nM (bp) 
(-40,000 cpm)] in a solution of tris-acetate (25 mM, pH 7.4), NaCl (100 mM), 
Calf thymus DNA [I00 pM (bp)] and incubated for 1 h a t  the reaction 
temperature. Cleavage reactions were initiated by addition of ascorbate (1 
mM) and allowed to proceed for 10 h at 37OC. The reactions were stopped by 
precipitation with ethanol and the cleavage products were analyzed by 
agarose gel electophoresis (BPB run near the bottom of the gel). Lanes 1-6: 
SV40 linearized with BclI and 3'end-labeled at both ends. Lane 1: control 
containing no oligonucleotide-EDTAoFe(I1). Lane 2: DNA size markers 
obtained by digestion of BclI linearized SV40 with HaeII and BglI: 5243 
(undigested), 3305, 2778, 2465, 1938 bp. Lane 3: DNA cleavage products 
produced by 29*Fe(II). Lane 4: DNA cleavage products produced by 
26*Fe(II). Lane 5: DNA cleavage products produced by 27 oFe(I1). (Lane 6) 
DNA cleavage products produced by 25*Fe(II). 
Con. MW Ab C PI 1 
Figure l l c  Autoradiogram of double strand cleavage of SV40 DNA (5.24 kbp) 
analyzed on a 0.9% agarose gel. The reactions were carried out by 
combining a mixture of oligonucleotide-EDTA (2 pM), spermine (1 mM), 
and Fe(I1) (2 pM) with the 3 2 ~  labeled linearized plasmid [-I00 nM (bp) 
(-40,000 cpm)] in a solution of tris-acetate (25 mM, pH 7.4), NaCl (100 mM), 
calf thymus DNA [I00 pM (bp)] and incubated for 1 h a t  the reaction 
temperature. Cleavage reactions were initiated by addition of ascorbate(1 
mM) and allowed to proceed for 10 h a t  the reaction temperature. The 
reactions were stopped by precipitation with ethanol and the cleavage 
products were analyzed by agarose gel electophoresis (BPB run near the 
bottom of the gel). Lanes 1-12: SV40 linearized with BclI and 3'end-labeled 
a t  both ends. Lanel: Co 
Lane 2: DNA size mark 
with HaeII and BglI: 5243 (undigested), 3305,2778,2465,1938 bp. Lanes 3 to 
7: reaction a t  30°C. Lanes 8-12: reaction at  37°C. Lanes 3 and 8: DNA 
cleavage products produced by 29*Fe(II). Lanes 4 and 9: DNA cleavage 
products produced by 26*Fe(II). Lanes 5 and 10: DNA cleavage products 
produced by 27*Fe(II). Lanes 6 and 11: DNA cleavage products produced by 
30*Fe(II). Lanes 7 and 12: DNA cleavage products produced by 31*Fe(II). 

Third Strand 
Figure l ld.  Bar graph representing the relative cleavage data fkom the 
densitometric analysis in Figure l lc .  
130 
Conclusions 
The novel base 3-methyl-5-amino-pyrazolo(4, 3-d)pyrimidine-7-one (PI), 
cytosine and an abasic compound (Ab) enable the selective cleavage of a 
site containing all four base pairs by triple helix formation. However 
isoguanosine analogs (G and G") and isocytidine (C") do not recognize a 
CG base pair in triple helix formation. Because oligonucleotides containing 
the 2-a-pyrimidinone (C') nucleoside give a mixture of a-anomer, P- 
anomer and hydrolyzed products due to its acid sensitivity, it is not clear 
whether this base recognizes a CG base pair in triple helix formation. 
Although the Pl*CG, C*CG and Ab*CG triplets within a pyrimidine 
oligonucleotide extend triple helix specificity to all four possible base pairs 
of double helical DNA, some limitations on sequence composition exist. 
This result provides important structural ideas for the design of 
nucleosides (or their analogs) with nonnatural heterocycles directed 
toward a more general solution to  sequence-specific recognition of double 
helical DNA a t  any sequence. 
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Experimental method and Materials 
Sy~lthesis. ~ N M R  spectra were recorded at 400 MHz on a JEOL-GX 400 
NMR spectrometer. Chemical shifts are reported in parts-per-million 
downfield from tetramethylsilane. IR spectra were recorded on a Shimadzu 
IR-435 Infrared Spectrometer. High resolution Fast Atom Bombardment 
Mass Spectra (FABMS) and EI mass spectra were obtained at  the 
University of Nebraska, Lincoln and the Mass Spectra Lab at  the University 
of California, Riverside. Flash chromatography was carried out under 
positive air pressure using EM Science Kieselgel 60 (230-400 mesh). 
Elemental analyses were performed by the analytical lab at  Caltech. 
Reagent grade chemicals were used as received, except for 
diisopropylethylamine, which was distilled from CaH2. A Beckman 
System1 Plus DNA synthesizer was utilized for the synthesis of 
oligonucleotides. Concentrations of oligonucleotides were determined by 
UV using a Perkin-Elmer Lambda 4C UV-Vis spectrometer. Analytical 
HPLC was performed on a BrownLee Labs Aquapore OD-300 4.6 mm x 22 
cm 7 micron C18 column using no precolumn. All enzymes for DNA 
manipulation were purchased from Boehringer Mannheim. 
5-methylamino- 1- (2', 3', 5'-triacetyl-P-D-ribofuranosyl)imidazole-4- 
car-bonitrile (2). To a solution of compound 1 (2.8 g, 7.03 mmol ) and 
triethylamine in chloroform (100 mL) was added phosphorous oxychloride 
(3.22g , 21 mmol), and the mixture was stirred for 30 minutes under argon. 
Cold water (100 ml) was added to the reaction solution and the mixture was 
extracted with chloroform (200 mL). The organic layer was washed with 
water (100 mL), dried over Na2S04, and concentrated in vacuo to  give a 
crude product of 3, which was then chromatographed on a silica gel 
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column with chloroform and 10% ethanol in chloroform (vlv, Rf=0.48) to  
give 2 (2.0 g, Y=75%). ~ N M R  (DMSO-d6) 6 7.58 (s, lH), 6 6.54 (m, 1H) , 6  5.79 
(d, lH, J=6.12, HI' ), 6 5.56 (t, 1H, J=6.12, H2'), 6 5.32 (m, lH), 6 4.25 (m, 3H), 
6 2.95 (d, 3H, J=3.12, methyl), 6 2.10 (s, 3H), 6 2.07 (s, 3H), 6 2.05 (s, 3H). IR 
(KBr) 2200 cm-1. FABMS calcd. for C16H21N407 (M+H)+ 381.1410. Found 
381.1418. 
3-Methylisoguanosine (3). A solution of compound 2 (2.0 g, 5.26 mmol) 
and benzoylcyanate (1.16 g, 7.80 mmol) in DMF was stirred a t  room 
temperature overnight. The solvent was then evaporated in vacuo (50°C) t o  
afford an oily residue. The residue was suspended in a mixture of ethanol 
(40 mL) and 33% aqueous ammonia (40 mL) in a round bottom flask. The 
flask was well tightened with a rubber stopper, and the mixture was stirred 
a t  room temperature for 72 h. After 72 h, the solvent was removed under 
reduced pressure to  give a yellowish residue. The residue was triturated 
with ethyl acetate, and the precipitated solid was collected by filtration t o  
give 3 (920 mg, Y=58%). ~ H N M R  (DMSO-d6) 6 8.03 (s, lH), 6 7.31 (s, ZH), 6 
6.00 (d, lH, J=6.22, HI'), 6 5.63 (d, lH, J=4.23, 2' hydroxy ), 6 5.27 (d, lH, 
J=4.12, 3' hydroxy,), 6 5.07 (t, lH, J=5.11, 5' hydroxy), 6 4.35 (t, lH, J=6.22, 
H2'), 6 4.06 (m, lH), 6 3.91 (lH, m), 6 3.57 (m, 5H). FABMS calcd. for 
CllH15N504 (M+) 281.1124. Found 281.1130. 
~-be1~zoyl-3-methylisogu~osine (4). Compound 3 (500 mg, 1.69 mmol) 
was suspended in dry pyridine (25 mL) in a 100 mL round bottom flask 
equipped with a drying tube and cooled in an ice bath, and benzoyl chloride 
(2.44 g, 16.8 mmol) was added dropwise to the stirring solution. The 
reaction was allowed to warm to room temperature and stirred for 6 h. The 
reaction mixture was neutralized by addition of saturated NaHC03, 
evaporated several times with toluene and ethanol. Ethyl acetate (100 mL) 
was added to this residue and washed with water (50 mL) and 
concentrated to  give a residue. To this residue was added 20 ml of pyridine- 
methanol-water solution (65:35:5, vlvlv) and cooled in an ice bath. 2N NaOH 
solution (20 mL) in pyridine-methanol-water (65:35:5) was added dropwise 
to the reaction mixture with stirring a t  O°C. The reaction mixture was 
stirred over 40 minutes a t  O°C, and 2.4 g of ammonium chloride in water (5 
mL) was added to neutralize the solution. The resulting solution was 
concentrated in vacuo t o  give a solid mixture. 20 ml of 20% methanol in 
ethyl acetate was added and insoluble solid was filtered and washed with 8 
ml of water. The remaining solid was dried to  give 470 mg of compound 4 
(Y=68%). ~ H N M R  (DMSO-d6) 6 12.50 (s,lH), 6 8.21(s, lH), 6 8.09 (m, 2H), 6 
7.53 (m, lH), 6 7.47 (m, 2H), 6 6.06 (d, lH, J=5.23, HI'), 6 5.70 (d, lH, J=5.24, 
2' hydroxy), 6 5.32 (d, lH, J=5.01, 3' hydroxy), 6 5.13 (t, lH, J=4.34, 5' 
hydroxy), 6 4.38 (m, lH), 6 4.12 (m, lH), 6 3.96 (m, lH), 6 3.50-3.70 (m, 5H). 
FABMS calcd. for C18H20N506 (M+H)+ 402.1413. Found 402.1420. 
3-~ethyl- f l -benzo~l-9-  (3', 5'-0- (1,1,3,3-tetraisoprop yldisiloxanyl- P-D- 
ribofuranosy1)isoguanosine (5). To a solution of compound 4 (412 mg, 1 
mmol) in pyridine (10 mL) was added 1,3-dichloro-1,1,3,3-tetra 
isopropyldisiloxane (TIPDC12) (346 mg, 1.1 eq.) and the mixture was stirred 
under argon a t  room temperature for 3 h. Water (20 mL) was added to the 
reaction solution and the mixture was extracted with three 50 mL portions 
of ethyl acetate. The extract was dried over Na2S04; upon concentration it 
afforded a yellowish residue, which was purified on a silica gel using ethyl 
acetate-chloroform solvent (50:50 vlv, Rf=0.51) to  give 500 mg of compound 5. 
~ H N M R  (DMSO-d6) 612.73 (s, lH), 6 8.23 (m, 2H), 6 7.93 (s, IH), 6 7.53 (m, 
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lH), 6 7.46 (m, 2H), 6 6.21 (s, lH), 6 5.98 (d, lH, J=4.46, 2' hydroxy), 6 4.51 (t, 
lH, J=3.12, H3'), 6 4.23 (m, 2H), 6 4.10 (d, lH, J=8.97), 6 3.94 (d, lH, J=13.43), 
6 3.68 (s, 3H). 6 1.10(s, 28H) FABMS calcd. for C30H46N507~i2 (M+H)+ 
644.3285. Found 644.3270. 
3-methyl-Nt;-benzoyl-m-metbl-9-(2'-0-methyl-3', 5'-0-(1,1,3,3,-- te tra- 
isopropyldisiloxanyl-~-D-ribofuranosyl)isoguanosine(6). To a solution of 
compound 5 was added 12 mL of methyl iodide along with silver oxide (400 
mg, 0.63 mmol), and the mixture was stirred under arg& a t  room 
temperature for 3 h and filtered. (The reaction was carried out in the dark 
due t o  the light sensitivity of silver oxide.). The filtrate was evaporated to 
give a yellowish solid, which was chromatographed on silica gel using 40% 
ethyl actate in chloroform (vlv, Rf=0.55) to give 180 mg of 6 (Y=44%). ~ H N M R  
(Aceton-dg) 6 7.93 (d, 2H, J=9.01, benzoyl), 6 7.61 (s, lH), 6 7.46 (m, lH), 6 7.38 
(m, 2H), 6 6.21 (s, lH), 6 4.54 (dxd, lH, J=4.43, 3.35), 6 4.41 (d, lH, J=4.12), 6 
4.12 (m, 3H), 6 3.75 (s, 3H), 6 3.73 (s, 3H), 6 3.47 (s, 3H), 6 1.10 (m, 28H). 
F'ABMS calcd. for C ~ ~ H ~ O N ~ O ~ S ~ ~ ( M + H ) +  672.3248. Found 672.3240. 
3 - M e t h y l - @ - b e n z o y l - M - m e t h y l - 9 - ( 2 ' - 2 ) -  
isoguanosine(7). To a solution of compound 6 (180 mg, 0.28 mmol) in 
tetrahydrofuran (THF) (5 mL) was added dropwise 0.56 mL of 1N 
tetrabutylammonium fluoride solution (TBAF) in  THE' a t  room 
temperature, and the reaction mixture was stirred at room temperature for 
10 minutes, where upon 10 mL of cold water was added. The mixture was 
extracted with 80 ml ethyl acetate and washed with 10 mL of water. The 
organic layer was concentrated under reduced pressure to  give a residue. 
The residue was chromatograped on silica gel using 10% methanol in ethyl 
acetate (vlv, Rf= 0.46) to give 100 mg of 7 (Y=85%). IHNMR(DMSO-~~) 6 7.89 
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(s, lH), 6 7.82 (d, 2H, J=8.56, benzoyl), 6 7.46 (m, 1H), 6 7.38 (m, 2H), 6 5.95 (d, 
lH, J=6.11, Hl'), 6 5.35 (d, lH, J=5.16, 3' hydroxy), 6 5.02 (t, lH, J=4.45, 5' 
hydroxy), 6 4.24 (m, 2H), 6 3.93 (m, IH), 6 3.63 (s, 3H), 6 3.49 (m, 3H), 6 3.43 
(s, 3H), 6 3.33 (s, 3H), 61.10 (m, 14H). FABMS calcd. for C20H24N506 
(M+H)+ 430.1726. Found 430.1730. 
3-methyl-fl-benzoyl-~methyl-9-(2'-0~methyl-5'-0-(4,4'-dimethoxy- 
trity1)-P-D-riboffiranosy1)isogumoshe (8). Compound 7 (90 mg, 0.21 mmol) 
and 4, 4'-dimethoxytritylchloride (DMTC1) was dissolved in dry pyridine (3 
ml). The mixture was stirred at 4OC overnight. The reaction was stopped by 
the addition of methanol (2 mL) and diluted in ethyl acetate (50 mL). The 
organic layer was washed three times with water (20 mL), dried over 
anhydrous Na2S04, filtered, and evaporated to a yellowish solid. This solid 
was chromatographed on silica gel using ethyl acetate t o  afford 125 mg of 8 ( 
Y=83%). ~ H N M R  (acetone-d6) 67.95 (d, 2H, J=8.46, benzoyl), 6 7.56 (s, lH), 6 
7.47 (m, lH), 67.35 (m, 4H), 6 7.21 (m, 7H), 66.80 (d, 4H, J=13), 66.11 (d, 
1H,J=6.34, HI'), 6 4.47 (t, lH, J=5.03, H2'), 6 4.40 (m, 2H), 6 4.21 (m, lH), 6 
3.83 (s, 3H), 6 3.75 (s, 6H), 6 3.52 (s, 3H), 6 3.48 (s, 3H), 6 3.32 (m, lH), 6 3.26 
(m, 1H). FABMS calcd. for C41H42N508 (M+H)+ 732.3011. Found 732.3031. 
Phosphoramidite 9. 2-Cyanoethyl-N, N-diisopropyl-chlorophosph- 
oramidite (69 mg, 0.29 mmol) was added dropwise to  a solution of 8 (120 mg, 
0.16 mmol) and diisopropylethylamine (90.4 mg, 70 mmol) in dry methylene 
chloride (3 mL) under argon. The reaction mixture was stirred a t  room 
temperature for 1 h and then diluted with ethyl acetate (50 mL) and washed 
with saturated NaHC03 (2x50 rnL) and brine (3x50 mL). The organic layer 
was dried over Na2S04 and concentrated under reduced pressure. The 
phosphoramidite diastereomers were purified by flash chromatography 
(ethyl acetatelmethylene chloridelisopropyl alcholeltriethylamine, 
30:64:1.5:1, v/v/v/v, Rf=0.52) to  give 125 mg of 9 (Y=84%). ~ H N M R  (acetone- 
dg) 6 7.95 (d, 2H, J=8.45, benzoyl), 6 7.56 (s, 1H), 6 7.47 (m, lH), 6 7.37 (m, 
2H), 6 7.32 (m, 2H), 6 7.21 (m, 7H), 6 7.6.80 (d, 4H, J=13.10), 6 6.11 (d, lH, 
J=6.11, HI'), 64.47 (t, lH, J=4.98, H2'), 64.40 (m, lH), 64.21 (m, lH), 6 3.83 
(s, 3H), 6 3.75 (s, 6H), 6 3.52 (s, 3H), 6 3.30-3.50 (m, 4H), 6 .47 (s, 3H), 6 2.57 (t, 
lH, J=5.11, methylene), 6 2.42 (t, lH, J=5.11, methylene), 6 0.90-1.30 (m, 
14H). FABMS calcd. for C50H58N70gP 932.4091. Found 932.4108. 
Oligonucleotides Oligonucleotides 12-31 were machine synthesized 
using P-cyanoethyl phosphoramidite chemistry. Modified nucleosides 
coupled with ~ 9 7 %  efficiency except phosphoramidites 12,16,23 and 30. The 
oligonucleotides were removed from the support and deprotected by 
treatment with 0.1 N NaOH(1.5 mL/1 mmol, 55OC, 24 h), neutralized with 
glacial acetic acid (6-7 pL11.5 mL 0.1 N NaOH), applied to a column of 
Sephadex G-10-120 (Sigma), and eluted with water. The crude 
oligonucleotides were lyophilized and purified by the electrophoresis (550V, 
20 h) on a 2 mm-thick 20% polyacrylamide gel (Maxam-Gilbert). The major 
UV-absorbing bands were cut out and eluted (0.2 N NaC1, 1 mM EDTA, 
37"C, 24 h), then passed through Sephadex G-10-120, and dialyzed against 
water for 3 days. 
HPLC analysis. 3 nmols of purified oligonucleotide were digested 
simultaneously with snake venom phosphodiesterase (3 pL, 2 pg/pL) and 
calf intestine alkaline phophatase (3 pL, 1 a L ) ,  in 50 mM Tris, pH 8.1, and 
100 mM MgC12. The reaction mixture was incubated at  37OC for 2 h and 
lyophilized to  dryness. The dry sample was dissolved with 10 pL of Milli-Q 
water. 5 pL of the solution was injected onto a C18 reverse phase column 
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utilizing 8% MeOH in 10 mM ammonium phosphate, pH 5.1, as eluent. 5 
pL of a standard solution containing dC (2 nmol), dT (2 nmol), 2- 
pyrimidinone (2 nmol) and C' (a and P anomer) (2 nmol) was also injected 
under identical conditions as a standard. 5 pL of the digested 
oligonucleotide was mixed in 5 pL of the solution containing the standard 
nucleosides, and 5 pL of the resulting solution was injected to  show that 
each nucleoside peak is identical. 
DNA manipulation. Doubly distilled water was used for all aqueous 
reactions and dilutions. Enzymes were purchased from either Boehringer- 
Mannheim or  New England Biolabs. Deoxynucleoside triphosphates were 
purchased from Pharmacia as 100 mM solutions. 5 ' a - 3 2 P - d ~ ~ P s  (3,000 
Cilmmol) and 5 ' y - 3 2 ~ - ~ ~ ~  (7,000 Cilmmol) were obtained from Amersham. 
The plasmid SV40 was purchased from Bethesda Research Laboratories. 
The plasmid pHIV-CAT was a gift from Dr. Alan Frankel and Tom Povsic. 
DNA reactions were typically carried out in 1.5 mL polypropylene tubes 
obtained from Tekma company. Calf thymus DNA was purchased from 
Sigma, sonicated, and extracted with 3x0.2 volume water-saturated 
phenol, 0.2 volume 24:l CHC1~/isoamylalcOhol, and 0.2 volume CHC13. 
After extensive dialysis against water, the DNA was passed through a 0.45 
micron Centrex filter (Schleicher Schull) and assayed for concentration by 
UV assuming &260=11,800 L/mol.bp.cm. Agarose gel electrophoresis was 
carried out using 40 mM Tris-acetate, 5 mM NaOAc, 1 mM EDTA, pH 7.9 
buffer. Ten-fold concentration (lox) loading buffer for agarose gels was 25% 
(wlv) ficoll solution, which contained 0.2% (wlv) bromophenol blue (BPB) 
and xylene cyan01 (XC) tracking dyes. Polyacrylamide gel electrophoresis 
was carried out using 100 mM tris-borate, 1 mM EDTA, pH 8.3 buffer. 
Loading buffer for denaturing polyacrylamide gels was 80% formamide in 
100 mM Tris-borate, 1mM EDTA, pH 8.3 buffer. The DNA were labeled by 
standard procedures (47). Specific radioactivity was measured with a 
Beckman LS 2801 Scintillation counter. Gels were dried (after transferring 
them to Whatman 0.3 mm paper) on a Bio-Rad Model 483 slab dryer at  
80°C. Autoradiography was carried out using Kodak X-Omat film. Optical 
densitometry was performed using LKB Broma Ultrascan XL Laser 
Densitometer operating at  633nm. The relative peak area for each cleavage 
band or locus was equated to the relative cleavage efficiency at  that site. 
Procedure for the preparation of 5' 3- end-labeled 30 mer duplex. 50 
picomoles of each single-stranded oligonucleotide AgT7YT7G10 (Y=T, C, G, 
A) were dissolved in 28 pL water, 5 pL lox kinase buffer (10x700 mM 
Tris:HCl, 100 mM MgC12, 1 mM spermidine, 1 mM EDTA, pH 7.6), and 5 
pL 10 mglml DTT. This solution was treated with 10 pL 5' y 3 2 ~  ATP and 2 
pL T4 polynucleotide kinase (20 u). The 5' end-labeling was allowed to 
proceed for 45 minutes at  37OC. The end-labeled DNA was precipitated with 
NaOAcIEtOH, washed with 70% EtOH, and dried. The pellets were 
dissolved in 100 mM NaC1, 50mM tris-acetate, pH 7.4, and 50 picomoles of 
the complementary 30 mer in a total volume of 30 pL. To effect hybridization 
of the 30 mers, the oligonucleotide mixture was heated to  90°C for 5 minutes 
and allowed to cool to room temperature. 15 pL 25% ficoll loading b s e r  was 
added and the mixture was loaded onto a nondenaturing polyacrylamide 
gel (15%) and electrophoresed at  240 V until the BPB tracking dye was near 
the bottom of the gel. The four bands (Y=T, C, G, A) of end-labeled DNA 
were visualized by autoradiography, excised from the gel, crushed, 
transferred to 1.5 ml polypropylene tubes, and eluted into 0.2 N NaCl at 37OC 
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for 24 h. The end-labeled DNA 30mer duplexes were recovered by passing 
the eluents through a 0.45 micron Centrex filter and extensive dialysis 
with water. The labeled DNA solution was used for the cleavage reaction. 
For the cleavage reactions the DNA (20,000 cpdreaction) was mixed with 
salts, buffer, spermine and the oligonucleotide-EDTA with Fe(I1). This 
solution was incubated for 30 minutes at  37OC before the cleavage reaction 
was initiated by the addition of DTT to make a final volumn of 40 pL. The 
reaction was stopped by lyophilization. To each eppendorf tube a certain 
volume of formamide loading buffer was added (80% formamide, 20% 5X 
TBE buffer, 0.02% bromophenol blue and 0.02 % xylene cyanol) to  give 
approximately 3,000 cpm/pL for each reaction. To dissolve the solid the 
tubes were vortexed (10 sec). 5 pL of the resulting solutions were transfered 
to  new tubes and counted afterwards. The volume of buffer was loaded on 
each lane to give the same amount of radioactivity (-6000 cpm/lane) for each 
reaction. Electrophoretic separation of the cleavage products was achieved 
on a 20% denaturing polyacrylamide gel until the bromophenol blue was 25 
cm from the starting position. Cleavage products were visualized by 
autoradiography without drying the gel. The relative cleavage was analyzed 
by LKB densitometry. 
Cleavage of SV40 PpuMI-BglI restriction fragment. 3' and 5' end- 
labeling were carried out by standard methods (47). For the cleavage 
reactions the DNA (20,000 cpdreaction) was mixed with calf thymus DNA 
(100 pM bp), NaCl(100 mM), Tris-acetate (50 mM pH 7.4), spermine (1 mM) 
and the oligonucleotide-EDTA (2pM) with Fe(I1) (25 pM). This solution was 
incubated for 30 minutes at  25OC before the cleavage reaction was initiated 
by the addition of sodium ascorbate (1 mM) to make a final volumn of 40 pL. 
1 4  
The cleavage reactions were carried out at  37OC. The reaction was stopped 
by precipitation: 60 pL water was added followed by 20% NaOAc solution (10 
pL) and 300 pL cold ethanol, and the DNA was precipitated as usual. The 
pellets were rinsed with 70% cold ethanol (50 pL), and briefly dried in vacuo. 
To each pellet a certain volume of formamide loading buffer was added 
(80% formamide, 20% 5X TBE buffer, 0.02% bromophenol blue and 0.02% 
xylene cyanol) to  give approximately 1,800 cpdpL  for each reaction. To 
dissolve the pellet the tubes were vortexed (10 sec). 10 pL of the resulting 
solutions was transferred to new tubes and counted afterwards. The tubes 
were heated a t  90°C for 2 minutes and cooled to  0 OC. The volume of buffer 
loaded on each lane was controlled to give each reaction the same amount 
of radioactivity (-6000 cpdane).  Electrophoretic separation of the cleavage 
products was achieved on an 8% denaturing polyacrylamide gel until the 
bromophenol blue was 30 cm from the starting position. The gel was dried 
on a Bio-Rad Slab Gel Dryer Model 483 (1.5 h at 80°C) and cleavage products 
visualized by autoradiography. The relative cleavage was analyzed using 
the LKB densitometer 
Double strand cleavage of pHN-CAT. The plasmid pHIV-CAT was 
precipitated twice from NaOAc with ethanol, rinsed with 70% ethanol, 
briefly dried in vacuo and digested with BamHI according to  the conditions 
provided by the manufacturer. The linearized plasmid (10 ng) was labeled 
with a - 3 2 ~ - ~ G T P  and DNA polymerase (large Klenow fragment, reaction 
volumn =I00 pL) according to standard procedures. 100 pL Milli-Q water 
was added to  the reaction mixture. The resulting DNA solution was 
extracted with 2x1 volume water saturated phenol and 3x1 volume ether. 
Half of the resulting DNA-solution (100 pL) was passed through a column 
containing 1 mL Sephadex G-50-80 resin to remove unincorporated 
mononucleotides. The labeled DNA solution was used for the cleavage 
reaction. For the cleavage reactions the DNA (20,000 cpmlreaction) was 
mixed with NaCl (50 mM), tris-acetate (25 mM), spermine (1 mM) and the 
DNA EDTA (2 pM) with Fe(I1) (2 pM). This solution was incubated for 30 
minutes at  25OC before the cleavage reaction was initiated by the addition of 
sodium ascorbate (1 mM) to make a final volume of 40 mL. The reactions 
were carried out at  25OC. The reactions were stopped by precipitation: 60 pL 
water was added followed by 20% NaOAc solution (10 pL) and 300 pL cold 
ethanol, and the DNA was precipitated as usual. The pellets were rinsed 
with 70% cold ethanol (50 pL), and briefly dried in vacuo. To each pellet a 
certain volume of ficoll loading buffer was added (2.5% ficoll 400, IxTAE- 
buffer, 0.02% bromophenol blue and 0.02% xylene cyanol) t o  give 
approximately 600 cpm1pL for each reaction. To dissolve the pellet the tubes 
were vortexed (10 sec). 20 pL of the resulting solutions were transferred to 
new tubes and counted afterwards. The volume of buffer was loaded on 
each lane to  give the same amount of radioactivity (-6000 cpdane )  for each 
reaction. Electrophoretic separation of the cleavage products was achieved 
on a 0.9% agarose gel (20~14~0.4  cm, TAE-buffer, 120 V, 4.0 h) until the 
bromophenol blue was 15 cm from the starting position. The gel was dried 
on a Bio-Rad Slab Gel Dryer Model 483 (1.5 h at  80 OC) and cleavage products 
visualized by autoradiography. 
Double -strand cleavage of SV40 DNA. HIV-CAT was precipitated 
twice from NaOAc with ethanol, rinsed with 70% ethanol, briefly dried in  
vacuo and digested with BaclI according to conditions provided by the 
manufacturer. The linearized DNA was labeled with C Z - ~ ~ P - G T P  using 
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DNA polymerase according to standard procedures. Purification of the 
labeled DNA and performance of the cleavage experiments were carried out 
exactly as described for the double-stranded cleavage of pDMAGlO except 
sodium ascorbate was substituted for DTT. 
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PART I1 
Design of DNA-Cleaving Functional Groups 
Chapter 3 
Design of New DNA-Cleaving Functional Groups and Studies 
of Their DNA-Cleaving Mechanisms 
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Inb?oduCtion 
Nucleases, molecules which cleave DNA either at  specific sites along 
the strand or in an indiscriminant, nonspecific fashion, have become the 
molecular scalpels of the biochemist. The reactions performed by both site- 
specific and nonspecific cleaving molecules are quite remarkable and 
intriguingly complex. These reactions can be broken down in terms of two 
distinct chemical events: (1) the binding step, involving recognition of a 
particular aspect of DNA base sequence or structure; and (2) the cleaving 
step, involving a series of transformations which lead either directly or 
indirectly to  hydrolysis of the phosphodiester linkage and scission of the 
DNA backbone. There has been an explosion in the research effort directed 
toward the isolation and evaluation of naturally occurring DNA cleaving 
agents and toward the design and synthesis of model compounds that can 
sequence-specifically recognize and cut DNA. The potential scope of the 
utility of these compounds is enormous and ranges from the creation of 
synthetic restriction enzymes for use by molecular biologists to  the 
development of chemotherapeutic agents that may be effective against a 
variety of neoplastic diseases. The work I describe here encompasses the 
design and synthesis of sequence-specific DNA cleaving molecules and 
studies of their DNA cleaving mechanisms. 
DNA structure. DNA is a polymer in which each monomer is a 
nucleotide consisting of a phosphate group, a 5-carbon sugar moiety, and a 
purine or pyrimidine base. DNA contains the sugar deoxyribose and the 
bases adenine(A), thymine(?'), guanine(G), and cytosine(C). The 
nucleotides are linked by phosphodiester bonds, creating a sugar 
phosphate backbone via the 3'- and 5'-positions of the sugar. The bases are 
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linked to  the 1-position of the sugar. The phosphodiester is a strong acid, 
and the polymer has 1 negative chargelrepeat unit. Most DNAs are double 
helical molecules in which the two strands run in opposite directions. The 
strands are held together through hydrogen bond interactions between the 
bases; A hydrogen bonds with T and G hydrogen bonds with C. 
A-DNA B-DNA Z-DNA 
Figure 1. Structural conformers of double helical DNA. 
The helical conformation of DNA can be classified into three general 
families: the A, B, and Z forms (Figure 1) (1). Although each conformation 
involves bases paired through Watson-Crick hydrogen bonding, the overall 
shapes of the helices are quite different. A-DNA is a right-handed helix 
seen in DNA fibers at  low hydration. It is the predominant conformation of 
DNA-RNA hybrids and double-stranded RNA segments. B-DNA is a right- 
handed helix with base pairs oriented essentially perpendicular to the helix 
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axis and is the predominant conformation of DNA in solution. Z-DNA is a 
left-handed helix formed by a CpG dinucleotide. In this symmetrical unit 
the deoxyguanosine has an unusual glycosidic bond angle (syn) and 
deoxyribose pucker (C3'-endo) when compared with B-DNA. 
Since B-DNA constitutes the dominant conformation of DNA under 
physiological conditions, the sequence-specific recognition of B-DNA is of 
great interest. The clearest view of the B conformation is derived from the 
crystal structure of a dodecamer determined by Richard B. Dickerson and 
coworkers (2). This structure shows the pronounced major and minor 
MAJOR GROOVE MAJOR GROOVE 
MINOR GROOVE MINOR GROOVE 
Figure 2 Effects of Watson-Crick base pairing on the availability of base 
functional groups. 
grooves of B-DNA, which spiral along the helix axis. This structure also 
shows that local DNA conformational properties such as base propeller 
twist, roll, slide, tilt, and groove width vary with the local DNA sequence. 
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In addition, the pattern of hydrogen bond donor and acceptor groups found 
on the floors of the DNA major and minor grooves were observed. 
In the minor groove when an A:T base pair is present, the lone pairs 
of electrons from adenine N3 and thymine 0 2  atoms are available for 
hydrogen bonding; while when a G:C base pair is present, the hydrogen 
from the exocyclic N2 amino group of guanine is available for hydrogen 
bonding (Figure 2). In the major groove when a A:T base pair is present, 
the lone pairs from adenine N7 and the hydrogen from the exocyclic N6 
amino group of adenine are available for hydrogen bonding; when a G:C 
base pair is present, the lone pairs from N7 and 0 6  of guanine are 
available. 
DNA binding molecule-DNA complexes. A variety of molecules have 
been observed to  bind specifically to DNA. These compounds appear to exert 
antitumor and antibiotic activities by forming tight complexes with their 
cognate DNA sites, resulting in the blockage of transcription (3). Three 
modes of interaction have been observed in the DNA complexes of such 
molecules (4). One mode involves the intercalation of a flat aromatic 
molecule between two base pairs. In general, this mode has a relatively low 
specificity, presumably because a major interaction is the relatively 
nonspecific x-x stacking interaction (5). Usually there is a slight preference 
for G, C bp because of the increased width and flatter conformations of G, C 
sequences. 
The other recognition modes involve interactions within one of the 
grooves of the helix. Either the major o r  minor groove could serve as a 
complexation site, with the appropriate segregation of base recognition 
elements. Examples of nonintercalative DNA binding molecules which 
bind t o  the minor groove of A:T-rich regions include the oligo(N- 
methylpyrrolecarboxamide) antibiotics netropsin and ditamycin A (isolated 
from Streptomyces cultures) (3). The crystal structure of netropsin reveals 
that it has a crescent shape (in which amide NH and pyrrole C2H atoms 
form the concave edge) and a right-handed twist of one N- 
methylpyrrolecarboxamide residue relative to  the other (6). Dodecamer- 
netropsin and dodecamer-distamycin A complexes have been examined 
recently by X-ray crystallography (7-9). In both cases the antibiotic is set 
deeply into the minor groove so that the pyrrole a~nide hydrogens form 
Figure 3 Structural features of the DNA complexes of netropsin and 
distamycin A (8-9). The small molecules are set deeply in the minor groove, 
in close van der Waals contact to the sugar phosphate backbones. Circles 
represent the lone pair electrons of the thymine 0 2  and adenine N3. Dashed 
lines represent hydrogen bonds existing in the complex. The distance in A 
between donor and acceptor atoms is shown beside each interaction. 
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bifuricated hydrogen bonds with the N3 of adenine and the 0 2  of thymine 
onthe floor of the groove. In the netropsin complex, the width of the minor 
groove has increased by an average of 1.7 A. The adjustment allows the 
pyrrole rings to fill the minor groove completely and to form extensive van 
der Waals contacts with the sides of the grooves. These close contacts 
require the pyrrole rings to  be parallel to  the sides of the groove, increasing 
the overall screw sence of the antibiotic so that it matches the minor groove. 
The helix axis is bent away from the netropsin molecule by 8O, increasing 
the distance between the utmost T carbonyl by about 0 . d .  These carbonyls 
also form the strongest hydrogen bonds to the pyrrole amides, suggesting 
that the overall distance of the unbound DNA site is smaller than that 
required for optimum contacts with netropsin (10). A similar situation 
exists in the DNA-distamycin A cocrystal (9). ~ H N M R  studies of netropsin- 
GGAATTCC (1 I), a netropsin-GGTATACC (12), and a distamycin- 
CGCGAATTCGCG complex (16) conclude that the structure in solution is 
very similar to  that found in the solid state. 
Site-specific DNA Cleavage. The prototypical system to examine site- 
specific recognition and reaction at  a DNA is that of restriction enzymes 
and naturally occurring compounds such as  bleomycine and 
neocarzinostatin. The restriction enzymes are able to  recognize a particular 
sequence and, in the presence of divalent metal ions, cleave each of the two 
DNA strands producing 5'-phosphoryl and 3'-hydroxy termini through the 
phosphodiester hydrolysis (14). Metallobleomycin (BLM) (15) and 
neocarzinostatin (NCZ) (16) have the ability to recognize and noncovalently 
bind to specific sequences in DNA and then to  perform chemistry on a 
specific deoxynucleoside residue that can ultimately lead to a strand 
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scission. The activity of BLM in vitro depends on Fe(I1) and 0 2  or  Fe(I1) and 
H 2 0  2. The initial BLM*Fe(II)*02 complex undergoes a one-electron 
reduction to yield an activated BLM which can initiate DNA damage leadin 
to  strand scission (Figure 4) (17). Pathway a in Figure 4 results in the 
formation of nucleic acid base propenal and a DNA strand scission that 
yields 3'-phosphoglycoate and 5'-phosphate termini. Pathway b in Figure 4 
results in the liberation of nucleic acid base plus an alkali-labile site that 
cleaves at pH 12 with piperidine to  afford a 3'-phosphate and a 5'-phosphate 
terminus. 
Dervan and coworkers have shown that the coupling of the nonspecific 
nucleolytic chemistry of EDTA-Fe(I1) to  a sequence specific DNA-binding 
molecule creates a sequence-specific nuclease (18-20). One of the first 
examples of this is ferrous EDTA tethered to  the antibiotic distamycin. Here 
the EDTA moiety is tethered to  either the amino or  carboxy terminus of tris- 
N-methylpyrrolcaboxamide yielding distamycin-EDTA(DE) o r  EDTA- 
distamycin (ED) (Figure 5). From sequencing gel analysis, both DE*Fe(II) 
and ED*Fe(II) are found to  cleave the sites adjacent t o  five base pairs 
consisting of A-T-rich DNA sequences. A synthetic 52-residue peptide, 
forming the DNA-binding domain of Hin reconbinase which recognizes a 
13 bp sequence, has also been equipped with the Fe(I1)-EDTA-cleaving 
function, tethered, in this case, to  the amino terminus of the peptide 
fragment (21). DNA cleaving is illustrated also in the attachment of EDTA- 
Fe(I1) to  a strand of homopyrimidineoligonucleotides containing 15-20 base 
residues. In this case, it is shown that this homopyridine nuclease 
specifically binds and cleaves a t  precisely the corresponding homopyrimi- 
RC~P-o  
O ? 2 H B  




H  B-form DNA/BLM*Fe*02 
O >HB 
0 
RO- P- 0 
RO- P- 0 
0 
- 4 O  
0 - 
o - 
R'O P= 0 
O -  \ 
0 - 
I ? - ? - .RO- P - 0 RO- P- 0 
0 
R'O P= 0 o -  
0 - R'O- P: 0 R'O-P: 0 
0-  0 -  
Figure 4. (Top) Proposed structure of the BLMaFe.02. (Middle and Bottom) 
Proposed unified mechanism for the cleavage of DNA by "activated BLM". 
Figure 5. The structure of Distamycin-EDTA*Fe(DE*Fe) and EDTA- 
Distamycin*Fe(ED *Fe). 
idine-homopurine tracts of DNA by triple helix formation (22). The studies 
of Sigman using a 1, 10-phenanthroline-copper complex [(OP)2Cu(I)] 
tethered to the tryptophan gene repressor of E. coli (23) and Barton with 
chiral transition-metal complex[tris(4, 7-diphenylphenanthro1ine)cobalt- 
(111) (co(DIP)~~+)] (24) have shown site-specific cleavage of DNA through 
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the scission of the DNA backbone. Since the DNA cleavage of EDTAoFe(I1) 
and 1, 10-phenanthroline-copper complex [(OP)2Cu(I)] gives multiple 
cleavage patterns on double helical DNA (18, 24), we have turned our 
attention to  the development of non-diffusible cleaving functions that would 
produce a single cleavage site. The design for the DNA-cleaving functions 
was based on the naturally occurring bleomycin (BLM), neocarzinostatin 
(NCZ), and dopamine-P-monohydroxylase. Bleomycin, as mentioned 
earlier, cleaves DNA at two base recognition sites in a reaction dependent 
on Fe(I1)ldithiothreitol o r  Co(III)/UV (15, 17). Neocarzinostatin cleaves 
DNA through radical formation in the presence of thiol (16). Dopamine-P- 
monooxygenase, a copper-containing enzyme, catalyzes the hydroxylation 
of dopamine to  norepinephrine (25). 
Figure 6a. Structure of ligand to be connected to sequence-specific DNA 
binding molecule R. M is Metal ions (Fe++or Cu++). 
We designed and synthesized three different cleaving functional 
groups in an effort to create a nondiffusible cleaving moiety (Figure 6). 
Compound 19 (P3-M-PYML) shows the sequence-specific cleavage of DNA 
in the presence of Fe(I1) and DTT, while compound 12 (P3-Ga-His) shows 
the sequence-specific cleavage of DNA in the presence of Cu(I1) without 
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adding a reducing agent such as DTT. The cleavage of DNA by P3-M- 
PYNIL*Fe(II)/dithiothreitol (DTT) near the distamycin binding site is 
multiple as in an experiment of distamycin-EDTA*Fe(II), while the 
cleavage of DNA by P3-Ga-His*Cu(II) shows the less multiple cleavage. 
Interestingly, compound 23 (P3-Ga-Phe) shows the sequence-specific 
cleavage of DNA in  the presence of UV light and P -  
carbonato(trien)cobalt(III)perchlorate complex. The end product analysis of 
the cleaved oligonucleotide shows 5'-phosphate and two different 3' 
products. 

Resulks and Discussion 
Synthesis (Figure 7, 8, 9 and lo). 4-Nitropyrrole-2-carboxlic acid 
ethylester 1 was prepared by the published method (26). The reaction of 1 
with 2-bromoethyl amine t-butylcarbamate 2 and subsequent hydrolysis of 3 
produced the pyrrole 4. The coupling of 4 with N-methy-4-nitropyrrole-2- 
(N, N-dimethylpropy1amino)-carboxamide 5 (27) produced compound 6. 
Reduction of 6 and coupling with N-methy-4-nitropyrrole-2-carboxlic acid 
(27) produced compound 7. Compound 9 was obtained in three steps from 
compound 7. The coupling of 9 with 1-Histidine-t-boc carbamate and 
subsequent deprotection of the t-boc group produced compound 10 (P3-M- 
His). Compound 11 was synthesized by the published method (27). 
Compound 12 (P3-Ga-His) was synthesized by coupling 11 with 1-histidine-t- 
boc carbamate and subsequent deprotection as described above. 
Compound 18 was synthesized by the known method (28). The coupling 
of 9 with 18 and subsequent deprotection of the resulting products produced 
compound 20 (P3-PYML). Compound 21 (P3-EDTA) was synthesized by 
coupling of 9 with the triester of EDTA and hydrolysis of the resulting ester 
product (27).The coupling of 9, which was prepared by the published 
method (27), with 1,lO-phenanthroline-2-carboxylic acid produced 
compound 21 (P3-M-Phe). The same method was applied for the synthesis of 
compound 23 (P3-Ga-Phe). 
DNA cleavage by P3-M-PYML Fe (11) 19 and P3-M-EDTA* Fe(I1) 
2O.The cleavage of the 167 bp fragment from plasmid pBR322 by P3-M- 
PYML(19) in the presence of dithiothreitol and 0 2  was studied.An 
autoradiograph of the cleavage patterns produced by P3-M-PYML*Fe(II) 
and P3-M-EDTA on the 167 base pair restriction fragrnent is shown in 
Figure l l a .  The DNA cleavage patterns on this autoradiograph were anal- 
EtO 
EtO 
d0L02Nd< 1 3 NHt-BOC b
O2N 
Figure 7. a)  NaIIacetone, BrCH2CH2NHCOOC(CH3)3 b)OH- c) H2/Pd/C, n- 
hydroxybenzotriazole(l-HOBT)/dicyclohexylcarbodiimide (DCC)/DMF d) 
DCCI1-HOBTI N-methyl-4-nitro-2-carboxylic acid1DMF e) H2/Pd/C. 
carbonyl-diimidazole (CD1)Iacetic acid/DMF f) trifluoroacetic acid g )  1- 
histidine-t-boclDCC11-HOBT h) trifluoroactic acid. 
CHO q.I qo- 4 0 + H2"J A NH-t-Boc 
HO Me0 Me0 
Figure 8. The synthetic scheme for the synthegis of P3-M-PYML(19). a) 
MeOHlH2S04 b) I2DMSO c )  Molecular Sieve 4A/acetonitrile, H2/Pd/C d) 
C6H50COCl/HO- e) OH- f) 18, DCC11-HBT g)  trifluoroacetic acid. 
Figure 9. The synthetic scheme for the P3-M-EDTA (20). a) EDTA-esterICD1 
b) HO-. 
lyzed by densitometry and converted to histogram (Figure llb). It can be 
seen that P3-M-PYMLoFe(I1) and P3-M-EDTAoFe(I1) produce specific 
DNA cleavage near the binding sites. The cleavage patterns produced by the 
two compounds near the distamycin binding site show mutiple sites of 
cleavage. Since the reactive group is in the middle of a molecule, the 
cleavage patterns do not show two orientations near the binding site as in 
distamycin-EDTA and EDTA-distamycin (which has a reactive group at the 
carboxy terminal or amino terminal of distamycin). The cleavage efficiency 
of DNA by P3-M-PYMLoFe(I1) is better than that of P3-M-EDTA (20). The 
strongest cleavage site is 5'-GTTAAATTG-3' 
DNA cleavage by P-Ga-His (12). The cleavage of a 167 bp fragment from 
bacterial plasmid pBR322 by compounds 10 and 12 was studied at various 
2 2 2 3 
Figure 10. The synthetic scheme for the synthesis of P3-M-Phe (21) and 
P3-Ga-Phe (23). a )  1,lO-phenanthroline-2-carboxylic acidlDCC11- 
HOBTIDMF. minal of distamycin). The cleavage efficiency of DNA by 
P3-M-PYMLoFe(I1) i s  better than tha t  of P3-M-EDTA (20). The 
strongest cleavage site is  5'-GTTAAATTG-3'. 
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pH's in the presence of Cu(I1) ion. Footprintings of DNA by MPE*Fe(II) 
for compounds 10 and 12 were also examined by using the 167 base pair 
restriction fragment. An autoradiograph of the cleavage patterns produced 
by P3-Ga-His (12) on the 167 base pair restriction fragment is shown in 
Figure 12a. The DNA cleavage patterns on this autoradiograph were 
analyzed by densitometry and converted to  histogram form (Figure 12b). 
Here it can be seen that the P3-Ga-His compound (12) produces specific 
DNA cleavage near the binding site. The cleavage patterns near the binding 
site are different from those produced by distamycin-EDTA analogs. A 
single sites of cleavage is seen near the 5'-CGATAA site in 5' labeled 167 
bp fragment. This cleavage pattern suggests that P3-Ga-His*Cu(II) cuts 
DNA cleavage via a nonfreely diffusing reactive species. Interestingly , P3- 
M-His (10) compound shows no cleavage of DNA ( data not shown). It is 
believed that the histidine-Cu(I1) complex of 10 is not accesible t o  minor 
groove because the molecule itself sits on the the minor groove. 
The type of end products produced during DNA cleavage is dependent on 
the type of cleavage reaction. Maxam-Gilbert chemical sequencing 
reactions produce 3'- and 5'-phosphate terminal groups. DNAase reaction 
produce 3'-hydroxy and 5'-phosphate terminal groups (29). Distamycin- 
EDTA*Fe(II) and MPEaFe(I1) produce 5'-phosphate and a mixture of 3'- 
phosphate and 3'-phosphoglycolate termini (30). BLM*Fe(II) produces 5'- 
phosphate and 3'-phosphoglycolate termini under aerobic conditions 
(15,17). Neocarzinostatin produces 3'-phosphate termini and a mixture of 
5'-phosphate and nucleoside 5'-aldehyde termini (11). 
The DNA end products produced upon P3-Ga-HisaCu(I1) cleavage 
were determined as part of an investigation into the mechanism by which 
Figure lla. Autoradiograph of DNA cleavage patterns produced by P3-M- 
EDTA*Fe(II)(20) and P3-M-PYML*Fe(II) (19) compounds on 5 ' - 3 2 ~  end- 
labeled 167 base pair restriction fragments (EcoRIIRsaI) from plasmid 
pBR322 DNA in the presence of dioxygen and dithiothreitol. Cleavage 
patterns were resolved by electrophoresis on a 1:20 cross-linked 8% 
polyacrylamide, 50% urea denaturing gel. Lane 1: Maxam-Gilbert 
chemical sequencing G reaction (33); lane 2: Control with 25 pM Fe(I1); 
lanes 3-5: P3-M-EDTA(BO)*Fe(II) at 25 pM, 5pM, 1pM concentrations; lanes 
6-9: P3-M-PYML(lS)*Fe(II) at 25 pM, 5 pM, lpM, and 0 pM concentrations. 

v v r 1  r r * r r  r 4 + v  
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3 ' - C T C C A A T A C T A G C T A T T C C ~ C C C C A T C ~ t g T " g X ~ c " X t 8 ~ " c g ~ " c ~ g ~ " c ~ g t c " g g f  ~XtX@$31f94c"T"~T" 
4. 4 r..... 4 1 1 , .  * 4  I *.. . * l 4 . .  
I~~S'-CACC AT ATCCATAAGC AATCCCGTAG AT ACACTTAAA CTAACCCACTCACCCACCCTGTATC AA AACACA 
3 ' - C T C G ~ T A C C T A T T C C ~ A C C C C A T C ~ T C T C A A ~ C A T T G C G T C A C T C C C T C C C A C A T A ~ T T C T C T  
Figure llb. Histogram of DNA cleavage produced by 5 pM P3-M-EDTA*Fe(II) (20) (Top) and 5 pM P3-M- 
PYML (19)*Fe(II) on 167 base pair fragment (EcoRI/RsaI) from plasmid pBR322 DNA in the presence of 
DTT and dioxygen (Figure l l a ) .  Length of arrows corresponds to the relative amount of cleavage, 
determined by optical densitometry, which result in removal of indicated base. Boxes represent equilibrium 
binding site. Sequence positions of cleavage were determined by comparing the electromobilities of DNA 
cleavage fragments to bands in Maxam-Gilbert chemical sequencing lane. 
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P3-Ga-His*Cu(II) mediates DNA cleavage. The identities of DNA end 
products produced with P3-Ga-HisaCu(I1) were determined by analyzing 
the electrophoretic mobilities of short DNA cleavage fragments on 15% 
denaturing polyacrylamide gels, and the way in which the mobilities of 
these fragments were affected by treatment with phosphatase enzymes. 
Figure 12c (left) shows an autoradiograph of cleavage patterns produced by 
Maxam-Gilbert reaction, DNAase reaction, MPE*Fe(II)/dithiothreitol 
reaction, P3-Ga-His*Cu(II) reaction, and digestion of these with T4 
polynucleotide kinase (which converts 3'-phosphate groups to 3'-hydroxy 
groups) on the 3 ' - 3 2 ~  end-labeled 167 base pair EcoRIIRsaI restriction 
fragment from pBR322. Electromobilities of the radio-labeled cleavage 
fragment produced on these substrates depend on their length and the 
nature of their 3'-termini. The doublets produced with MPE*Fe(II) are due 
to faster-running fragments that terminate in 3'-phosphoglycolate and 
slower-running fragments that terminate in 3'-phosphate groups (30). The 
short DNA fragments produced by P3-Ga-His*Cu(II) do not comigrate 
with 3'-phosphate, 3'-hydroxy, and 3'-phosphoglycolate except in the case of 
the shortest fragment. The electromobilities of these fragments are not 
reduced upon treatment with T4 polynucleotide kinase. Thus, P3-Ga- 
His*Cu(II) mediates the direct formation of DNA strand breaks having 
different 3'-ends from Maxam-Gilbert, DNAase, and MPE*Fe(II). Figure 
12c (right) shows an autoradiograph of cleavage patterns produced by 
Maxam-Gilbert reaction, DNAase reaction, MPE*Fe(II)/dithio- thretol 
reaction, P3-Ga-His*Cu(II) reaction, and digestion with calf intestine 
alkaline phosphatase (CAP) (which converts 5'-phosphate groups to  5' 
hydroxy groups) on the 5 ' - 3 2 ~  end-labeled 167 base pair EcoRIflRsaI restric- 
Figure 12a. Autoradiograph of MPE*Fe(II) footprinting by P3-Ga-His and 
cleavage patterns produced by P3-Ga-His(lB)*Cu(II) on 3'- and 5'- 3 2 ~  end- 
labeled 167 base pair fragments (EcoRI/RsaI) from plasmid pBR322 DNA in 
the presence of dioxygen. Cleavage patterns were resolved by 
electrophoresis on a 1:20 cross linked 8% polyacrylamide, 50% urea 
denaturing gel. Lanes 1, 3, 5, 7, and 9-11 were with 5' end-labeled DNA, 
whiles lanes 2,4, 6, 8, and 12-14 were with 3' end-labeled DNA. Lanes 1 and 
2, Maxam-Gilbert chemical sequencing G reactions; lanes 3-4, MPE*Fe(II) 
at 2 pM concentration; lane 5, MPE*Fe(II) at  2 pM concentration in the 
presence of P3-Ga-His (5 pM) and dioxygen; lane 6, MPE*Fe(II) at 2 pM in 
the presence of P3-Ga-His (5 pM) and dioxygen; lanes 7-8, Cu(I1) at 200 pM 
concentration; lanes 9-11, P3-Ga-His at 5 pM concentration in the presence 
of Cu(I1) (200 pM) and dioxygen at  pH 73, 8,5, and 9.5; lanes 10-14, P3-Ga- 
His at  5 pM concentration in the presence of Cu(I1) (200 pM) at  pH 7.5, 8.5, 
and 93. 
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Figure 12b. (Top) MPE*Fe(II) protection patterns for 5 pM P3-Ga-His on the 167 bp fragment of PBR322. 
(Bottom)Histogram of DNA cleavage produced by P3-Ga-HiseCu(I1) (12) on 167 base pair fragment 
(EcoRI/RsaI) from plasmid pBR322 DNA in the presence of dioxygen (Figure 12a). Length of arrows 
corresponds to  the relative amount of cleavage, determined by optical densitometry, which result in 
removal of indicated base. Boxes represent equilibrium binding site. Sequence positions of cleavage were 
determined by comparing the electromobilities of DNA cleavage fragments to bands in Maxam-Gilbert 
chemical sequencing lane. 
Figure 12c. (left) Analysis of DNA 3'-end products produced with P3-Ga- 
His(l2)*Cu(II) on the 5 ' - 3 2 ~  end-labeled 167 bp restriction fragment 
(EcoRI/RsaI) from pBR322 plasmid DNA. Cleavage patterns were resolved 
by electrophoresis on a 1:20 cross-linked 15% polyacrylamide, 40% urea 
denaturing gel. Lane 1, Maxam-Gilbert chemical sequencing G reaction; 
lane 2, DNase I reaction; lane 3, DNA cleavage by MPEeFe(I1) a t  2 pM 
concentration in the presence of dithiothreitol (4.0 mM) and dioxygen; lane 
4, DNA cleavage by P3-Ga-His at  5 pM concentration in the presence of 
CuS04 (200 pM) and dioxygen; lane 5, DNA cleavage by P3-Ga-His at  5 pM 
concentration in the presence of CuS04 (200 yM) and dioxygen with 
subsequent 3'-dephosphorylation using T4 polynucleotide kinase. (right) 
Analysis of DNA 5'-end products produced with P3-Ga-HiseCu(I1) (12) on 
the 3 ' -32~  end-labeled 167 bp restriction fragrnent(EcoRYRsa1) from pBR322 
plasmid DNA. Cleavage patterns were resolved by electrophoresis on a 1:20 
cross-linked 15% polyacrylamide, 40% urea denaturing gel. Lane 1, 
Maxam-Gilbert chemical sequencing G reaction; lane 2, DNAase reaction; 
lane 3, DNA cleavage by MPEeFe(1I) at 2 pM concentration in the presence 
of dithiothreitol (4.0 mM) and dioxygen; lane 4, DNA cleavage by P3-Ga-His 
at  5 pM concentration in the presence of CuS04 (200 pM) and dioxygen; lane 
5, DNA cleavage by P3-Ga-His at 5 pM concentration in the presence of 
CuS04 (200 yM) and dioxygen with subsequent 5'-dephosphorylation using 
calf intestine alkaline phosphatase (CAP). 




tion fragment from pBR322. Electromobilities of radio-labeled cleavage 
fragments produced on these substrates depend on their length and the 
nature of their 5' termini. Fragments produced by the Maxam-Gilbert 
chemical reaction, DNAase, and MPE*Fe(II)/dithiothreitol terminate in 5'- 
phosphate group (30). The short DNA fragments produced by P3-Ga- 
His Cu(I1) comigrate with the MPE *Fe(II) DNA fragments having 5'- 
phosphate groups. The electromobilities of these fragments are reduced 
upon treatment with CAP. Thus, P3-Ga-His(I1) mediates the direct 
formation of DNA strand breaks having 5'-phosphate termini. 
DNA cleavage by P3-Ga-Phe (23). The sequence-specific cleavages of 
DNA by P3-M-Phe (21) and P3-Ga-Phe (23) in the presence of P -  
carbonato(trien)Co(III)perchlorate and UV light was examined using the 
167 bp restriction fragment from pBR322. Footprinting of DNA by 
MPE*Fe(II) for P3-Ga-Phe and P3-M-Phe in the presence of dithiothreitol 
was also examined. An autoradiograph of the cleavage pattern produced by 
P3-Ga-Phe, P3-M-Phe and bleomycin*Co(III) on 167 base pair restriction 
fragments is shown in Figure 13a. The results of footprinting and cleavage 
sites were analyzed by densitometry and converted to  histogram form 
(Figure 13b). Here it can be seen that P3-Ga-Phe produces the single DNA 
cleavage on 167 base restriction fragment which has 4 strong binding sites. 
Interestingly, P3-M-Phe (2 1 ) does not show any cleavage 
Bleomycine*Co(III) shows strong photochemical DNA cleavage as 
reported, with preference for G:C base pairs. The identities of DNA end 
products produced by P3-Ga-Phe (23) in the presence of UV light and P- 
carbonato(trien)Co(III)perchlorate were determined by analyzing the 
electrophoretic mobilities of short DNA cleavage fragments on 20% dena- 
Figure 13a. Autoradiograph of MPE*Fe(II) footprinting by P3-M-Phe (21) 
and P3-Ga-Phe (23) in the presence of dithiothreitol and dioxygen, and 
cleavage patterns produced by P3-M-Phe (21) and P3-Ga-Phe (23) on 3'- and 
5 ' - 3 2 ~  end labeled 167 base pair fragments (EcoRIIRsaI) from plasmid 
pBR322 DNA i n  t h e  presence of dioxygen, P -  
carbonato(trien)Co(III)perchlorate, and UV light (366 nm). Cleavage 
patterns were resolved by electrophoresis on a 1:20 cross linked 8% 
polyacrylamide, 50% urea denaturing gel. Lanes 1, 3, 5, 6, 9,11, 13, 15, 16, 
19, 21 were with 5'end-labeled DNA, and lanes 2,4, 7, 8, 12,14, 17, 18, 20, 22 
were with 3'end-labeled DNA. Lanes 1 and 2, Maxam-Gilbert chemical 
sequencing G reaction; lanes 3-4, MPE*Fe(II) at  2pM concentrations; lanes 
5 and 7, MPE*Fe(II) at  2 pM concentrations in the presence of P3-Ga-Phe (5 
pM), dithiothreitol and dioxygen; lanes 6 and 8, MPE*Fe(II) at 2 pM in the 
presence of P3-M-Phe (5 pM) and dioxygen; lanes 9-10, P3-Ga-Phe at  5 pM 
concentrations in the presence of UV (366 nm) and dioxygen; lanes 11-12, 
P3-M-Phe a t  5 pM concentration in the presence of UV(366 nm) and 
dioxygen; lanes 13-14, P-carbonato(trien)Co(III) at 25 pM concentration in 
the presence of UV(366 nm) and dioxygen; lanes 15 and 17, P3-Ga-Phe at  5 
p M  concentration in  the presence of UV (366 nm), P -  
carbonato(trien)Co(III)perchlorate (25 pM), and dioxygen; lanes 16 and 18, 
P3-M-Phe a t  5 pM concentration in the presence of UV(366 nm), P- 
carbonato(trien)Co(III)perchlorate (25 pM), and dioxygen; lanes 19 and 20, 
bleomycin (BLM)Co(III) at 5 pM concentration in the presence of UV (366 
nm) and dioxygen; lanes 21 and 22, UV light (366 nm). 

Figure 13b. (Top) MPEoFe(I1) protection patterns for 5 pM P3-Ga-Phe (22) on the 167 bp fragment of PBR322. 
(Bottom) Histogram of DNA cleavage produced by 5 pM P3-Ga-Phe (22) on 167 base pair fragment 
(EcoRIlRsaI) from plasmid pBR322 DNA in the presence of dioxygen, P-carbonato(trien)Co(III)perchlorate, 
and UV light (366 nm) (Figure 13a). Length of arrows corresponds to the relative amount of cleavage, 
determined by optical densitometry, which result in removal of indicated base. Boxes represent equilibrium 
binding site. Sequence positions of cleavage were determined by comparing the electromobilities of DNA 
cleavage fragments to  bands in Maxam-Gilbert chemical sequencing lane. 
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turing polyacrylamide gels. 
Oligonucleotide duplex 26 containing the same sequence near the 
strong cleavage site of the 167 base fragment was synthesized by P-  
cyanoethylchemistry and labeled on the 3'-end and the 5'-end of the cleaving 
strand (Figure 13c). 3' and 5' end labeled duplex oligonucleotide 26 were 
prepared by standard methods. Figure 13d shows an autoradiograph of 
cleavage patterns produced by Maxam-Gilbert G reaction, 
MPE.Fe(II)/dithiothreitol, P3-Ga-Phe (23)IP-carbonato(trien)Co(III)per- 
chlorateW reaction, and digestions with T4 polynucleotide kinase (which 
converts 3'-phosphate groups to  3' hydroxy groups) on the 3 ' - 3 2 ~  27 mer 
oligonucleotide. Electromobilities of radio-labeled cleavage fragments 
produced on these substrates depend on their length and the nature of their 
3'-termini. The doublets produced with MPE.Fe(II) are due to  faster- 
running fragments that terminate in 3'-phosphoglycolate and slower- 
running fragments that terminate in 3'-phosphate groups. The DNA 
fragments produced by P3-Ga-PheIP-carbonato(trien)Co(III)perchlor- 
ate/UV comigrate with 3'-phosphate and 3'-phosphoglycolate. The 
electromobilities of slower-running fragments are reduced upon treatment 
wi th  T4 polynucleotide kinase.  Thus ,  P3-Ga-Phe/P - 
carbonato(trien)Co(III)perchlorate/UV mediates the direct formation of 
DNA strand breaks having two different 3'-ends: 3'-phosphate and 3'- 
phosphoglycolate as in MPE.Fe(I1). 
Figure 13e shows an autoradiograph of cleavage patterns produced by 
Maxam-Gilbert G reaction, MPE.Fe(II)/dithiothreitol reaction, P3-Ga- 
Phe(23)IP-carbonato(trien)Co(III)perchlorate reaction, and digestion 
with calf intestine alkali phosphatase (CAP) (which converts 5'-phosphate 
3 2 ~ 3  ' -GcCATCAAA 
5' end product 
3' end product 
Figure l3c . Oligonucleotides 24'25, and 26 and the DNA cleavage with P3- 
Ga-Phe(23). 
groups to 5'-hydroxy groups) on the 5 ' - 3 2 ~  end-labeled 27 mer 
oligonucleotide DNA. Electromoblities of radio-labeled cleavage fragments 
produced on these substrate depends on their length and the nature of their 
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5'-termini. Fragments produced by Maxam-Gilbert chemical G reaction, 
and MPE*Fe(II)/dithiothreitol terminate in 5'-phosphate group. The DNA 
fragrnents produced by P3-Ga-Phe (23)IP-carbonato(trien)Co(III)perchlor- 
a t e m  comigrate with the DNA fragrnents having 5'-phosphate groups 
produced by MPE*Fe(II). The electromobilities of these fragments are 
reduced upon treatment with CAP. Thus, P3-Ga-Phe (2 3 )/P - 
carbonato(trien)Co(III)perchlorate~ mediates the direct formation of 
DNA strand breaks having 5'-phosphate termini. 
Figure 13d. Analysis of DNA 3'-end products produced by P3-Ga-Phe (23) /P- 
carbonato(trien)Co(III)perchlorate/UV lightldioxygen on the 5 ' - 3 2 ~  end- 
labeled 27 bp oligonucleotide (26). Cleavage patterns were resolved by 
electrophoresis on a 1:20 cross-linked 20% polyacrylamide, 40% urea 
denaturing gel. Lane 1, uncleaved DNA; lane 2, UV light (366 nm); lane 3, 
Maxam-Gilbert chemical sequencing G reaction; lanes 4-5, DNA cleavage 
by MPE*Fe(II) at  10 pM concentration in the presence of dithiothreitol (4.0 
mM) and dioxygen; lane 6, DNA cleavage by P3-Ga-Phe a t  5 pM 
concentrat ion i n  t he  presence of dioxygen, j3 - 
carbonato(trien)Co(III)perchlorate (25 pM), and UV light (366 nm); lane 7, 
DNA cleavage by P3-Ga-Phe at  5 pM concentration in the presence of 
dioxygen, P-carbonato(trien)Co(III)perchlorate (25 pM), and UV light (366 
nm) with subsequent 3'-dephosphorylation using T4 polynucleotide kinase. 

Figure 13e. Analysis of DNA 5'-end products produced with P3-Ga-Phe /P- 
carbonato(trien)Co(III)perchlorateRJV lightldioxygen on the 5' 3 2 ~  end- 
labeled 27 bp oligonucleotide (26). Cleavage patterns were resolved by 
electrophoresis on a 1:20 cross-linked 20% polyacrylamide, 40% urea 
denaturing gel. Lane 1, uncleaved DNA; lane 2, UV light (366 mm); lane 3, 
Maxam-Gilbert chemical sequencing G reaction; lane 4, DNA cleavage by 
MPEeFe(I1) at lOpM concentration in the presence of dithiothreitol (3.0 
mM) and dioxygen; lanes 5 and 7, DNA cleavage by P3-Ga-Phe at  5 pM 
concentrat ion i n  t he  presence of dioxygen, P - 
carbonato(trien)Co(III)perchlorate (25 pM), and UV light (366 nm); lanes 6 
and 8, DNA cleavage by P3-Ga-Phe at  5 pM concentration in the presence of 
dioxygen, P-carbonato(trien)Co(III)perchlorate (25 pM), and UV light (366 
nm) with subsequent 3'-dephosphorylation using T4 polynucleotide kinase. 

Discussion 
Both P3-M-PYML*Fe(II) (19) and P3-M-EDTA (20) produced multiple 
cleavage patterns near the binding site. Since these patterns are indicative 
of diffusible reactive species, the DNA-cleaving mechanism of P3-M- 
PYML*Fe(II)/DTT appears to  be similar to that of EDTA*Fe(II)/DTT 
(18,30), which produces a diffusible hydroxyl radical that abstracts a proton 
of the sugar ring of DNA and induces breakdown of the deoxyribose. 
In the light of the results described in P3-Ga-His*Cu(II) (12) mediated 
DNA cleavage, several observations about the mechanism(s) by which P3- 
Ga-His*Cu(II) mediates DNA cleavage may be made. First, DNA cleavage 
stems from oxidative modification and breakdown of deoxyribose residues. 
Second, given that the DNA cleaving species is located in the DNA minor 
groove, C-H bonds within or on the edges of the minor groove (C-HI', C-HZ', 
C-H4', C-H5') should be considered as the most likely candidates for 
activation. Third, since the cleavage patterns are not diffused, it must be 
considered that the reactive species is not diffusible and may be a metal 
0x0. 
Figure 14 depicts four possible pathways, each of which involves the 
activation of a deoxyribose C-H bond located within or on the edge of the 
minor groove by P3-Ga-His*Cu(II) to  afford hydroxylated products. 
Considering the work of Klinman et al. (25) on dopamine P-monooxygenase 
(enzymes catalyzing the hydroxylation of dopamine to norepinephrine), C-H 
activation is likely to involve hydroxylation by copper-mediated oxidant 
species. The disproportionation of Cu(I1) complex into Cu(1) and Cu(II1) 
complexes may also produce a reactive species as in copper-mediated 
oxidative C-terminal N-dealkylation of peptide (38-39). 
C-HI' activation would produce a hemiortho ester which could 
decompose to  an unstable 3' dehydrolactone derivative, liberating a free 
base and a DNA fragment with a 5'-phosphate group. The dehydrolactone 
H,' H,' pow/ H4' \""" . . H; 
4 ' % 
PO H,' 
H,' H,' "5' H,' H,' H; OH 
0 H4* \\'"" 0 H41 \\.'.. 0 ' " ~ l H l ,  
."'J/ HI ' 
HO\\l"' 
. . . . " " "  ~1 ' H4' \""'. . . . . . . p g 2 k p % J % 
POI H,' 
# 
PO OH POI h,' PO H,' 
I HO- 
Figure 14. Four possible pathways of cleavage mediated by P3-Ga- 
His *Cu(II). 
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would undergo further decomposition under mild conditions (room 
temperature a t  neutral pH) to liberate an  unstable methylene 
dehydrolactone and a DNA fragment with a 3'-phosphate group. Activation 
of C-HI' bonds has been shown to occur during DNA cleavage with bis(1,lO- 
phenanthroline)copper(II) (31). It is likely that NCZS and the related 
antibiotics Esperamicin A1 and Calicheamicin ylI activate C-HI' bonds (32). 
C-H2' activation could afford a ribonucleotide residue within a DNA 
molecule. Ribonucleotides may be hydrolyzed under basic conditions t o  
liberate DNA fragments having 5' hydroxy groups and 3'- or 2'-phosphate. 
C-H4' activation would afford an unstable hemiacetal derivative which 
could decompose, liberating free base and creating a bis hemiacetal. This 
species represents the base labile lesion produced by BLmeFe(I1) in the 
absence of sufficient dioxygen (33). In the presence of base this species 
decomposes to  a DNA fragment having a 5'-phosphate group and a DNA 
fragment having a 3'-nonphosphate group (15, 17). 
C-H5' activation could afford a hemiacetal phosphate ester which 
should decompose under ambient conditions to  liberate a DNA fragment 
with a 3-phosphate group and a DNA fragment with a nucleoside 5'- 
aldehyde group. These products are produced upon DNA cleavage with 
NCZS or the related antibiotics Esperamicin A1 and Calicheamicin y l f .  
DNA fragments terminating in nucleoside 5'-aldehyde groups can be 
converted to the corresponding fragments that terminate in 5'-phosphate 
groups by base workup, which would also liberate the DNA base and 
furyhral(34). 
The cleavage products of DNA by P3-Ga-HiseCu(I1) are unknown 3'- 
end (which is not 3'-phosphate, 3'-phosphoglycolate, or 3'hydroxy group) 
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and one 5'-phosphate. Thus, the most possible mechanism is C-H4' 
activation which produces 3'-nonphophate group and 5'-phosphate group. 
Higher cleavage efficiency at high pH might be due to the pH-dependence of 
decomposition of hydroylated product though C-H4' activation or  the pH 
dependence of complex formation. 
Bleomycin Co(II1) (35) and lamda-tris(dipheny1 phenanthro1ine)- 
Co(II1) (24) cleave DNA in the presence of UV light. It is well known that 
when the Co(II1) amine complex is excited, Co(I1) and cation amine 
radical are produced as intermedates (36, 37). The appearance of DNA 
cleavage by P3-Ga-Phe/Ulrl~-carbonato(trien)Co(III)perchlorate with the 
same 3'- and 5'- end products as in the MPE*Fe(II)/DTT DNA cleavage 
reaction suggests that the active radical species produced by P3-Ga- 
PheIUVlP-carbonato(trien)cobalt(III)perchlorate photoreaction attacks the 
deoxyribose ring, and subsequent reactions lead to  strand scission It is 
likely that the phenanthroline cation radical is generated by intermolecular 
electron transfer to the excited Co(II1) complexes when the reaction 
mixture is irradiated a t  366 nm (the ligand field excitation of P -  
carbonato(trien)cobalt(III)perchlorate). Intramolecular electron transfer 
from phenanthroline to  cobalt(II1) mediated by the transient cobalt(II1) 
phenanthroline complex cannot be excluded. The single cleavage site (T) 
on the 167 base fragment which has 4 binding sites indicates that reactive 
species are not diffusible like free hydroxyl radical. Since the distance 
between binding site and reactive sugar is sequence-dependent, the 
observation of a single cleavage event suggests that only one of the 5 sites 
has the right distance and orientation. 
191 
Experimental 
Methods and materials. 1~ NMR spectra were recorded at  90 MHz on 
Varian EM-390 or JEOL FX-9OQ instruments, or at  400 MHz on a JEOL 
JNM-GX 400. The NMR solvent was Me2SO-d6 unless otherwise noted, and 
chemical shifts are reported in parts per million downfield from internal 
standard MeqSi. High resolution Fast Atom Bombardment Mass Spectra 
(FABMS) and Electron Impact Mass Spectra (EIMS) were obtained from 
Midwest Center for Mass Spectrometry at  the University of Nebraska, at  
Lincoln. UV visible spectra were recorded on a Cary 219 spectrometer in the 
base line correction mode. Chromatography was carried out under positive 
air pressure using EM Science Kiesgel 60 (230-400 mesh). Reagent grade 
chemicals were used as received except for dimethyl formamide (DMF, 
Mallinckrodt), which was dried over 4A molecular sieves. P -  
Carbonato(trien)Co(III)perchlorate was purchased from Sigma. Non- 
aqueous reactions were carried out under Argon. 
4-Nitmpmle-2-carbovLic acid ethyl ester (1). 7 g of 4-nitropyrrole-2- 
carboxylic acid (48 mmol) was prepared by the published method (31) and 
added to 8 mL H2SO4 and 72 ml ethanol in a 250 mL round bottom flask. 
This solution was then refluxed for 8 h, cooled slowly to  O°C, and filtered. 
The filtered solid was recrystalized in MeOH. 6 g of ester 1 (32 mmol) was 
obtained in 60% yield. 1~ NMR (90 MHz) 6 7.76 (s, lH), 7.23 (s, lH), 4.33 (q, 
2H), 1.40 (t, 3H). EIMS calcd. for C7HgN204 (M+) 184.0848. Found 184.0843. 
2-bromoethylamine-t-butylcarbamate (2). A solution of 2- 
bromoethylamine hydrobromide (4.08 g, 20 mmol) and triethylamine (2.02 
g, 20 mmol) in 50% aqueous dioxane was stirred at RT for 1 h. The reaction 
mixture was treated with 0.95 eq. di-t-butyldicarbonate (Aldrich) and 
stirred until the solution became clear. After a mixture was stirred for 12 h, 
the solvent was removed in vacuo. The residue was dissolved in ether and 
washed 3 times with water. The ether solution was dried over MgS04 and 
evaporated to give 3.56 g of 2 (9 mmol, Y=75%) as a white solid. 1~ NMR 
(DMSO, 400 MHz) 6 5.2 (s, lH), 3.56 (t, 2H), 3.42 (t, 2H), 1.42 (s, 9H). EIMS 
calcd. for C7H14N02 (M+) 224.0114. Found 224.0116 
N-(2-f.butylcarbamatoethyl)-Q-nitrop~le2~arboxyli~ acid ethylester 
(3): A solution of 1 (1.72 g, 9.3 mmol), 2 (2.24 g , 10 mmol), 1 eq. NaI and 
potassium carbonate in 20 mL acetone was refluxed under argon for 48 h. 
The mixture was then filtered and the solvent was evaporated under 
reduced pressure. Chromatography on silica gel using 5% acetonitrile in 
dichloromethane gave 2.7 g of 3 (8.25 mmol) as a white solid. 1~ NMR 
(DMSO, 400 MHz) S 8.04 (s, lH), 7.41 (s, lH), 6.84 (t, lH), 4.41 (t, 2H), 4.26 (q, 
2H), 3.31 (m, 2H). 1.14 (m, 12H). EIMS calcd. for C14H21N306 (M+) 
327.1430. Found 327.1434. 
N-(2-t-butylcarbamatoethy1)-4-ni~2-c~~ a id (4). A solution of 3 
(1.6 g, 4.9 mmol) and NaOH (40 mg, 10 mmol) in aqueous ethanol was 
refluxed for 3 h then cooled to O°C and neutralized with 1N HC1 solution. 
The solvent was removed in vacuo, and the residue was chromatographed 
on silica gel using methanol affording 1.2 g of the acid 4 (4.01 mmol) as a 
solid. 1~ NMR (400 MHz) S 7.71 (s, lH), 7.14 (s, lH), 6.83 (s, lH), 4.46 (t, 2H), 
3.32 (m, 2H), 1.32 (s, 9H). EIMS calcd. for C12H17N306 (M+) 299.1117. 
Found 299.1123. 
N-methyl-Q-(N-(2-~buty1carbamatoethyl)-4ni~p~1e-2~arbo~de- 
1-pyrrole-2-carboxamide-N,N'-dimethylpropline (6). A solution of N- 
methyl-4-nitropyrrole-2-(N, N-dimethylpropy1amino)-carboxamide (5) (300 
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mg, 1.25 mmol) was prepared by the published method (27), in 10 mL DMF 
and was hydrogenated a t  atmospheric pressure and RT for 12 h using 40 
mg of PdC. The mixture was then filtered and treated with 1-HOBT (270 
mg, 2 mmol), DCC (270 mg, 1.3 mmol), and acid 4 (360 mg, 1.25 mmol). The 
mixture was stirred a t  RT under argon for 16 h, it was then filtered, and 
the solvent was distilled in vacuo. The residue was chromatographed on 
silica gel using 1% NH40H in MeOH to afford 450 mg of 6 (0.89 mmol) as a 
light yellow foam. 1~ NMR 6 10.21 (s, lH), 8.12 (t, lH), 8.00 (s, 1H), 7.62 (s, 
lH), 7.21 (s, lH), 6.90 (t, lH), 6.87 (s, lH), 4.42 (t, 2H), 3.83(s, 3H), 3.37(m, 
2H), 3.23(m, 2H), 2.23(t, 2H), 2.19(s, 6H), 1.60(m, 2H), 1.36 (s, 9H). FABMS 
calcd. for C23H36N706 (M+H+) 506.2727 Found 506.2734. 
N-methyl4-~-(2-t-buty1cabamatoethyl)4-~-methyl-4nitrop~1e-2- 
c a r b o d d e ] p ~ l e 2 ~ a r b o d d e ] p ~ l e - 2 - c a b o d d e - N ~ - ~ e t h y l -  
propylamine (7): A solution of 6 (260 mg, 0.54 mmol) in 10 mL DMF was 
hydrogenated using 40 mg of PdC under one atmosphere of H2 a t  RT for 12 
h. The mixture was filtered and treated with 1-HOBT (140 mg,1.04 mmol), 
DCC (120 mg, 0.58 mmol) and N-methyl-4-nitropyrrole-2-carboxylic acid 
(100 mg, 0.58 mmol). The mixture was stirred under argon a t  RT for 16 h. 
The solvent was distilled in vacuo. Chromatography on silica gel using 1% 
NH40H in MeOH afforded 270 mg of 7 (0.44 mrnol, Y=81%) as a beige solid. 
1~ NMR (400 MHz) 6 10.3 1 (s, lH), 9.97 (s, 1H),8.18 (s, 1H), 8.03 (t, lH), 7.6 1 
(s, lH), 7.28 (s, lH), 7.20 (s, lH), 7.03(s, IH), 6.85 (t. lH), 6.83 (s, lH), 4.36 (t, 
2H), 4.91 (s, 3H), 3.81 (s, 3H), 3.27 (m, 2H), 3.21 (m, 2H), 2.24 (t, 2H), 2.17 (s, 
6H), 1.61(m, 2H1, 1.38 (s, 9H). FABMS calcd. for C31H42Ng06 (M+H+) 




dimethylpropylamine (8). A solution of 7 (260 mg, 0.41 wnol) in 10 mL DMF 
was treated with 5% PdIC (40 mg), and hydrogenated under one 
atmosphere of Hz a t  RT for 20 h. This mixture was filtered and added to a 
stirred solution of AcOH (102 mg, 1.7 mmol) and carboxydiimidazole (CDI) 
(278 mg, 1.7 mmol) in 5 mL DMF. After stirring a t  RT for 16 h, the mixture 
was filtered, and the solvent was removed in vacuo. Chromatography on 
silica gel using 1% NH40H/MeOH afforded 250 mg of 8 (0.39 mmol) as a 
solid. 1~ NMR (DMS0,400 MHz) 6 9.92 (s, lH), 9.90 (s, lH), 9.82 (s, lH), 8.06 
(t, lH), 7.28 (s, lH), 7.21 (s, lH), 7.18 (s, lH), 7.09 (s, lH), 6.87 (t, lH), 6.85 (s, 
lH), 6.84 (s, lH), 4.32 (t, 2H), 3.85 (s, 3H), 3.82 (s, 3H), 3.26 (m, 2H), 2.23 (t, 
2H), 2.24 (t, 2H), 2.17 (s, 6H), 2.01 (s, 2H), 1.62 (m, 2H), 1.38 (s, 9H). FABMS 
calcd. for C31H43Ng06 (M+H+) 637.3336. Found 637.3339. 
N-methyl-4- ( N - ( 2 - a m i n o e t h y 1 ) - 4 - F J - m e t ; h  
bodde]-p~le-2carboxamide}pyrrole-2-carboxamide-N,N'-dimethyl- 
propylamine(9). A solution of 8 (220 mg, 0.36 mmol) in dichloromethane (2 
ml ) was stirred under argon a t  O°C. Trifluoroacetic acid (TFA) (1 mL) was 
added via syringe, and the mixture removed from the cooling bath and 
stirred a t  RT for 30 min. The product was precipitated with anhydrous 
ether (10 mL). The supernatant was decanted. The residue was 
chromatographed on silica gel using 5% NH40H in MeOH to give 170 mg of 
9 (0.33 mmol) as a white solid. 1~ NMR (400 MHz) 6 10.10 (s, lH), 9.94 (s. 
lH), 9.80 (s, lH), 8.04 (t, lH), 7.33 (s, lH), 7.21 (s, lH), 7.18 (s, lH), 7.04 (s, 
lH), 6.82 (s, lH), 6.80 (s, lH), 4.25 (t, 2H), 3.82 (s, 3H), 3.78 (s, 3H), 3.20 (m, 
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2H), 2.82 (t, 2H), 2.27 (t, 2H), 2.21 (s, 6H), 1.99 (s, 3H), 1.62 (m, 2H). FABMS 
calcd, for C26H38Ng04 (M+H+) 540.3046. Found 540.3050. 
Distamycin-M-histidine (10, P3-M-His). A solution of 9 (110 mg, 0.21 
mmol), 1-HOBT (54 mg, 0.4 mmol ), DCC (45 mg, 0.22 mmol), and 1-t-boc 
histidine (56 mg, 0.20 mmol) in 10 ml DMF was stirred under argon at RT 
for 12 h. The solvent was removed in vacuo, and the residue was 
chromatographed on silica gel using 1% NH40H in MeOH to afford 120 mg 
of a white solid product . The solid product was dissolved in 
dichloromethane (1 mL), cooled in an ice bath under argon, and treated 
with 0.5 mL TFA. The mixture was removed from the cooling bath and 
stirred for 1 h a t  RT. The product was precipitated with ether (4mL) and the 
supernatant was discarded. The residue was dissolved in 5 mL 7% NH40H 
in MeOH, then concentrated under reduced pressure. Chromatography on 
silica gel using 7% NH40H in MeOH afforded 60 mg of 10 (0.09 mmol). 1~ 
NMR (400 MHz) G 9.93 (s, lH), 9.91 (s, lH), 9.81 (s, 1H), 8.07 (t, 1H), 7.99 (t, 
lH), 7.49 (s, lH), 7.23 (s, lH), 7.20 (s, lH), 7.15 (s, lH), 7.09 (s, 1H),6.85 (s, 
lH), 6.82 (s, lH), 6.71 (s, lH), 4.34 (t, 2H), 3.79 (s, 3H), 3.78 (s, 3H), 3.45 (m, 
2H), 3.18 (m, 2H), 3.16 (m, 2H), 2.81 (d, lH), 2.49 (t, 2H), 2.20 (s, 6H), 2.04 (s, 
3H), 1.60 (m, 2H). FABMS calcd. for C32H45N1205 (M+H+) 677.3635. 
Found: 677.3637. 
Distamycin-GABA-histidine (12, P3-Ga-His): The compound 11 was 
prepared by the published method (32). A solution of 11 (110 mg, 0.2 mmol), 
DCC (45 mg, 0.22 mmol), HOBT (54 mg, 0.4 mmol), and 1-t-boc-histidine (56 
mg, 0.2 mmol) in DMF (10 ml) was stirred under argon at RT for 10 h. The 
solvent was removed in vacuo, and the residue was chromatographed on 
silica gel using 1% NH40H in MeOH to afford 110 mg of a light yellow solid. 
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The above product was dissolved in dichloromethane (1 mL) and stirred at 
0 C under argon. TFA (0.5 mL) was added via syringe, the mixture was 
removed from the cooling bath and stirred a t  RT for 1 h. The product was 
precipitated by adding ether (4 mL), and the supernatant decanted. The 
residue was dissolved in 3 mL 10 % NH40H in MeOH, concentrated at  
reduced pressure and chromatographed on silica gel using the same 
solvent to afford 60 mg of 12 (0.083 mmol, Y=83%) as a white solid. 1~ NMR 
(400 MHz) 6 9.90 (s, lH), 9.87 (s, lH), 9.84 (s, lH), 8.32 (t, lH), 8.06 (t, lH), 7,92 
(s, lH), 7.52 (s, 1H), 7.22 (s, lH), 7.17 (s, lH), 7.15 (s, lH), 7.01 (s, lH), 6.85 (s, 
lH), 6.78 (s, lH), 3.83 (s, 3H), 3.81 (s, 3H), 3.78 (s, 3H), 3.24 (m, 2H), 3.17 (m, 
2H), 2.84 (m, lH), 2.50 (m, 2H), 2.24 (m, 4H), 2.19 (s, 6H), 1.67 (m, 2H), 1.60 
(m, 2H). FABMS calcd. for C33H47N1205 (M+H+) 691.3792. Found 691.3789. 
6-methylpicolinic acid (13). A solution of 6-methylpyridine-2- 
carboxyaldehyde (10.2 g, 84 mmol, Aldrich) in water was vigorously stirred 
and heated to 60°C. The heating bath was removed and 30% 
hydrogenperoxide (11.2 mL) was added so as to maintain 50' C. The 
reaction mixture was allowed to sit overnight. The aqueous solution was 
washed twice with methylene chloride. The solvent was evaporated under 
reduced pressure and the residue was chromatographed on silica gel using 
ethylacetate to  afford 9 g of 13 (65 mmol, Y=77%). 1~ NMR (D20,90 MHz) 6 
8.5 (d, lH), 8.33 (t, lH), 8.00 (d, 1H). EIMS calcd. for C7H7N02 (M+) 137.0476 
Found 137.0466. 
6-methylpicolinic acid methylester (14). A solution of 13 (8 g, 58 mmol) 
in excess thionyl chloride (20 mL) was refluxed for 2 h. ,Then the thionyl 
chloride was removed under reduced pressure. The remaining residue was 
treated with 20 mL of methanol. After 1 h the solvent was removed in vacuo 
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and the residue distilled a t  95 C a t  0.1 torr to  afford 4.6 g of the ester 14 (42 
mmol, Y=72%). 1~ NMR (CDCl3,400 MHz) S 7.81 (d, lH), 7.67 (t, lH), 7.26 
(d, lH), 3.94 (s, 3H), 2.61 (s, 3H). FABMS calcd. for C8HgN02 (M+) 151.0633. 
Found 151.0633. 
6 - c a r x y d e h y d e p i c o c  acid methylester (15). A mixture of 14 (3.3 
g, 20 mmol) and 12 ( 5.08 g, 20 mrnol) was stirred a t  RT for 3 h. The reaction 
mixture was added dropwise to DMSO (7 mL) a t  130°C (27) . The reaction 
mixture was cooled to O°C and neutralized with 3 N sodium bicarbonate 
solution. The aqueous solution was extracted twice with ether, and the 
solvent was removed under reduced pressure. The resulting residue was 
chromatographed on silica gel using dichloromethane to  afford 1.70 g of 15 
(10.2 mmol). 1~ NMR (CDC13,400 MHz) S 10.20 (s, lH), 8.64 (d, lH), 8.15 (d, 
lH), 8.06 (q, lH), 4.07 (s, 3H). EIMS calcd. for C8H8N03 (M+) 166.0504. 
Found 166.0504. 
2-aminoethylamine-t-butylcarbamate (16). A solution of 1,2- 
diaminoethane (2.4 g, 40 mmol, Aldrich) and imidazol-t-butylcarbamate 
(6.7 g, 40 mmo1,Aldrich) in 20 mL of dried THF was stirred with a catalytic 
amount of NaOH a t  RT for 2 h. Then the solvent was removed under 
reduced pressure. The residue was chromatographed on silica gel using 
2% NH4OH in MeOH to  afford 1.6 g of 16 ( 10 mmol) as a beige liquid. 1~ 
NMR (90 MHz) G 5.7 (t, lH), 3.14 (m, 2H), 2.74 (m, 2H), 2.43 (s, 2H), 1.38 (s, 
9H). EIMS calcd. for C7H16N202 (M+) 160.1211. Found 160.1214. 
6-~-(2-t-buty1carbamatoethyl)aminomethy1]pi~olinic ac d methylester 
(17). A solution of 16 (1.66 g, 10 mmol) and 15 (1.6 g, 10 mmol) was stirred 
overnight in 50 mLof acetonitrile containing 10 g of 4A sieves. The mixture 
was filtered, and the solvent was distilled in vacuo. The remaining residue 
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was immediately dissolved in 50 ml of absolute ethanol and hydrogenated 
with 200 mg of 5% Pd/C a t  50 psi overnight. The solution was filtered and 
the solvent was removed under vacuo to give 2.6 g of 17 (8.4 mmol, Y=84%). 
1~ NMR (CDCl3 400 MHz) S 8.04 (d, lH), 7.80 (m, lH), 7.53 (d. lH), 4.07 (s, 
3H), 4.03 (s, 2H), 3.21 (m, 2H), 2.81 (m, 2H), 2.12 (s, lH), 1.42 (s, 9H). FABMS 
calcd. for C 15H24N304 (M+H+) 310.1766. Found 310.1763. 
&[~-2-trbuty~amatoethy1)benzylcarbamatoe~l]pi~0lini~ acid (18). 
The amine 17 (2.0 g, 6.5 mmol) was dissolved in methylene chloride. The 
solution was added to aqoeous NaOH (0.25 N) and treated a t  O°C with 
benzylchloroformate (1.9 mL, 10.7 mmol, Aldrich) After 1 h methylene 
chloride layer was dried and the solvent was removed under vacuo to give 
2.5 g of protected product (5.6 mmol, Y=86%). A solution of above product 
(1.5 g, 3.35 mmol) in 20 mL MeOH was treated with aqueous sodium 
hydroxide solution (2 N, 4 mL) and stirred for 3 h. The solution was 
neutralized with aqoeous 1 N HCl. the solvent was removed under reduced 
pressure to give the crude residue. The crude acid was passed through 
silica gel using methanol to  afford acid 18 (1.1 g, 2.62 mmol , Y=77%) 1~ 
NMR (DMSO, 400 MHz) G 12.2 (s, lH), 9.11 (t, 1H),7.92 (m, 2H), 7.59 (s, lH), 
7.38 (m, 3H), 7.21 (s, lH), 7.11 (s, lH), 6.90 (m, 2H), 5.14 (s, lH), 5.02 (s, lH), 
4.79 (m, lH), 4.61 (s, 2H), 3.19 (m. 4H), 3.12 (m, 2H), 1.31 (s, 9H). FABMS 
calcd. for C22H28N306 (M+H+) 430.1978. Found 430.1968 
Distamycin-N-PYML(19, P-PYML). A solution of 10 (50 mg, 0.073 
mmol), the acid 18 (30 mg, 0.073 mmol), DCC (16 mg, 0.08 mmol), and 1- 
HOBT (19 mg, 0.14 mmol) was stirred under argon a t  RT for 12 h. The 
reaction mixture was distilled i n  vac uo,  and the residue was 
chromatographed on silica gel using 1% NH40H in MeOH to afford 52 mg 
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of a white solid. 40 mg of the above product was dissolved in AcOH (4 mL) 
and a 32% HBrIAcOH solution (1 mL) was added dropwise. The reaction 
mixture was stirred under argon a t  RT for 8 h. The product was 
precipitated with ether (4 ml) and the supernatant discarded. The solid 
was dissolved in 15% NH40H in MeOH, then concentrated a t  reduced 
pressure. Chromatography using 15% NH4OH in MeOH afforded 20 mg of 
19 (0.023 mmol, Y=62%). 1~ NMR (400 MHz) 6 9.94 (s, 2H), 9.82 (s, lH), 8.93 
(m, lH), 8.28 (t, lH), 8.06 (t, lH), 7.84 (m, 2H), 7.56 (d, lH), 7.50 (s, lH), 7.21 
(s, lH), 7.17 (s, lH), 7.15 (s, 1H),7.07 (s, lH), 6.80 (s, lH), 6.76 (s, lH), 6.74 (s, 
1H), 4.66 (m, lH), 4.28 (t, 2H), 3.88 (s, 2H), 3.78 (s, 3H), 3.77 (s, 3H), 3.43 (m, 
2H), 3.20 (m, 2H), 3.00 (m, 2H), 2.81 (m, 2H), 2.68 (t, 2H), 2.21 (t, 2H), 2.17 (s, 
6H), 1.99 (s, 3H), 1.61 (m, 2H).FABMS calcd. for C42H56N1506 (M+H+) 
868.4694. Found 868,4650. UV(H20) h 306(e=34 200) 
Distamycin-M-EDTA(20, P3-M-EDTA). A solution of EDTA- 
triethylester (Group stock, 62 mg, 0.76 mmol) in 5 mL DMF was activated 
with 1.1 eq. of carboxydiimidazole (CDI) and stirred for 2 h. at  RT under 
argon. The mixture was taken up in a syringe and added to a solution of 9 
(40 mg, 0.77 mM) in DMF (3 mL). After stirring for 12 h under argon at 
RT, the solvent was removed in vacuo, and the residue was 
chromatographed using 1% NH40H in MeOH to give 50 mg of triester 
product as a beige foam. The triester product was dissolved in 60% 
aqueous methanol containing 10 mg LiOH, and stirred for 12 h under argon 
a t  RT. The solvent was evaporated in vacuo, and the residue was 
chromatographed using 2% NH40H in MeOH to affored 26 mg of 20 (0.033 
mmol) as a solid. 1~ NMR (CF300WDMSO,400 MHz) G 9.94 (s, 2H), 9.80 (s, 
lH), 9.20 (s, lH), 8.52 (t, lH), 8.20 (t, lH), 7.25 (s, lH), 7.20 (s, lH), 7.17 (s, 
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lH), 7.06 (s, lH), 6.86 (s, lH), 6.83 (s, lH), 4.38 (t, 2H), 4.01 (s, 2H), 3.80 (s, 
2H), 3,79 (s, 5H), 3.76 (s, 3H), 3.50 (s, 2H), 3.26 (s, 4H), 3.20 (s, 2H), 3.05 (m, 
2H), 2.81 (d, 6H), 1.98 (s, 3H), 1.84 (m, 2H). FABMS calcd. for 
C3@51N11011 (M+H+) 814.3836. Found 814.3841. W(H2O) h 308(e=33 000) 
Distamycin-W1,lO-phenanthroline(21, P3-M-PH). A solution of 9 (220 
mg, 0.42 mmol), 1,lO-phenanthroline-2-carboxylic acid (92 mg, 0.39 mmol), 
1-HOBT (122 mg, 0.9 mmol), and DCC (93 mg, 0.45 mmol) in 10 mL DMF 
was stirred under argon a t  RT for 12 h. The solvent was removed in vacuo. 
The residue was chromatographed on silica gel using 2% NH40H in MeOH 
to afford 290 mg of 21 (0.27 mmol, Y=64%) 1~ NMR (DMSO, 400 MHz) 6 9.91 
(s, 2H), 9.79 (s, lH), 9.13 (s, lH), 8.93 (d, lH), 8.69 (d, lH), 8.60 (d, lH), 8.33 (d, 
lH), 8.12 (m, 2H), 8.01 (t, lH), 7.83 (t, lH), 7.90-7.30 (m, 4H), 6.80 (s, lH), 6.73 
(s, lH), 4.47 (t, 2H), 3.83 (s, 3H), 3.70 (s, 3H), 3.18 (m, 4H), 2.21 (t, 2H), 2.16 
(s, 6H), 2.00 (s, 3H), 1.58 (m, 2H). FABMS. calcd. for C3gH44N1105 
(M+H+):746.4526. Found: 746.4520.W (ethanol) h=302(e= 34 200) 
Distamycin-GABA-l , lO-phe~throl in .e-2-de(22  P3-Ga-pH). 
A solution of 9 (550 mg, 0.84 mmol), l,10-phenanthroline-2-carboxylic acid 
(224 mg, 1 mmol), DCC (202 mg, 1 mmol), and 1-HOBT (270 mg, 2 mmol) in 
10 ml DMF was stirred a t  RT under argon for 12 h. The solvent was 
removed in vacuo, and the residue was chromatographed using 2% NH40H 
in MeOH to afford 400 mg of 22 as a solid. 1~ NMR (400 MHz) 6 9.82 (s, 3H), 
9.17 (d, lH), 8.92 (t, lH), 8.65 (d, lH), 8.57 (d, lH), 8.40 (d, lH), 8.06 (m, 2H), 
7.81 (q, lH), 7.23 (s, lH), 7.20 (s, lH), 7.18 (s, IH), 7.03 (s, lH), 6.83 (s, lH), 
6.80 (s, lH), 3.86 (s, 3H), 3.80 (s, 3H), 3.76 (s, 3H), 3.53 (m, 2H), 3.21 (m, 2H), 
2.38 (t, 2H), 2.23 (t, 2H), 2.19 (s, 6H), 1.94 (m, 2H), 1.63 (m, 2H). FABMS 
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calcd. for C40H45N1105 (M+H+) 760.3683. Found 760.3689. UV(ethano1) h 
303(~=34 200) 
DNA preparations and reactions. Doubly distilled water was used for 
all aqueous reactions and dilutions. pBR 322 plasmid DNA, from group 
stock, was used for reactions. Calf thymus (CT) DNA, from group stock, 
was purchased originally from Sigma and then sonicated, deproteinized, 
and dialyzed. Enzymes were purchased from Boehringer Mannheim or 
New England Biolabs. Gel scanning was performed at  633 nm using LKB 
Ultrascan densitometer Model XL. 
Cleavage of ende-labeled DNA restriction fragments: Preparation of 
specially end-labeled DNA restriction fragments began by cleaving 
superhelical pBR322 DNA with restriction endonuclease EcoRI. Linearized 
pBR322 DNA was labeled on the 3'-ends using 5'-[a-32~1dA~P (Amersham, 
3000Ci/mmol) in the presence of the Large (Klenow) fragment of DNA 
polymerase I (41). This procedure also included dTTP and dATP which 
were purchased from Phamarcia as 100 mM solutions. Removal of 5'- 
phosphate groups from linearized pBR322 with calf alkaline phosphatase 
was followed by treatment with 5 ' - [ y - 3 2 ~ ] d ~ ~ ~  (New England Nuclear, 
7000Cilm mol) in the presence of polynucleotide kinase which afforded 5'- 
end-labeled DNA. Digestion of both 3' and 5' end-labeled DNA with 
restriction endonuclease RsaI yielded 3'-and 5'-end-labeled restriction 
fragments of 167 and 517 nucleotides in length. These were isolated by 
preparative gel electrophoresis on a 2 mm thick, 5% 1:20 cross-linked 
polyacrylamide gel. The bands of DNA were visualized by autoradiograph, 
and were excised from the gel. The fragments were eluted into 1 ml buffer 
(500 mmol NH40Ac, 10 rnmol MgCl2, 1 mmol EDTA, 0.25% SDS), 
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microfiltered, extracted with phenol, dry butanol, and then ethanol 
precipitated several times before use. 
Fe(I1) complexes of each compound were made by mixing one 
equivalent of Fe(NH4)2 (SO4)2-6H2O with 19 and 20. DNA cleavage 
reactions with Fe(I1) in the presence of DTT and dioxygen were run in a 
total volume of 15 p1. For each reaction, 6 pL of a solution containing > 
10,000cpm of 3 2 ~  end-labeled restriction fragment, 1.5 pL of a 1mM (bp) CT 
DNA solution, 1.5 pL of 400 mM Tris150 mM NaOAC buffer (pH 7.9) (final 
concentrations; 100 mM CT DNA(bp), 40 mM Tris15 mM NaOAc). To the 
reaction mixture was added 3 pL of an appropriately diluted solution of 19 
Fe(I1) and 20. Fe(I1). After equilibriation for 30 minutes at 37OC, cleavage 
was initiated by the addition of 3 pL of 20 mM dithiothreitol (DTT, 
Beohringer Manheim) solution. Final concentrations were: CT DNA, 100 
pM bp; Tris base, 40 mM; NaOAc, 5 mM; DTT, 4 mM. The reactions were 
run for 40 minutes at  37 C, then frozen, lyophilized, and suspended in 5 pL 
of 10 mM Tris borate, 80% forrnamide solution. After heat denaturation 4 
pL of each sample were loaded onto a 0.4 mm thick, 40 cm long, 8% 1:20 
cross-linked polyacrilamide/50% urea gel and electrophoreised at 1200 V. 
Gels were then transferred to  chromatography paper (Whatman 3mm 
Chr), dried on a Bio-Rad Model 483 slab dryer, and autoradiographed at  - 
78°C using Kodak X-omat AR film with an intensifing screen. The DNA 
cleavage patterns were quantified by densitometry. The relative peak area 
for each site was equated to the relative cleavage efficiency at  that site. 
Sequence-specific cleavage of DNA by P3-M-His (10) and P3-Ga-His (12) 
in the presence of CuS04 (200 pM) was examined using the 167 base pair 
restriction fragment. DNA cleavage reactions with Cu(I1) were run in a 
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total volume of 30 pL. For each reaction, 12 pL of a solution containing 
>10,000 cpm of 3 2 ~  end-labeled restriction fragment, 3 pL of a lmM(bp) CT 
DNA solution, 3 pL of 400 mM Trid5O mM NaOAC buffer (pH 7.5, 8.5, and 
9.5) was treated with 12 pL of an appropriately diluted solution of 10 and 12. 
Final concentrations were: CT DNA, 100pM bp; Tris base, 40 mM; NaOAc, 
5mM; Cu(II), 20 pM. The reactions were run for 72 h a t  50' C, then frozen, 
lyophilized, and suspended in 5 ml of 10 mM Tris borate, 80% formamide 
solution. After heat denaturation 4 pL of each sample was loaded onto a 0.4 
mm thick, 40 cm long, 8% 1:20 cross linked polyacrylamide/50% urea gel 
and electrophoreised a t  1200 V. Gels were then transferred t o  
chromatography paper (Whatman 0.3 mm Chr), dried on a Bio-Rad Model 
483 slab Dryer, and autoradiographed at  -78 C using Kodak X-omat AR 
film. The DNA cleavage patterns were quantified by densitometry. The 
relative peak area for each site was equated to the relative cleavage 
efficiency at  that site. Footprinting of DNA by MPE.Fe(I1) for compound 12 
in the prescence of DTT and dioxygen was also examined by using the 167 
base pair restriction fragment. P3-Ga-His(l2) was allowed to equilibriate 
with DNA restriction fragments at  RT for 0.5 h before MPEaFe(I1) was 
added. MPEaFe(I1) was allowed to equilibriate with the DNA-P3-Ga-His 
(12) mixtures for 15 min at 37'C before the reaction was initiated by addition 
of DTT. After reaction for 12 min at  37'C, the samples were frozen, 
lyophilized, suspended in formamide buffer, heat denatured and loaded. 
Sequence-specific cleavage of DNA by 21 and 23 in the presence of UV 
light and P-carbonato(trien)Co(III)perchlorate complex was also examined 
using the 167 base pair restriction fragment. Photo-induced DNA cleavage 
reactions were run in a total volume of 30 pL. For each reaction, 15 pL of a 
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solution containing > 2000 cpm of 32~-end  labeled restriction fragments 
was used. Final concentrations were: 100 pmol CT DNA (bp), 10 mmol 
sodium cacodalate, appropriately diluted 21 and 23 and 1 equivalent P- 
carbonato(trien)Co(III)perchlorate. A range of concentrations of each 
molecule was allowed to equilibrate with the DNA restriction fragment for 
0.5 h at  room temperature before the reaction was initiated by UV light (366 
nm) using a Model UVGI-58 ( UVP Inc., 115 volts, 60 Hz, and 0.16 AMPS). 
The reaction were photolyzed for 3 h a t  room temperature, then frozen, 
lyophilized, and resuspended in 5 pL of 100 mmol Tris borate, 80% 
formamide solution and then the gel run and developed the same as above. 
The cleavage reactions of DNA by bleomycin~Co(III) were done using the 
same conditions a s  above i n  t he  absence of P -  
carbonato(trien)Co(III)perchlorate. 
Footprinting of DNA by MPE.Fe(I1) for compound 23 in the presence of 
DTT and dioxygen was also examined by using the 167 base pair restriction 
fragment. A range of P3-Ga-PH (23) was allowed to  equilibriate with DNA 
restriction fragments a t  RT for 0.5 h before MPE*Fe(II) was added. MPE 
-Fe(II) was allowed to equilibriate with the DNA-P3-Ga-PH mixtures for 15 
min a t  37OC. Then the reaction was initiated by addition of DTT. After 
reaction for 12 min a t  37OC, the samples were frozen, lyophilized, 
suspended in formamide buffer, heat denatured and loaded. 
Preparations of oligonucleotides. Oligonucleotides 24 and 25 were 
synthesized with a Beckman Oligonucleotide Synthesizer. Synthesized 
oligonucleotides were dried in vacuo, transferred to  a vial, and 1 ml 
ammonium hydroxide was added to the vials t o  remove the 
oligonucleotides from the solid support. After 2 h, the supernatant was 
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transfered into a screw capped eppendorf tube, and the solvent was 
removed with dry argon. Concentrated NH40H (1 ml) was added to the 
eppendorf tube and the tubes allowed to stand at  55°C. 24 h latert the solvent 
was removed by lyophilization. The remaining solid was suspended in 250 
pl of pH 8.3, 100 mM Tris-borate, 80% formamide loading buffer and loaded 
onto five lanes of a 2 mm thick, 20% 1:20 cross-linked polyacrilamide/40% 
urea denatured gel and electrophoresed at  550 V for 24 h. The band of 
desired oligonucleotide was visualized under UV light and excised from the 
gel. The oligonucleotides were eluted into a solution of 1.5 M NaC1, 1 mM 
EDTA, microfiltered and dialyzed against doubly distilled water for 72 h. 
Preparation of end-labeled 27 base pair oligonucleotide. The two 
strands were mixed in 20 mM Tris HC1, pH 7.4, 50 mM NaCl, heated to 95' 
C for 5 minutes, and cooled slowly to  RT. The resulting double-stranded 
oligonucleotide was ethanol precipitated, and labeled on the 3'-end using 5'- 
a - 3 2 ~  dCTP (Amersham, 3000Ci/mmol) in the presence of the large 
(Klenow) fragment DNA polymerase I, and 3'-labeled oligonucleotide was 
isolated by preparative gel electrophoresis on a 2 mm thick, 15% 1:20 cross- 
linked polyacrylamide gel. The band of labeled DNA was visualized with 
autoradiography using Kodak X-omat AR film, and was excised from the 
gel. The oligonucleotide was eluted into 1 mL of buffer (500 mM NH40Ac, 10 
mM MgCl2 1 mM EDTA, 0.25% SDS), microfiltered, extracted with phenol 
and butanol, and dialyzed for 24 h before use. For 5' end-labeled 27 base 
pair oligonucleotide, a single stranded oligonucleotide was labeled on 5'- 
end using [ ~ - ~ ~ P I ~ A T P  in the presence of polynucleotide kinase. The labeled 
strand was hybridized as before. After hybridization, the 3'-end was filled 
using dATP,dTTP, dGTP, and dCTP in the presence of DNA polymerase I. 
#Xi 
Cleavage of 3' and 5' end-labeled 27 base pair DNA. Oligonucleotide 
cleavage reactions were run in a total volume of 30 pL. Each reaction 
contained 20,000 cpm of 3 2 ~  end-labeled oligonucleotide, 100 pM (bp) cold 
oligonucleotide which has same sequence, 10 mM sodium cocodalate, 25 
pM P-carbonato(trien)Co(III)perchlorate complexes, and 5 pM compound 
23. Photocleavage reactions were conducted as described for the 167 base 
pair fragment. After reaction, the samples were frozen, lyophilized, and 
resuspended in 5 pLof lOOmM tris borate (pH 8.30), 80% formamide 
solution. After heat denaturation at  90°C, 4 pL of each sample was loaded 
onto a 0.4 mm thick, 40 cm long, 20% 1:20 cross-linked polyacrylamide/40% 
urea denatured gel and electrophoresed at 1500 V. The gel was covered with 
saran wrap and autoradiographed at -78OC using Kodak X-omat AR film. 
Analysis of termini by gel electrophoresis. The presence of phosphate 
groups on the 5'-termini of the cleavage site was tested by using calf 
intestine alkaline phosphotase (CAP). Degraded DNA was ethanol 
precipitated, dissolved in 20 pL of 40 mM Tris-HC1 (pH 7.8), mM NaOAc and 
heat denatured a t  90°C for 5 min. 1 pL of CAP(12 dpL)  was added and 
incubated at 37OC for 1 h. The reaction was terminated by ethanol 
precipitation and taken up in loading buffer for gel electrophoresis. The 
nature of the 3'-termini was examined by using Tq polynucleotide kinase to 
remove 3'-phosphate groups (30). DNA derived from the cleavage reaction 
was ethanol precipitated. The pellet was dissolved in 20 pL of H20, heat 
denatured a t  90°C for five min and chilled on ice. 20 pL of a buffer 
containing 20 mM Tris-HC1, pH 6.6, 20 mM magnesium chloride, and 10 
mM P-mercaptoethanol was added followed by 0.5 pL of T4 polynucleotide 
kinase (19 units/pL). The reaction was incubated at  37OC for 1 h and ethanol 
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precipitated. The DNA derived from the cleavage reaction was suspended 
in 5 WL of a pH 8.3,100 mM Tris-Borate, 80% formamide loading buffer and 
heat denatured at  90°C for 2 min. The samples were loaded onto a 0.4 mm 
thick, 40 cm long, 20% polyacrilamide, 1:20 cross-linked, 40 % urea gel and 
electrophoresed a t  1500 V until the bromophenol blue tracking dye had 
moved 30 cm. Autoradiography was carried out at  -78OC on Kodak X-omat 
AR film. 
Refemces and notes. 
1) Saenger, W.; in " Principles of Nucleic Acid Structure", edited by, Cantor, 
C. R.; Springer-Verlag, New York Inc (1984). 
2) a) Drew, H. R.; Wing, R. M.; Takano, T.; Broka, C.; Tanaka, S.; Itakura, 
K.; Dickerson, R. E. Proc. Natl. Acad. Sci. U. S. A. 1981,  78, 2179. b) 
Dickerson, R. E.; Drew, H. R. J. Mol. Biol. 1981,149, 761. 
3) Zimmer, C.; Wahnert, U. Prog. Biophys. Mol. Biol. 1986,47, 31. 
4) Neidle, S.; Pearl, L. H.; Skelly, J. V. Biochem. J. 1987,243,l. 
5) Neidle, S. R. CRC Crit. Rev. Biochem. 1984,17, 73. 
6) Berman, H. M.; Neidle, S.; Zimmer, C.; Thrum, H. Biochim. Biophys. 
Acta. 1979,561, 124. 
7) Kopka, M. L.; Yoon, C.; Goodsell, D.; Pjura, P.; Dickerson, R. E. Proc. 
Natl. Acad. Sci. U. S. A. 1985.82, 1376. 
8) Kopka, M. L.; Yoon, C.; Goodsell, D.; Pjura, P.; Dickerson, R. E. J. Mol. 
Biol. 1985,183,553. 
9) Coll, M.; Fredrick, C.; Wang, AH.-J.; Rich, A. Proc. Natl. Acad. Sci. U. 
S. A. 1987,84,8385. 
10) Goodsell, D.; Dickerson, R. E.J. Med. Chem. 1986,29, 727. 
11) Patel, D. J.; Shapiro, L.; Hare, D. Biopolymers 1986,25,693. 
12) Patel, D. J.; Shapiro, L. J Biol. Chem. 1986,261, 1230. 
13) Klevitt, R. E.; Wemmer, D. E.; Reid, B. R. Biochemistry 1986,25, 3296. 
14) Halford, S. E. Trends Biochem. Sci. 1983,8,455. 
15) Stubbe, J.; Kozarich, J. W. Chem. Rev. 1987,87,1107. 
16) a) Goldberg, I, H.; "Free radicals in Biology and Medicine 1987,3, 41. b) 
Chin, D. H.; Zeng, C. H.; Costello, C. E.; Goldberg, J. H. Biochemistry 1988, 
27,8106. 
209 
17) Kozarich, J .  W.; Worth, L.; Frank, B. L.; Christner, D. F.; Vanderwall, 
D. E.; Stubbe, J. Science 1989,245,1396. 
18) Schultz, P. G.; Dervan, P. B. Proc. Natl. Acad. Sci. U. S. A. 1983, 80, 
6834. 
19) Schultz, P. G.; Dervan, P. B. Tetrahedron 1984,40,457. 
20) Griffin, J. H.; Dervan, P. B. J. Amer. Chem. Soc. 1987,109, 6840. 
21) Sluka, J. P.; Horvath, S. J.; Bruist, M. F.; Simon, M. I.; Dervan, P. B. 
Science 1987,238,1129. 
22) Moser, H. E.; Dervan, P. B. Science 1987,238,645. 
23) Chen, C-H. B.; Sigman, D. S. Science 1987,237, 1197. 
24) Muller, B. C.; Raphael, A. L.; Barton, J. K. Proc. Natl. Acad. Sci. U. S. 
A 1987,84,1764. 
25) a) Miller, S. M.; Klinman, J .  P. Biochemistry 1985,24, 2114. b) Brenner, 
M. C.; Klinman, J. P. Biochemistry 1989,28, 4664. 
26) Org. Syn. Coll. Vol. IV, p. 944. 
27) Sluka, J .  P. Ph.D. Thesis, Caltech, Pasadena, California, 1988. 
28) Taylor, J. S. unpublished results. 
29) Maxam, A. M.; Gilbert, W. Methods Enzymol. 1980,65,499. 
30) Hertzberg, R. P., Ph. D. Thesis, Caltech, Pasadena, California, 1984. 
31) Sigman, D. S. Acc. Chem. Res. 1986,19, 180. 
32) Zein, N. Sinha, A. M.; McGahren, W. J.; Ellestad, G. A. Science 1988, 
240,1198. 
33) Sugiyama, H.; Xu, C.; Murugesan, N.; Hecht, S. M. J. Amer. Cherm. 
Soc. 1985,107,4104. 
34) Povirk, L. F.; Houlgrave, C. W.; Han, Y.-H. J. Biol. Chem. 1988,263, 
19263 and references therein. 
210 
35) Chang, C.-H.; Mears, C. F. Biochemistry 1982,21, 6332. 
36) Klein, F. D.; Moeller, C. W. Inorg. Chem. 1965,4, 394. 
37) Malone, S. D.; Endicott, J. F. J. Phys. Chem. 1973, 76,2223. 
38) Kurtz, J. L.; Burce, G. L.; Margerum, D. W. Inorganic Chemistry 1978, 
17,2454. 
39) Reddy, K. V.; Jin, S-J.; Arora, P. K.; Sfeir, D. S.; Malony, S. S. C.; 
Urbach, F. L.; Sayre, L. M. J. Amer. Chem. Soc. 1990,112, 2332. 
